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1. General Characteristics of Dengue
Dengue virus (DENV) belongs to the Flavivirus genus of the family Flaviviridae 
together with yellow fever virus, West Nile virus and Japanese encephalitis virus1. It is 
transmitted by the bite of the female mosquito of the Aedes genus, of which A. aegypti is 
the main vector, followed by A. albopictus2. There are four different serotypes of DENV 
called DENV-1 to DENV-4. 
Infection by DENV can be asymptomatic or result in a variety of clinical manifestations 
ranging from comparatively mild dengue fever (DF) to severe disease such as dengue 
haemorrhagic fever (DHF) and dengue shock syndrome (DSS)3,4. 
Dengue viruses (DENVs) are present in the tropical and sub-tropical areas of the 
world and are endemic in more than 120 countries within Africa, America, Eastern 
Mediterranean, Asia, Australia, islands within the Indian Ocean, central and south 
Pacific and the Caribbean4. The average number of DF/DHF cases reported by the 
World Health Organization (WHO) has increased considerably in the past decades and 
dengue is expanding to new areas5. Recently, dengue outbreaks occurred in European 
countries including France, Croatia and Portugal (Madeira)6. Currently, it is estimated 
that 390 million dengue infections occur annually worldwide, including both symptomatic 
and asymptomatic cases7. Some of the reasons for the expansion of dengue are 
discussed below.  
2. Factors Related to the Increase of Dengue Incidence
2.1. Uncontrolled Urbanization
In recent years, a considerable exodus from rural to urban areas of people looking 
for better economic conditions has taken place in tropical and sub-tropical countries8. As 
a consequence, an increase in population density in urban areas and the establishment 
of new, largely uncontrolled, urbanization has occurred9. Irregular water supply and 
the lack of trash collection are some of the principal characteristics of this unplanned 
urbanization8,9. 
The storage of water in containers and an increased use of non-biodegradable 
plastics that are left outdoors make appropriate mosquito breeding sites close to domestic 
areas10,11. A. aegypti is a domesticated mosquito with a fly range of approximately 100m 
in urban areas12. The mosquito feeds more than once in each gonotrophic cycle13. 
Because A. aegypti is very sensitive to movement, it interrupts its feeding several times 
and tries to take bloodmeals from the same or different individuals until its meal is 
completed10. The high population density is a risk factor for dengue infections due the 
short flying distance that the mosquito covers in order to take bloodmeals from one or 
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several individuals14.
2.2. Spread of the Dengue Viruses
A boost in international tourism contributed to the globalization of the four dengue 
serotypes15. The number of international air passengers has increased 40 times 
between 1950 and 201116. International movement of dengue-infected individuals is 
one of the main reasons of the global transmission of the disease8. Increased travel 
from Latin America to the USA and from Asia to Europe represents a major risk for 
dengue importation according to a geo-spatial model of the transmission of the disease 
by infected air passengers17.
2.3. Spread of the Dengue Vector
The introduction of A. aegypti to Asia and the Americas probably occurred from 
Africa, where dengue outbreaks were reported among passengers traveling by ship18. 
Recently, the presence of A. aegypti and A. albopictus larvae/eggs has been reported 
in Europe. These early stages of the mosquitos have been found in used car tires and 
lucky bamboo plants transported by cargo ship from the USA and Asia to Europe19,20. 
Globalization has allowed the spread of the mosquito through international transport. 
2.4. Inefficient Vector Control
In 1947, PAHO organized a plan to eradicate the vector of yellow fever virus (A. 
aegypti) from the Americas21-23. This plan, vertically established, mainly involved 
elimination of the mosquito larvae and the monitoring of larvae density3,24. In addition, 
adult mosquitoes were eliminated through outdoor fumigations using insecticide 
with residual activity such as DDT3,21. A aegypti was eliminated from 17 countries of 
South and Central America25. However, this campaign gradually deteriorated and was 
discontinued in the early 1970s without complete mosquito eradication from Cuba, the 
USA, Venezuela and other Caribbean countries26. 
One of the reasons for the weakening of the campaign was the declaration that the 
“war against yellow fever” had been won and the consequent re-direction of resources 
to the control of other diseases22. Another reason was the development of resistance 
to DDT and other organochlorine insecticides by the mosquito26. As a consequence, A. 
aegypti re-emerged in several countries producing new dengue epidemics21,25. 
In 1994, PAHO decided to abandon the concept of mosquito eradication. Instead, 
the limited resources were used to reduce the vector to levels of low importance to the 
health sector12. Within this new plan, strategies of prevention and control were developed 
in five key areas: 1) active disease surveillance, involving clinical and laboratory-based 
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dengue surveillance for early detection of epidemics; 2) rapid response in an emergency 
for efficient mosquito control; 3) contingency plan to hospitalize large numbers of 
patients with DHF; 4) medical education in clinical diagnosis and management of DHF 
patients and 5) involvement and integration of the community into mosquito control27-29. 
The impact of this plan on dengue incidence is still under evaluation.  
3. Cell Biology and Immunology
3.1. Dengue Virus: Structure and Replication
Dengue virus is an enveloped virus with a positive-sense, single-stranded RNA 
genome.  The RNA spans approximately 10.1 kb which is translated into three structural 
proteins (capsid C, membrane precursor prM and envelop E) and seven non-structural 
proteins (NS1, NS2A, NS2B, NS3, NS4A, NS4B and NS5)30 (Figure 1). The nucleocapsid 
is formed by a single copy of the RNA genome complexed to multiple copies of the C 
protein31. The nucleocapsid is surrounded by a lipid bilayer in which 180 M proteins and 
180 E proteins are anchored32,33. The M protein is formed after the cleavage of the ‘pr’ 
portion from the prM protein by a cellular protease (furin) during the process of virus 
secretion34. The glycoprotein E is dimeric and is positioned parallel to the lipid bilayer. 
Each monomer consists of three domains. Domain I is the central domain that binds to 
both domains II and III. Domain II is dimeric and is related to virus-cell fusion activity. 
Domain III, has binding sites to cellular receptors and Ig antibodies (immunoglobulin)30,35. 
The non-structural NS1 glycoprotein can be found inside the cell, on the cell surface 
or can be secreted outside the infected cell36. NS1 has immunological importance and 
circulates in the blood from the first day of fever onset until day 9 when usually the 
disease is over37,38. Therefore, NS1 antigen has been used for the early detection of 
dengue infection39. 
Figure 1. Representation of dengue virus genome. The single-strand of RNA encode three structural 
proteins, the capsid protein (C), the pre-membrane (prM) and membrane (M) protein and the envelop protein 
(E), and seven non-structural proteins mainly involved in viral replication.  Adapted from Guzman et al., 20105.
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The main mechanism of DENV cell entry is clathrin-mediated endocytosis40. 
However, depending upon the serotype and target cell, the virus is able to use alternative 
internalization routes, consisting of caveolae and lipid rafts41. Principal target cells 
for DENV infection are monocytes, macrophages and dendritic cells42. Viral particles 
spread along the cellular surface and roll over different receptors for the E glycoprotein 
until they find pre-existing clathrin-coated pits43,44. Clathrin-coated pits evolve until they 
become clathrin-coated vesicles. These vesicles deliver their cargo to endosomes45. 
It is well established that the mildly acidic pH within the endosomal lumen produces 
a major conformational change in the E protein allowing the fusion loop of domain II 
to be exposed46. The highly hydrophobic fusion loop is subsequently inserted into the 
endosomal target membrane allowing the formation of an E trimer. This E trimer is 
necessary for the formation of a lipidic fusion pore and release of the genome into the 
cell cytosol47. 
As indicated above, the positive-sense RNA genome is translated into a single 
polyprotein which is processed by the host and viral proteases. Viral assembly is 
performed in the endoplasmic reticulum where particles with prM on their surface are 
formed. These immature particles are then transported to the trans-Golgi network where 
conformational changes on the viral surfaces occur within a mildly acidic environment 
during which the prM protein protects E from undergoing a premature conformational 
change48,49. Subsequently, the host protease furin cleaves the prM into M and “pr” 
peptides. When the viral particles are released from the cell, the change to neutral 
pH produces the dissociation of the “pr” peptide from the viral surface and infectious 
mature particles are formed50,51.
3.2. The Immune Response to DENV Infection
In a primary DENV infection, naïve DENV-specific B cells are selected and 
stimulated. These cells then differentiate into memory B cells and plasma cells (PCs). 
There are two types of PCs, short-lived PCs and long-lived PCs. Both of these PCs 
are able to secrete antigen-specific antibodies52. The short-lived PCs produce IgM 
antibodies in the acute phase of the disease (4-5 days after fever onset, Figure 2) 
which remain detectable for approximately 6 months52,53. The long-lived PCs migrate 
to the bone marrow where affinity maturation takes place. Here, only those clones with 
specific high-affinity antibodies survive for a long time54. These clones produce high 
concentrations of antigen-specific IgG antibodies (mainly IgG1 and IgG3)52,55,56. This 
antigen-specific IgG appears one week after the fever onset with a maximum production 
during the convalescent phase. Then, IgG concentrations decrease until levels that 
remain detectable for a long time57.
In case of a secondary DENV infection by a heterologous dengue serotype, the 
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IgM response is variable and sometimes not detectable57. The memory B cells with 
homologous serotype-specific antibodies retained on their surface are rapidly activated. 
These memory B cells cross-react with the heterologous serotype58. The long-lived PCs 
produce IgG with high homologous serotype affinity, but cross-reacting and weakly 
neutralizing antibodies to the heterologous dengue serotype56,58. IgG antibodies that 
are specific for the heterologous dengue serotype are produced three months post-
infection56.
Figure 2. Antibody production during a primary and secondary dengue infection. In a primary dengue 
infection, IgM antibodies (—) can be detected since day 4-5 after fever onset and remained detectable for 
three months. IgG levels (----) can be detected a week after fever onset and remain detectable for long period 
of time. In a secondary infection with a heterologous dengue serotype, the IgM level is low and sometimes 
undetectable. IgG levels are higher than in a primary infection. Adapted from Peeling et al., 201039.
4. Clinical Manifestations and Dengue Classification
4.1. Clinical Manifestations of DENV Infection
The majority of DENV infections are considered to be asymptomatic24. However, 
when the infections are symptomatic, after an incubation time of 3-8 days59, the 
symptomatology of dengue begins with a sudden onset of fever that lasts 2-7 days 
and is frequently accompanied by myalgia, arthralgia, anorexia, headache, retro-ocular 
pain, rash and nausea60,61. During this febrile period, mild haemorrhagic manifestations 
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like petechiae and bruising at the venepuncture sites can also be present4. Laboratory 
tests show mild to moderate thrombocytopenia, leukopenia and moderate increase 
of hepatic aminotransferase levels62. The critical phase starts 24h-48h after the fever 
recedes. A small proportion of patients may develop increased vascular permeability, 
demonstrated by haemoconcentration, pleural leakage and ascites63. When the loss of 
plasma volume is critic, the pulse pressure narrows (≤ 20mmHg) and the patient can 
develop shock. To avoid shock, medical doctors must be alert to warning signs like 
persistent vomiting, severe abdominal pain, hepatomegaly, high levels of haematocrit 
or increased levels of haematocrit accompanied by a quick decrease in platelet levels, 
mucosal bleeding, lethargy or restlessness in order to give appropriate and timely 
treatment62. In the recovery phase, a gradual reabsorption of extravascular fluid occurs 
after 48-72. A second rash may appear with itchy lesions and adults can present with 
fatigue for several weeks4.
4.2. Dengue Classification
Initially, dengue was classified as DF, DHF (grade I,II) and DSS (DHF grade III and 
IV)3. This classification has been widely criticized, because it was too rigid. Patients with 
suspected DHF had to meet all four criteria (fever for 2-7 days, positive tourniquet test or 
spontaneous bleeding, platelets level ≤ 100 x 109 per litre, plasma leakage determined 
by changes of haematocrit levels and/or pleural effusion) frequently resulting in the 
inappropriate and delayed categorization of patients with severe dengue62,64,65. Several 
countries started to develop local adaptations of the 1997 dengue classification66,67. 
Therefore, epidemiological comparisons between counties became almost impossible68. 
Currently, WHO has proposed a new classification for dengue disease as follows: 
a) dengue with or without warning signs and b) severe dengue (defined as severe 
plasma leakage or severe bleeding or severe organ involvement)4 (Figure 3).  The main 
objectives of this new dengue classification are the timely identification of severe cases 
or potential severe cases for the proper management of the patient and, to use the 
limited resources for those that really need them68. Currently, this new classification is 
under evaluation in more than 12 countries of Asia and America68.   
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Figure 3. Dengue classification according to the World Health Organization guideline (2009).  Dengue 
is classified as: a) Dengue without warning signs, b) Dengue with warning signs and c) severe Dengue. 
Adapted from WHO, 20094.
4.3. Dengue Versus Other Febrile Illness
At the beginning of dengue illness, the patient presents with non-specific symptoms 
such as fever, headache, myalgia, arthralgia, retroocular pain, nausea, vomiting and 
rash. These symptoms can be easily confused with other febrile illnesses like influenza, 
leptospirosis, malaria, rickettsiosis, typhoid fever or chikungunya infection among 
others69-72. Up to now, there are no accepted guidelines for the early recognition of 
dengue infection73. Several clinical, haematological and biochemical parameters have 
been proposed to discriminate dengue from other febrile illnesses (OFI) at the early stage 
of the disease. The presence of rash, myalgia and mild haemorrhagic manifestations 
have been the most common clinical manifestations associated with dengue73-77. The 
mild haemorrhagic manifestations have been mainly represented by the presence 
of petechiae and positive tourniquet test. Among the haematological parameters, a 
majority of studies has reported a decrease of platelet counts, white blood cells and 
lymphocytes in dengue patients compared to OFI77-79. Indications of liver damage have 
been determined by biochemical parameters. Increased levels of transaminases, such 
as aspartate aminotransferase and alanine aminotransferase, have been associated 
with dengue patients73,77,80,81.
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4.4. Risk Factors for Severe Dengue
Dengue severity is related to multiple risk factors such as secondary infection, viral 
virulence and ethnic background of the patient. Epidemiological evidence has shown that 
a secondary infection is a risk factor for severe dengue2,60. A widely accepted explanation 
for this phenomenon is the hypothesis of “antibody-dependent enhancement” (ADE) of 
disease proposed by Halstead60.  People infected by one dengue serotype produce 
a lifelong protective antibody response to the homologous serotype and a short-
lived (2-3 months) cross protection to heterologous serotypes82. After this period, the 
concentration of the non-specific antibodies starts to wane to sub-neutralising levels. 
These antibodies cross-react with heterologous serotypes facilitating the cellular uptake 
of the virus through Fc receptors82,83.  
Recently, prM-mediated ADE has also been proposed84,85. This hypothesis postulates 
that antibodies against the viral prM protein can potentially produce ADE. Cells 
infected by DENV release high levels of immature particles containing prM protein86. 
In a primary infection, antibodies directed against prM are being produced. These anti-
prM antibodies are highly cross-reactive between the different dengue serotypes and 
are non-neutralizing even at high concentrations84. In an infection with a heterologous 
serotype, anti-prM antibodies facilitate the binding and cell entry of immature particles 
into Fc-receptor-expressing cells85.  In either case, the consequence of ADE is a high 
viral load due to an increased number of infected cells87. A high viral load and the slow 
rate of viral clearance have been associated with severe dengue, resulting in immune 
activation for a prolonged period of time88. It has been postulated that a large mass of 
infected cells release high levels of cytokines and vasoactive mediators that increase 
vascular permeability59. 
Although, severe dengue is more likely to occur in secondary infections, only a small 
proportion of secondary infections results in severe dengue89. Moreover, the fact that 
severe dengue has also been observed in primary infections89,90, indicates that, besides 
ADE, other unknown factors related to the host and/or virus are also involved in the 
evolution of severe disease. There is epidemiological evidence that relate some dengue 
genotypes with dengue epidemics and a higher proportion of cases of severe dengue 
(viral virulence)91-93. A higher proportion of individuals infected with DENV-2 Asian 
genotype and DENV-3 genotype III develop severe dengue compared to those infected 
with DENV-2 American genotype and DENV-3 genotype V, respectively91,94. 
In addition, it has been described that ethnicity is a risk factor for severe dengue. 
Sporadic DHF cases have been reported in Haiti despite the co-circulation of different 
dengue serotypes95. Caucasian and Asian individuals have a higher risk to develop 
severe dengue compared to those of African descent. This fact is evidenced by the low 
incidence of severe dengue in black populations of Cuba96. White Cubans generally 
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exhibit a stronger and remarkably cross-reactive dengue virus-specific memory CD4+ T 
lymphocyte proliferation and interferon gamma (IFN-γ) release compared to the black 
Cuban population97. IFN-γ indirectly induces plasma leakage by enhancing tumour 
necrosis factor (TNF-α) production in activated monocytes98. 
5. Health-Seeking Behaviour 
A significant association between the delay of healthcare seeking and DHF has 
been found99. Health or care seeking behaviour (HSB) has been defined by Kasl and 
Cobb’s in 1966 as “any activity undertaken by individuals who perceive themselves to 
have a health problem or to be ill for the purpose of finding an appropriate remedy”100. 
According to Tipping & Segall (1995)101, HSB could be addressed in two ways:
a) Healthcare-seeking behaviour or utilization of the formal system: mainly focused 
on the analysis of barriers to care that lie between patients and services, and the 
process of healthcare seeking. The latter involves the identification of pathways 
(from home-care to the formal system) to the formal healthcare system102. 
b) Health-seeking behaviour or process to illness: has a general point of view 
and varies according to the disease. The perception of the illness severity, the 
perception of susceptibility to the disease, perceived benefits of taking health 
action and perceived barriers to taking health action are the four main elements 
of individuals’ health behaviour according to the health belief model102.
Few studies on HSB have been performed in case of dengue. Most of them have 
been done in Asia. Symptoms recognition by caretakers and patients, the perception 
about the quality of care, social-economic factors, individual perception of the illness 
and previous experiences are factors that influence health-seeking behaviour103-105.
Probably due to the high proportion of DF in endemic areas, dengue is considered 
a harmless disease that can be treated at home with traditional medical practices, self-
medication and rest103-105. The perception of low susceptibility to infection among young 
adults and elderly in Malaysia is mainly due to the notion of a “natural ability to withstand 
infection” and the perception of low risk to be bitten by the mosquito, respectively104. 
Only when traditional medical practices or drugs fail to bring relief or when the health 
is perceived as declining, caretakers and patients decide to seek healthcare in health 
centres or by a formal practitioner; this normally occurs only after the third day of the 
onset of symptoms105. 
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6. Dengue in Venezuela
6.1. History of Dengue Epidemics in Venezuela
Although the first description of dengue-like illness in the Americas dates from 
1634106, the first reports of such disease in Venezuela go back to 1828 and then to 
1946107. However, these reports were only based on clinical manifestations. It was not 
until the year 1953, when dengue virus was isolated from a patient in Trinidad, that 
dengue cases were laboratory confirmed108,109. No dengue epidemics were reported in 
the Americas between 1946 and 1963, possibly related to the decrease of A. aegypti 
during the yellow fever eradication plan110. 
Since the year 1963 until 2010, Venezuela has reported eight dengue epidemics. 
These epidemics could be a consequence of:  
a) Introduction of new serotypes: the epidemics in the years 1963, 1969, 
1978 were attributed to the introduction of DENV-3, genotype V21, DENV-2, 
American genotype (V)109 and DENV-1, genotype III109,110 respectively. The 
presence of DENV-4 in Venezuela was first reported in the year 1985 without 
producing an epidemic111. During these epidemics no cases of DHF were 
reported.
b) Introduction of new genotypes: the first DHF outbreak reported in 
Venezuela, and the second in the Americas, took place in 1989-1990. A total of 
12,220 dengue cases were reported in Venezuela, of which 3,108 (25.4%) were 
DHF, and 73 individuals died112. During this epidemic DENV serotypes 1, 2 and 4 
were circulating, but mainly serotype 2. Later, this serotype 2 was identified as the 
Asian genotype (III) which was gradually displacing the American genotype91,113. 
Due to unknown reasons, DENV-3 disappeared from the Americas11 and was 
absent from Venezuela for 32 years94. In the year 2000 DENV serotype 3 was 
re-introduced producing the greatest dengue epidemic since 1989, with 104,282 
reported dengue cases, including 8,727 cases (8.4%) of DHF114. The introduced 
DENV serotype 3 was of genotype III94, which is generally considered a virulent 
virus93,94. Since the re-introduction of this serotype in the year 2000, the four 
dengue serotypes co-circulate in Venezuela115.
c) DENV evolution ”in situ”: Phylogenetic analyses of samples taken 
during 1997-2000 in Aragua state, showed the circulation of a DENV-2 mixed 
genotype (American/Asian), indicating the evolution and the re-combination of 
this serotype in situ116,117. This serotype was positively associated with DHF/
CHAPTER 1
21
DSS cases during the 1998 epidemic in Venezuela116,117. The shift of DENV-
1 clades or lineages could be the reason of the dengue epidemic in 2007. 
The evolution of DENV-1 genotype V has been associated with high dengue 
morbidity in Aragua estate118,119.
The most recent and biggest dengue epidemic in Venezuela occurred in 2010, with 
approximately 125,000 dengue cases, including 10,300 cases (8.6%) of DHF cases120. 
In this year, Venezuela was the third country with the highest number of dengue cases 
in the Americas and the second reporting a high number of DHF cases114.
At the beginning, the reported dengue epidemics in Venezuela were relatively 
isolated in time and were caused by introduction of new serotypes. However, since 
1980, dengue became hyperendemic in Venezuela with epidemic cycles of narrow 
intervals (3-5 years) and higher peak incidences each time121. The epidemic years are 
followed by inter-epidemic periods. The number of cases in each inter-epidemic period 
has increased122. The augmented dengue incidence in Venezuela has coincided with 
an increased number of cases in other American countries123. However, the augmented 
dengue incidence throughout time cannot be explained by the introduction of new 
serotypes or genotypes indicating that other factors are involved.
An important event in 2009 was the identification of A. albopictus for the first time in 
Venezuela124. A. albopictus is the second vector of dengue transmission and it has been 
involved in dengue epidemics24,93. 
6.2. Risk Factors for Dengue Infection in Venezuela
Although dengue has been present in Venezuela for more than 180 years, Venezuelan 
people underestimate the severity of the disease. A study performed during the 1990s 
on the knowledge of people in Venezuela about dengue, revealed that, although the 
majority of the individuals have heard about dengue, few of them could identify the 
mosquito vector, its habitat or the symptoms of the disease. Most of the people did 
consider dengue as a problem. However, they perceived this problem like an external 
situation in which they are not involved125.  
Water supply became erratic and garbage collection less frequent in Venezuela 
due to the economic recession at the end of the 1980s125. In this context most of the 
entomological studies were performed. The majority of the people stored water in 208L 
metal drums which at the same time presented a high Aedes index compared to other 
containers126,127. A high correlation was found between the frequency and length of water 
supply interruptions and the proportion of households with at least one vector breeding 
site and the proportion of containers where the vector is present126,127. In the 1990s, 
high dengue incidences occurred during the raining season. However, more recently, 
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it has been reported that the frequency of dengue cases is similar in the rainy and 
dry season indicating a perennial transmission of the virus121,128. Factors related to the 
change of annual dengue transmission should be studied. In the years 1993-1998, the 
DF and DHF incidences of different municipalities of Maracay city were estimated using 
a geographical information system129. This study showed that a higher DF and DHF 
incidence was present in those municipalities with high population density. A persistent 
high dengue incidence was found in the same neighbourhoods of each municipality129. 
The presence of a high number of female A. aegypti inside the households has been 
related to neighbourhoods with high dengue incidence/persistence and accentuated 
deficiencies in the frequency and length of water supply interruptions, but also to 
those neighbourhoods with low dengue incidence/persistence that show any degree of 
deficiency in public services, indicating that other variables can determine the level and 
persistence of dengue transmission121. Identification of clusters (“hot spots”) at block 
and household level and its relation with risk factors to dengue infection could explain 
the level and persistence of dengue transmission within these neighbourhoods with high 
dengue incidence/persistence. Furthermore, identification of high-risk areas of dengue 
transmission can be used to target surveillance and control measures to those locations 
in a cost-effective manner.  
6.3. Clinical Presentation of Dengue in Venezuela
Clinical-haematological studies on dengue performed in Venezuela have mainly been 
focussed on fatal cases and on the differentiation of DF from DHF. A clinical-pathological 
study has demonstrated the development of leukopenia, neutrophilia, thrombocytopenia, 
increase in plasma levels of aminotransferase enzymes, prolongation of the partial 
time of thromboplastin and metabolic acidosis in fatal cases. Plasma leakage (pleural 
effusion and ascites) and an uncontrolled inflammatory process with multi-organ 
involvement mainly affecting the liver and lungs have also been found130. A decrease 
of platelet count and lymphocytes and an increase of neutrophil and IL10 levels have 
been associated with severe dengue131,132. However, the majority of Venezuelan people 
attend the health centres at the fourth or fifth day after fever onset132 when patients could 
be already critically ill133. Indeed, it has been reported that patients with DHF have been 
hospitalized later (4.3 days) than patients with DF (3.2 days)134. A genetic study has 
indicated a gradual evolution in the pattern of gene expression in patients infected by 
DENV independent of the disease severity. The main change occurs at the fourth day 
after fever onset resulting in the separation of the early acute (0-3 days) and late acute 
phases (4-6 days)131. An early treatment intervention can reduce the case fatality from 
20% to 1%4,5,135. Therefore, an early dengue recognition (<4 days) is required.
There are no reported studies in Venezuela that differentiate dengue from other febrile 
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illnesses (OFI) at the early stage of the disease. Diseases like influenza, leptospirosis 
and malaria are common in this country and their initial clinical manifestations are 
similar to dengue69,71,72. As mentioned before, there are no accepted guidelines for the 
early recognition of dengue infection in the world73. Serological tests confirms dengue 
infection at the late stage of the disease136 and, laboratory techniques for early dengue 
virus detection are not available at primary health care services75. On the other hand, 
suspected dengue cases are clinically detected at the early days of the disease present 
low concordance with laboratory-confirmed cases in the American countries137,138 
creating unnecessary hospitalizations due to closer clinical monitoring. A decision-tree 
algorithm that discriminates dengue from OFI at the early stage of the disease is needed 
in order to avoid fatalities due to misdiagnosis and overburdening of health centres.
The delay in presenting to the health centres in case of dengue in Venezuela could 
be related to health-seeking behaviour (HSB). In order to achieve an early diagnosis 
and a proper dengue treatment, the reasons for the observed delay in health seeking 
among the Venezuelan population have to be elucidated. Studies on health believes 
and practices, HSB and access to care related to dengue have to be performed with the 
aim to find ways to improve early attendance to health centres and medical care.
Scope and Summary of the Thesis
Despite control measures, dengue has become a major public-health problem in 
Venezuela. Epidemics of increasing magnitude regularly occur against a background of 
an established endemic situation. Concomitantly, the number of severe dengue cases 
has risen over time. An early diagnosis and proper treatment of dengue cases can 
reduce the risk of development of severe disease. Furthermore, in Venezuela, patients 
with suspected dengue infection tend to seek medical help at a relatively late stage after 
fever onset. 
The studies described in this thesis aimed to: 
• determine dengue seroprevalence and identify current risk factors for dengue 
transmission in high incidence areas of Maracay city, Venezuela.
• find clusters (“hot spots”) of dengue transmission that could help target 
surveillance and vector control measures in an effective way.
• identify clinical and laboratory parameters that differentiate dengue from other 
febrile illness at the early phase of the disease. 
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• recognize and understand the patterns of health-seeking behaviour (HSB) of 
Venezuelan people in order to improve early attendance to health centres. 
Chapter 2: In this chapter a detailed description is given of the set-up of a prospective 
community-based cohort study in Maracay city, Venezuela. The characteristics of the 
study area, the recruitment process, the data collection in individual and household-
structured questionnaires, the process of active surveillance as well as the training of 
the health personnel are fully described in this chapter. Approximately 2000 individuals 
belonging to three neighbourhoods of high dengue incidence were recruited into the 
study. Within the four years of follow-up, annual cross-sectional surveys were performed. 
During the recruitment process, a cross-sectional baseline study was accomplished in 
order to determine dengue seroprevalence and identify risk factor for dengue infection 
(the results which are presented in Chapter 4). Furthermore, the geoposition of each 
household was recorded with the aim to determine clusters (“hot spots”) of dengue 
transmission (as further discussed in Chapter 5). Socio-economic data and intended 
pathways to care in case of fever or suspected dengue were collected during the third 
annual cross-sectional survey and presented in Chapter 7 of this thesis. 
Chapter 3: This chapter describes in detail the establishment of an observational 
health centre-based cohort study to identify clinical and laboratory parameters that dif-
ferentiate dengue from other febrile illnesses (OFI). Inclusion criteria, data collection 
and documentation in a structured questionnaire are explained. Training of the health-
centre medical personnel in the study procedure is also reported. Training of the study 
nurses on identification of febrile patients, dengue criteria, explanation of the study to 
the patients according to the writing informed consent/assent form are fully described. 
Data collected in this study are presented in Chapter 6 of the thesis. 
Chapter 4: The aim of this chapter was to determine the seroprevalence of dengue 
infection and the identification of risk factors for dengue transmission in  the population 
recruited during the prospective community-based cohort study (as outlined in Chapter 
2). For this purpose, a baseline cross-sectional study involving 2014 recruited individuals 
was carried out in the three communities of high dengue incidence. The population 
under study presented a high seroprevalence (77.4%) with 10% of people experiencing 
recent infections. Multivariate analysis demonstrated that socio-economic factors and 
environmental factors related to mosquito breeding sites determine the risk of acquiring 




Chapter 5: In this chapter, the spatial distribution of dengue in the three selected 
neighbourhoods studied is presented. Risk maps identifying “hot spots” of dengue 
transmission at block and house level were generated. To these end, map technology 
and spatial analysis of epidemiological and seroprevalence data were used. We 
found that dengue prevalence is highly heterogeneous at the studied spatial scale. 
Also, our results suggest that transmission of dengue is very focal. These results can 
inform regional health authorities in order to reduce dengue transmission by direct 
the surveillance and the mosquitos control measures to those places of high dengue 
transmission. 
Chapter 6: In this chapter, clinical and laboratory parameters that differentiate 
dengue from other febrile illness (OFI) are presented. Data were derived from a three 
year health centre-based cohort study that was established in three health centres 
serving the same communities, as presented in Chapters 2 and 4. In this study, 254 
patients met the inclusion criteria of whom 112 (44%) were laboratory diagnosed as 
dengue and 142 (56%) were classified as presenting with OFI. The daily evolution of 
the most important clinical and haematological parameters in our study population is 
shown. Multivariate analysis of clinical and haematological parameters associated with 
dengue during the first 3 days of the illness and on days 4-7 are presented separately. A 
decision-tree algorithm that allows discriminate dengue from OFI during the first 3 days 
of the illness is proposed. 
Chapter 7: In this chapter, intended pathways to seek care for suspected dengue 
are described with the aim to understand patterns of health-seeking behaviour (HSB). 
To this end, structured questionnaires were applied to 105 individuals belonging to the 
three communities studied in Chapter 4 and recruited according to Chapter 2. Data 
were collected during the third annual survey. We showed that intended pathways to 
care differed for suspected dengue infection compared to fever, as well as for children 
and adults in case of suspected dengue. In case of fever, most individuals would 
firstly treat the disease at home before seeking medical care, while the contrary was 
reported in case of suspected dengue. Parents/guardians would take children earlier 
to the health facility than adults would seek care. Suspected dengue would prompt 
people to search medical help earlier than fever.  For dengue, the appearance of new 
symptoms (77.1%) and high fever (74.3%) were the main reasons for seeking medical 
help. Primary health centres were the first intended choice to find medical care for 
nearly (93%) all participants. Dengue risk perception was high with a relative good 
general knowledge of the disease. 
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Chapter 8: summarizes the results and discusses the most important conclusions of 
this thesis.
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Dengue is a mosquito-borne disease from the (sub-) tropical areas of the world1. It has 
been recently estimated, using cartographic approaches, that 390 million dengue cases 
occur yearly2. Dengue infection can be asymptomatic, or present with a symptomatic 
clinical spectrum ranging from comparatively mild dengue fever (DF) to severe disease 
including dengue haemorrhagic fever (DHF) and dengue shock syndrome (DSS)3. The 
dengue viruses consist of four distinct serotypes4. Dengue virus (DENV) belongs to the 
Flavivirus genus of the Flaviviridae family together with yellow fever virus, West Nile 
virus, Japanese encephalitis virus and tick-borne encephalitis virus5. Transmission of 
DENV occurs through the bite of a female Aedes mosquito, mainly A. aegypti6. Although 
A. albopictus is a less efficient vector, it has been related to dengue outbreaks7.
DENV and its vector have spread into previously unaffected areas and currently 
dengue is endemic in 125 countries8-10. Factors related with dengue expansion and with 
the increase of dengue incidence are human population growth, low socio-economic 
status, uncontrolled urbanization, international travel, transport of the mosquito larvae/
eggs, inefficient control vector strategies, expansion of mosquito habitats due to climate 
change4,11-13. Despite control measures in Venezuela, DENV epidemics started recently 
to occur within a 3-5 year interval, with an increase in the number of dengue reported 
cases since 198914,15. The rise in dengue cases has coincided with an increase in the 
proportion of severe cases13. 
Maracay is one of the Venezuelan cities with dengue hyperendemicity where the four 
dengue serotypes co-circulate14,16. A high dengue incidence had persisted through the 
years in some neighbourhoods of this city17, meaning that some conditions are stable 
over time. However, the presence of clusters (hot spots) of dengue transmission in these 
neighbourhoods needs to be identified in order to direct mosquitos control measures 
in a cost-effective manner, particularly when resources are scarce. Understanding 
the pattern of geographic distribution and expansion of dengue virus and the possible 
risk factors behind the increase and persistence of dengue infection may contribute to 
the development of new strategies for dengue control in Venezuela. With this aim, we 
established a community-based cohort study to determine the incidence, risk factors 
and geographical distribution of dengue in Maracay city, Venezuela. 
2. Study Area
Maracay is the capital of Aragua state and is situated in the north-central region of 
Venezuela (10° 15´ N, 67° 36´ W) (Fig. 1b). The climate is tropical with two defined 
seasons: a dry season (November-April) and a rainy season (May-October). The 
temperature ranges from 25°C to 35°C with a mean annual precipitation of 834 mm. 
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Maracay is at an altitude of 436 meters and has an estimated 1.300.000 inhabitants18,19. 
This city is divided into 8 municipalities of which the Girardot and Mario Briceño 
Iragorry municipalities are amongst those reporting a high dengue incidence in the 
area17 (LARDIDEV, personal communication). Within these two municipalities, we 
selected three neighbourhoods: a) La Cooperativa (Girardot municipality), located in 
the north-east part of Maracay, b) La Candelaria and c) Caña de Azúcar, both belonging 
to the Mario Briceño Iragorry municipality, in the north-west area of Maracay (Fig. 
1c,d). Health centres (HCs) covering the population of the above neighbourhoods, 
and where availability of 24h emergency units and laboratory facilities exist, were 
invited to participate in the study. The Unidad de Emergencia la Candelaria and the 
Instituto Venezolano de los Seguros Sociales (IVSS) El Limón, covered the population 
of Candelaria and Caña de Azúcar (sectors 1 & 2); while the Ambulatorio del Norte, 
covered Cooperativa neighbourhood. In each collaborating HC, a study nurse was 
appointed to attend study participants. Patients requiring hospitalization were referred 
to the Central Hospital of Maracay.
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Figure 1.- Study setting. a) Location of Venezuela in the South-American continent. b) Location of Aragua 
state in the map of Venezuela. c) Location of the Mario Briceño Iragorry (in red)  and Girardot (in green) 
municipalities in the Metropolitan area of Maracay (grey areas). d) Location of the areas of study: Caña de 
Azúcar (sectors 1 & 2, in red), Candelaria (in green) and Cooperativa (in blue) neighbourhoods in the northern 
area of Maracay, Aragua state. “Maracay, Aragua.” Map. Google Maps. Google, 3 March, 2014. Web. 3 
March, 2014.
3. Study Design
To determine the incidence, risk factors and geographical distribution of dengue 
infection in Venezuela, a community-based prospective cohort study was established 
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in Maracay city, Aragua state. This study involved a cohort of approximately 2000 
individuals, aged between 5 to 30 years. A 4-year prospective longitudinal study was 
initiated in the neighbourhoods mentioned above. 
3.1. Study Population
According to incidence figures reported by the Regional laboratory for diagnosis 
and research of dengue and others viral diseases (LARDIDEV), individuals aged 5 to 
30 years presented the highest dengue incidence in Maracay (Dr. Guillermo Comach, 
personal communication). In order to optimize the likelihood of identification of acute 




Between August 2010 to January 2011, study personnel invited people from the 
Cooperativa, Candelaria and Caña de Azúcar (sectors 1 & 2) neighbourhoods to 
participate in the study through house-to-house visits. The inclusion criteria were: a) 
age between 5-30 years, b) living in the study area with no intention to move in the 
following 3 years, c) consenting to attend the designated HC in case of any symptoms, 
d) absence of immune-compromising conditions, such as immunosuppressive therapy 
or human immunodeficiency virus infection. The aims and the scope of the study were 
clearly explained to all members of the household. Adults or parents of those fulfilling 
the criteria and willing to participate in the study were asked to sign an informed-consent 
form. A copy was left with the participant. 
During the recruitment process, a baseline cross-sectional study was performed in 
order to determine dengue seroprevalence and identify risk factors for dengue infection 
(Chapter 4). Socio-demographic, epidemiologic and clinical history data were collected 
in an individual questionnaire (section 3.2b, below). Socio-economic and environmental 
risk factors were collected in a household questionnaire (section 3.2b, below). At the 
same time, the geolocation of the households was recorded with a hand-held Global 
Positioning System (GPS, Garmin, Ltd), to identify hot spots of dengue transmission 
in the communities under study (Chapter 5). A unique code was assigned to each 
participant and household to ensure confidentiality. 
Each recruited individual was examined by medically trained study personnel and 
vital signs recorded. A blood sample was taken to determine dengue seropositivity 
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and a baseline total blood count. Results were handed over to each individual. An 
identification study card with the name and unique identification number of the participant 
was provided. Written information about dengue signs and symptoms, transmission 
routes, prevention and telephone numbers of the study personnel were also supplied. 
The steps to follow during the recruitment process and baseline study were written in 
the Standardized Operation Procedures of the baseline study (SOP-Base) (section 4, 
below) in order to standardize procedures.
b) Questionnaires
During the baseline study of the recruitment process a household and individual 
questionnaires were applied. Details of the two questionnaires are explained below.
•	 Household questionnaire
In a household questionnaire, data related to socio-economic and environmental 
risk factors were collected. Socio-economic data included: type of housing, household 
ownership, presence of all public services (piped-water supply, electricity, urban sanitation 
and sewer) and total number of people and rooms in the household (all rooms except 
bathrooms). The environmental data were related to indoor/outdoor potential mosquito 
breeding sites, including water storage in containers or tanks, final trash disposition, 
presence of used car tires, litter, bottles and flower vases. The use of insecticide spray/
coils, mosquito repellent, mosquito net, windows/doors screening and frequent washing 
of water containers were inquired in relation to dengue preventive measures.
•	 Individual questionnaire
Socio-demographic, epidemiological and clinical history data were collected in an 
individual questionnaire. Socio-demographic data included: age (date of birth), gender, 
place of residence, address of work or study place. Epidemiological data included: 
ethnicity, occupation, time living in the household and reported previous dengue infection. 
The presence of other illnesses that could influence the evolution of dengue including 
diabetes, hypertension, asthma, hepatitis and sickle cell anaemia were collected as part 
of the clinical history20-23. 
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c) Active and Passive Surveillance
To determine the incidence of dengue in the population under study, passive and 
active surveillance of febrile individuals were performed. Passive surveillance consisted 
of voluntarily attendance to the designated HC if the participant presented fever or 
dengue symptoms. Active surveillance was carried out by study nurses through weekly 
visits to the participants’ households. During these weekly visits, participants were 
reminded to visit the HC with their study card in case of fever. If a febrile participant was 
identified during the weekly visit, the surveillance personnel encouraged the participant 
to immediately visit the HC. A text message was sent to the HC study nurse with the 
name and identification number of the participant. If the febrile participant did not attend 
the HC, he/she was visited by the study medical doctor and surveillance nurse to 
perform a clinical evaluation and withdraw a blood sample for dengue diagnosis and full 
blood count. The patient was encouraged to continue clinical and laboratory monitoring 
at the HC (Fig. 2b).
d) Annual Cross-Sectional Surveys 
Within the community-based cohort study, annual cross-sectional surveys were 
performed. The aims of these annual surveys were to estimate the incidence of dengue 
and to assess the temporo-spatial dynamics of dengue transmission. A questionnaire 
was supplied to ask participants if they had been diagnosed with dengue infection 
during the previous year and/or if they had presented any dengue-like symptoms. Data 
of each participant’s education level, current occupation, monthly family income and 
attendance to a public or private health centre in case of disease were collected in a 
socio-economic questionnaire. Data on health seeking behaviour in case of dengue 
and fever also was collected. The individuals were clinically evaluated by the medical 
doctor of the study and a blood sample was collected to evaluate seroconversion or an 
increase in antibody titres that may denote a new dengue viral infection. 
4. Personnel Training
Different strategies were used in order to identify qualified medical personnel 
to work in the study (mainly nurses). The used strategies were: a) advertisements 
soliciting personnel were placed in hospitals, academic institutes and universities; b) a 
communication was sent to the president of the College of nurses of Aragua state and 
c) oral communication between nurses.
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Those nurses interested in working in the study were personally interviewed. The 
main purpose of the study, activities to be performed and the location of the activities 
were explained. Qualified nurses with a broad availability were selected.
4.1. Recruitment Process and Baseline Study
The selected personnel were trained in the standardised operation procedures of the 
baseline study (SOP-Base) and bioethics. The main points of the SOP-Base training 
were:
a) Study introduction to the prospective participants: Introduction of study 
personnel and the institutional affiliation of the study (University of Carabobo, 
CORPOSALUD-Aragua and University Medical Center Groningen), purpose, 
methodology and benefits to be derived from the study.
b) Inclusion criteria: Participants of the study must fulfil the inclusion criteria 
mentioned in section 3.2a 
c) Written informed consent and assent: All study personnel were subjected to 
training on the bioethical principles24 and good clinical practices of research. 
They were trained to give a clear explanation of all sections of the informed 
consent form. The training also included the type of consent/assent to be signed 
by the patient according to his/her age (section 5.1). 
d) Household and individual questionnaires: The meaning of each variable, and 
the correct and easy way to formulate the questions were explained and trained. 
Criteria were unified on how to document each variable.
e) Blood sampling: 10 ml of venous blood sample was extracted from the participant 
and placed in a vacutainer® tube with EDTA. This tube had to be marked with 
the participant study code, initials of the name and date of the sampling. Training 
on Good laboratory practices was given to all personnel involved in the study.
The training involved also basic dengue information and answers to possible 
questions that might be asked by the participants or relatives. 
A pilot study was performed in households not chosen for the study in Caña de Azúcar 
neighbourhood in order to test and improve study procedures and the questionnaires 
to be applied. 
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4.2. Active Surveillance
Three nurses or field workers (one for each neighbourhood) that participated in the 
enrolment process were also trained in the weekly active surveillance according to 
SOP-surveillance. The main points in the training were:
a) Distribution of households: an approximately equal number of households to 
be visited per day were planned. The distribution was performed taking into 
account the households proximity using maps of each neighbourhood where 
the study households were localized.
b) Filling of the surveillance questionnaire: During the weekly surveillance, nurses 
visited each house and questioned the head of the household or an adult for 
the presence or not of a febrile study participant. The answers were recorded in 
the surveillance questionnaire. The day of the visit, the name and the signature 
of the adult interviewed were also recorded. The latter information was used 
to randomly call households and ask if they had been visited by our study 
personnel. Three possible outcomes of the household visit were:
o Finding a febrile study participant: The procedure to follow in this case 
was described in section 3.2c and represented in Fig. 2a. 
o Absence of individuals in the household during the weekly visit: in 
this case the surveillance nurse visited the household once more at 
a different time during the same week. If the household was found 
without inhabitants for 2 consecutive weeks, the surveillance nurse 
tried to reach any of the household’s participants over the phone. If 
successful, the presence of any febrile participant was recorded in the 
surveillance questionnaire (Fig.2b).
5. Ethics
5.1. Written Informed Consent and Assent
This research was performed according to the principles contained in the Declaration 
of Helsinki24.  Individuals that agreed to participate in the studies signed a written 
informed consent form, once the study information had been understood. This informed 
consent form contained information on the aims and scope of the study, the procedures 
to be carried out, the expected duration of the individual’s participation, the sponsors 
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of the research, the institutional affiliation of the investigators, any foreseeable risk, 
pain or discomfort to the individual associated with the participation in the study, direct 
and expected benefits to the individual and community, preservation of the anonymity 
and freedom to withdraw from the research at any time without penalty or loss of 
actual benefits. If the individual was a minor or had any physical/mental incapacity, 
the informed consent form was signed by a legal guardian. The informed consent form 
was also applicable to adults (≥ 18 years old). In case of children (8 to 11 years) and 
adolescents (12 to 17 years), the signed informed consent form from the legal guardian 
was complemented with a written assent signed by the minor. The information contained 
in both consents and assents was the same but with a simpler explanation given in the 
assent form. The informed consent form from the community-based cohort study is 
presented in the native language in the Appendix.
5.2. Bioethics Committee
All scientific investigations in which humans are involved, must be analysed by one 
or two bioethics committees24.  The role of these committees is to analyse the scientific 
value and ethical acceptability of the investigation. Also, the balance of foreseeable 
risks and benefits for the participant is evaluated24. Our studies were approved by two 
bioethical committees: a) at the national level by the Ethics, Bioethics and Biodiversity 
Committee (CEBioBio) of the National Foundation for Science, Technology and 
Innovation (FONACIT) of the Ministry of Science, Technology and Innovation, and b) 
at the Institutional level by the Ethics Review Committee of the Biomedical Research 
Institute, Carabobo University (Aval Bioetico #CBIIB(UC)-014), Maracay, Venezuela. An 
annual report must be submitted annually to the latter in order to receive approval for 
the continuation of the study.
5.3. Approval from the Regional Health Authorities of Aragua State 
(CORPOSALUD Aragua)
CORPOSALUD is a governmental entity responsible for the planning, administration 
and supervision of the health system in Aragua state25. An approval letter for 
the establishment of the study in Maracay city was obtained from the director of 
CORPOSALUD before the start of the study, which enabled us to seek the collaboration 
and participation of the HCs in the study.
5.4. Informing the Communities Involved in the Community-Based 
Cohort Study
Once the study was approved by the ethical committees and CORPOSALUD, 
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the population of Caña de Azúcar, Candelaria and Cooperativa neighbourhoods was 



























































































































































and way of participation in the study. The different strategies used to give information 
about the study and seek cooperation were:
a) Community councils: The community council is a group of people elected every 
2 years by a community of 150-400 families26. Its function is to solve problems 
entailing the community involved. The members of the community councils 
usually meet once a month with people from their own community. People 
from each neighbourhood were invited to participate in the study during the 
community councils meetings. 
b) Radio programme: A 15 min local radio programme was used to disclose our 
study. People from the chosen neighbourhoods were invited to participate in 
the study.
c) Schools: At the beginning of the teaching period, the school personnel performs 
a meeting with the parents. General plans of the new scholar year are discussed 
there. Our research study was presented and explained in a meeting of one 
public school from Candelaria neighbourhood. People living in Candelaria and 
Caña de Azúcar (sectors 1 & 2) were invited to participate.
6. Funding
According to Article 110 of the Constitution of the Bolivarian Republic of Venezuela, 
the government recognizes the public interest in science, technology, knowledge, 
innovation and their applications. This knowledge has to be disclosed for the economic, 
social, and politic development of the country27. With the purpose to implement this law, 
the government developed the Law of Science, Technology and Innovation (LOCTI). 
This law states that public or private companies that have an income above a certain 
threshold have to contribute annually to the financial support of science, technology 
and innovation investigation projects. These investigation projects are evaluated and 
approved by the Ministry of Science and Technology28. Once the project is approved, it 
has to be registered in the System for Declaration and Control of Investment in Science, 
Technology and Innovation (SIDCAI). The SIDCAI registration consists of giving an 
online project outline on the system’s website (http://www.sidcai.fonacit.gob.ve). The 
title of the project, problem statement, aims of the study, activities to achieve the aims, 
social impact of the possible results, date of beginning and end of the project and 
required budget, have all to be mentioned in this outline.
The main purpose of SIDCAI is to check if the companies invest in projects, satisfying 
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the LOCTI and Article 110 of the constitution. For that, all public and private companies 
have to be registered with SIDCAI. In the year 2010, the companies had the freedom to 
invest in one or two projects of their choice.
Our 4-year study was approved on January, 2010 by the Ministry of Science and 
Technology (certification N° DGCAFIDCTI/204-214-10). The study was registered in the 
SIDCAI. In order to apply for the available funding from industry, we held meetings with 
directives of different companies at a national level where our project and its importance 
were presented. We obtained funding for the first year of the study from Shell de 
Venezuela, Venezolana de Iluminación IVISA, Ferretería Hermanos Fridegotto, PC 
actual Valencia and Fundación Vollmer. 
In the year 2011, the Ministry of Science and Technology created the National 
Science, Technology and Innovation Funds (FONACIT) where all company investments 
must be placed. As a consequence, since 2011, our project was entirely financially 
supported by FONACIT, Project No. 2011000303 under contract No. 201100129. 
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APPENDIX
FORMULARIO DE CONSENTIMIENTO INFORMADO DEL ADULTO
Personas de 18 años de edad o mayores
Consentimiento para Participar en un Estudio de Investigación - ESTUDIO DE 
COHORTE
TÍTULO DEL PROYECTO:     DENVEN
DENGUE EN VENEZUELA: Epidemiología, factores de riesgo, diversidad genética y 
determinantes de enfermedad severa hacia prueba de vacuna contra el dengue.
Laboratorio Regional del Diagnóstico e Investigación del Dengue y otras Enfermedades 
Virales (LARDIDEV-CORPOSALUD), Centro de Investigaciones Biomédicas de 
la Universidad de Carabobo, Maracay, Venezuela (BIOMED-UC) y Centro Médico 
Universitario Groningen (UMCG), Groningen, Holanda.
PARTICIPANTE NÚMERO: UCUG __ __ __ __     CÓDIGO VIVIENDA: VIV- __ __ __ __  
¿POR QUÉ HACEMOS ESTE ESTUDIO?
El Dengue es una enfermedad causada por un virus que es transmitido a las 
personas por la picadura de un mosquito, comúnmente llamado “patas blancas”. Las 
personas que se infectan con dengue generalmente tienen fiebre y síntomas leves pero 
algunas pueden desarrollar dengue severo con hemorragias o sangramientos. Aún no 
se sabe por qué a veces el dengue se transforma en severo.
El propósito de este estudio es determinar cómo se extiende el dengue en la 
comunidad, cuáles son las cepas circulantes (diversidad genética), cómo el virus 
dengue enferma a las personas y qué factores pueden predecir que alguien está a 
mayor riesgo de tener enfermedad de dengue severa, como anticuerpos especiales o 
citoquinas. Los resultados de este estudio servirán para mejorar el manejo médico de 
pacientes con dengue.
Nos gustaría solicitarle que participe en este proyecto de investigación que incluirá 
aproximadamente 3000 personas de diferentes sectores de la ciudad de Maracay 
seleccionados por su alta incidencia a dengue. Su participación en el estudio será de 
2,5 años. Si usted está de acuerdo en participar, se le pedirá firmar este formulario 
de consentimiento informado. A continuación le explicaremos en qué consistirá su 




Si acepta participar en el estudio, usted estaría de acuerdo en acudir durante los 
próximos 2 años y medio a la Unidad de Emergencia la Candelaria (Barrio Caña de 
Azúcar) o al Ambulatorio del Norte (Barrio la Cooperativa) cada vez que presente fiebre 
u otros síntomas. Es muy importante que acuda al centro de salud inmediatamente 
que presente fiebre, pues de esta forma se le podrá dar atención médica inmediata 
y podremos confirmar por pruebas de laboratorio si usted tiene dengue. En caso de 
tener dengue, deberá permanecer residenciado en Maracay durante los 30 días de 
seguimiento.  En la primera visita a su casa tomaremos sus datos personales y le 
haremos preguntas sobre su vivienda además de tomar las coordenadas de su casa con 
un dispositivo especial (un GPS) que le mostraremos. Las coordenadas nos servirán 
para ver en un mapa cómo se distribuyen geográficamente los casos de dengue en 
su comunidad. Tomará aproximadamente 10 minutos contestar todas las preguntas. 
Luego de firmar el consentimiento informado, una enfermera especializada del proyecto 
tomará una muestra de sangre de su brazo (10ml). La muestra de sangre será utilizada 
para determinar los valores sanguíneos de rutina (hematología) y determinar si ha tenido 
dengue en el pasado mediante estudio serológico. Posteriormente se le entregará un 
carnet que lo acreditará como participante del proyecto de investigación, el cual deberá 
mostrar en los centros asistenciales cuando acuda por presentar síntomas. 
Visitas semanales
Semanalmente enfermeras del estudio visitarán su casa para preguntar si presenta 
o ha presentado fiebre. En caso positivo y de tener síntomas compatibles con dengue, 
la enfermera lo remitirá a la Unidad de Emergencia la Candelaria o Ambulatorio del 
Norte (según aplique) con su carnet. Adicionalmente, un(a) Reportero(a) Comunitario(a) 
de su comunidad también lo visitará durante la semana para preguntar por su salud. 
En caso de que usted le manifieste que se siente enfermo, él se comunicará con la 
enfermera del proyecto en el Ambulatorio y le hará saber que usted se dirige al lugar 
para ser atendido.
En caso de sospecha de dengue:
Cuando usted presente fiebre u otros síntomas deberá acudir con su carnet al 
centro asistencial asignado al proyecto ya sea por iniciativa propia o al ser referido por 
la enfermera que lo visita semanalmente. Una vez allí será atendido por la enfermera 
del proyecto y evaluado por el médico del centro asistencial. Si el médico determina 
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que tiene criterios clínicos para dengue, se le tomará una muestra de sangre de 10ml 
para confirmar por prueba de laboratorio si tiene infección a dengue. Esta prueba se le 
hará completamente gratis. 
Si la prueba es negativa para dengue, su médico tratante decidirá su tratamiento, 
pero se le pedirá una muestra de sangre a los 21-30 días para chequear por serología 
si realmente no tuvo dengue. 
Si está infectado con el virus de dengue (la prueba es positiva), deberá asistir 
diariamente al mismo centro de salud, con su carnet, mientras tenga fiebre y luego en 
determinados días para hacerle seguimiento clínico. Se le solicitarán cinco muestras 
de sangre de 10ml cada una que serán tomadas a las 24, 48 y 72 horas después de 
colectada la primera muestra mientras dure la fiebre,  24 a 48 horas después de finalizada 
la fiebre y 21 a 30 días después de la muestra inicial. La finalidad de estas tomas de 
sangre es monitorear cambios hematológicos (hematología, plaquetas y otros en su 
sangre) y correlacionarlos con sus síntomas. Una parte de estas muestras se utilizará 
para estudiar factores predictivos de enfermedad severa de dengue (anticuerpos y 
citoquinas). Todas estas pruebas se realizarán de manera gratuita. El personal médico 
del centro de salud se encargará de indicarle tratamiento y monitoreará su salud. 
Durante cada visita mientras se sienta enfermo, la enfermera del proyecto le hará unas 
preguntas sobre cómo se siente, le tomará la temperatura y signos vitales y le hará 
la prueba del torniquete. La prueba del torniquete se utiliza para buscar trastornos 
hemorrágicos y consiste en aplicar presión en la parte superior de su brazo utilizando 
el brazalete para tomar la presión arterial durante menos de un minuto.
En caso de desarrollar dengue severo:
Si usted desarrolla la enfermedad severa, los médicos del centro asistencial 
decidirán hospitalizarlo en el mismo centro de salud o lo referirán al Hospital Central 
de Maracay para que sea hospitalizado y tratado por personal médico especializado. 
Durante su hospitalización será monitoreado por personal médico y de enfermería del 
centro de salud y del proyecto y se le tomarán dos muestras de sangre adicionales 
de 10ml cada una en días alternos. Estas muestras servirán para estudiar factores 
predictivos de enfermedad severa de dengue. Una vez salga del hospital, se le pedirá 




Una vez al año volveremos a su casa para tomar una muestra de sangre igual a 
la primera (10ml) la cual servirá para determinar si su hematología ha variado con 
respecto al año anterior y verificar si usted tuvo dengue sin presentar síntomas. También 
le haremos algunas preguntas sobre su salud y su residencia. 
¿CUÁLES SON LOS RIESGOS O INCOMODIDADES EN EL 
ESTUDIO?
La sangre le será extraída de su antebrazo con una aguja por un(a) enfermero(a) 
con experiencia o un(a) médico(a). Todo el material utilizado para la toma de muestra 
de sangre es estéril y descartable luego de su uso. El riesgo de que pueda salir 
lastimado durante la colecta de la sangre es mínimo, pero es posible que sienta algún 
dolor o incomodidad cuando le extraigan la sangre de su antebrazo; después puede 
presentarse algún moretón o hinchazón, y con muy poca probabilidad, infección en 
el sitio donde se extrajo la sangre. Puede sentir desfallecimiento cuando se le esté 
tomando la muestra, pero esto es poco común y la sensación pasará rápidamente. 
Para minimizar cualquier riesgo, toda muestra de sangre será tomada por personal 
experimentado. La prueba del torniquete para dengue puede causar dolor en el brazo 
en algunas personas mientras se infla el dispositivo de la presión sanguínea.  El dolor 
desaparece cuando el dispositivo se desinfla. Cuando este dispositivo se infla la piel de 
su brazo y de su mano debajo de este dispositivo puede cambiar de color (rojo, azul, 
púrpura). Este color cambiará luego de que el dispositivo se desinfle. Puede desarrollar 
una erupción en su antebrazo bajo la forma de pequeños puntos rojos.  Esta erupción 
desaparecerá luego de unos cuantos días.
¿CUÁLES SON LOS BENEFICIOS COMO PARTICIPANTE DE 
ESTE ESTUDIO?
Con su participación en el estudio, el personal médico y de enfermería del Ministerio 
de Salud y del proyecto tendrán un mejor conocimiento de la transmisión y características 
clínicas del dengue en Venezuela. Además, el personal del estudio espera determinar 
factores que ayuden a predecir si alguien desarrollará dengue severo.  Si usted es 
sospechoso de presentar dengue, tendrá resultados de laboratorio de manera gratuita 
y temprana que permitirán hacer un seguimiento de la evolución de su enfermedad de 
manera adecuada y oportuna minimizando así la aparición de la enfermedad severa. 
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CUIDADOS MEDICOS POR LESIONES RELACIONADAS CON 
LA INVESTIGACION: 
Si usted es lastimado como resultado directo de formar parte de este proyecto 
de investigación, recibirá atención médica para esa lesión. La atención médica se le 
proporcionará sin costo alguno. Usted  recibirá la atención médica  necesaria pero 
no una compensación monetaria por la lesión que el procedimiento de extracción de 
sangre le pueda ocasionar.
CONFIDENCIALIDAD DE SU INFORMACION: Toda la información 
relacionada con este proyecto será confidencial. Los documentos de esta investigación 
serán mantenidos en las oficinas del LARDIDEV/BIOMED-UC en Maracay, Venezuela, 
y en la oficina UMCG, Holanda. Nosotros mantendremos los documentos en privado 
hasta donde sea legalmente posible. Como usted será identificado con un número 
de código, su nombre no será utilizado para ningún análisis de datos (el cual será 
realizado de manera anónima) y no aparecerá en las publicaciones que se produzca 
del estudio. Solo la enfermera y el médico que lo atienda y el personal del laboratorio 
de diagnóstico de dengue conocerán su nombre.
PARTICIPACION VOLUNTARIA: Usted puede decidir no formar parte 
del estudio, la decisión es solo suya así como también puede dejar este estudio en 
cualquier momento sin consecuencias para usted y sin que cambien sus beneficios 
actuales. Usted puede decidir en cualquier momento del estudio negarse a que le 
tomen muestras de sangre para este proyecto de investigación, sin que esto tenga 
ninguna consecuencia para usted.  Si no desea continuar participando en el estudio, se 
le agradece que lo notifique a la enfermera en su próxima visita o a la co-responsable 
del proyecto Prof. Zoraida Velasco al 0416-345-08-18.
El personal del estudio puede retirarle del estudio en cualquier momento, incluso 
si todavía desea participar. Esto podría pasar si: Usted se muda del área de estudio, 
Usted no sigue instrucciones acerca del estudio, La investigación es finalizada por 
cualquier razón.
¿A QUIEN PUEDE CONTACTAR SI TIENE ALGUNA 
PREGUNTA O PROBLEMAS?
Si usted quiere conversar con alguien sobre este estudio, o si ha resultado lastimado 
por haber formado parte de este estudio, por favor contacte a la Prof. Zoraida Velasco 
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en el LARDIDEV/BIOMED-UC al 0416-345-08-18 o en su defecto, a la Dra. Diamélis 
Guzmán al 0414-461.8912.
CONSENTIMIENTO DEL ADULTO
Su firma en este formulario indica que se le ha explicado y ha entendido el estudio, 
y que ha decidido formar parte del mismo sin costo alguno para usted. Adicionalmente, 
su firma indica que ha tenido la oportunidad de hacer  preguntas. Usted debe saber 
que cualquier pregunta que pueda formular en el futuro le será respondida por uno 
de los investigadores del estudio. A usted se le proporcionará una copia de este 
consentimiento para que disponga de esta información.
Es posible que después de que completemos las pruebas de laboratorio con 
sus muestras de sangre, quede un remanente de las mismas. ¿Qué desea Ud. que 
hagamos con los remanentes de sus muestras de sangre? Coloque sus iniciales en 
una sola una opción:
_______
Iniciales




Después de completar el estudio, las muestras restantes pueden ser 
utilizadas para cualquier propósito científico siempre que este propósi-
to científico sea aprobado por la Comisión Bioética y que mi muestra 
no sea  identificada con mi nombre sino sólo con un número.  Tam-
bién entiendo que no habrá compensación por el uso futuro de mi(s) 
muestra(s).
Si cambia de opinión, en cualquier momento, y desea que se destruyan las muestras 
de sangre remanentes contacte a la Prof. Zoraida Velasco en el LARDIDEV/BIOMED-
UC al 0416-345-08-18
1. Nombre del  Participante: 
______________ ______________ ________________ ______________
Primer nombre Segundo Nombre Primer apellido Segundo Apellido
   
Fecha de nacimiento del Participante: Día __ __ Mes __ __ Año __ __ __ __
Firma del  Participante: ____________________________________   
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Fecha  dia_____mes_____año___
Si el Participante es analfabeto o tiene impedimentos físicos para firmar, debe colocar 
su huella digital en el sitio de la firma y se requerirá preferiblemente de un familiar o 
vecino como testigo. 
2. Nombre del Testigo: 
______________ ______________ ________________ ______________
Primer nombre Segundo Nombre Primer apellido Segundo Apellido
Fecha de nacimiento del Testigo: Día __ __ Mes __ __ Año __ __ __ __
Firma del Testigo _________________________________  
Fecha:  dia_____mes_____año___
3. Nombre del Investigador: _____________________________________  
Firma del  Investigador _________________________________  
Fecha:  dia_____mes_____año___
Nota: Copias firmadas de este Formulario de Consentimiento serán: a) guardadas en 
un archivo del Investigador Principal, b) entregadas al participante, c) incluidas en el 
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Dengue in Venezuela: Design of an Observational Health Center-Based Cohort Study
1. Introduction
Dengue is a febrile disease transmitted by the bite of its principal vector, the mosquito 
Aedes aegypti1. Aedes albopictus can also transmit the virus but in a less efficient way2. 
Dengue virus (DENV) is an enveloped single-stranded positive-sense RNA virus that 
belongs to the Flavivirus genus of the family Flaviviridae3. Yellow fever virus, West Nile 
virus and Japanese encephalitis virus also belong to the same family4. There are four 
serologically different types of dengue virus (DENV1-4)5. Dengue has become the most 
important mosquito-borne disease in the tropical and sub-tropical areas of the world5,6. 
In the last decades, the World Health Organization has reported an increase of dengue 
cases7 and 390 million annual cases have been recently estimated to occur according 
to cartographic studies8. Lately, autochthonous dengue cases have also been reported 
in new areas of Europe such as Portugal (Madeira), France and Croatia9.  
Dengue is endemic in Venezuela with a reported circulation of all four DENV 
serotypes10. Dengue epidemics occur every 3-5 years with increasing numbers of 
cases11,12. Since the first DHF epidemic reported in Venezuela in 1989-199013, the 
frequency of severe cases has increased resulting in Venezuela reporting the highest 
proportion of severe cases (35.1%) in the Americas between 1989-200711. 
It is estimated that the majority of dengue infections are asymptomatic14,15. 
Symptomatic infections present with a wide range of clinical manifestations ranging from 
mild dengue fever (DF) to more severe complications such as dengue haemorrhagic 
fever (DHF) and dengue shock syndrome (DSS)16. At the beginning of the disease, 
the patient presents with non-specific symptoms (fever, headache, myalgia, arthralgia) 
that can be easily confused with other diseases like influenza, leptospirosis, malaria, 
rickettsiosis, typhoid fever or chikungunya among others17-20. The patient has to be 
carefully monitored to guard the appearance of warning signs in the post-febrile phase 
(around 4-5 days after fever onset). However, the patient in this phase can be already 
critically ill21. An early treatment intervention can reduce the case-fatality from 20% 
to 1% or less5,7,22. To date there are no antiviral treatment modalities for dengue and 
vaccines are still under study23.
Currently, there are no accepted guidelines for the early recognition of dengue 
infection24. Suspected cases clinically detected in the early days of the disease present 
low concordance (32%-52%) with cases confirmed in the laboratory25,26. On the other 
hand, laboratory techniques for early dengue virus detection, such as molecular 
techniques (reverse transcriptase Polymerase Chain Reaction, RT-PCR) and virus 
isolation, are expensive and not available at primary healthcare services27. Serological 
tests based on IgM seroconversion or 4-fold titre elevation in paired samples (frequently 
used in diagnostic laboratories) confirm dengue infection at the late stage of the disease28 
or produce false-negatives due to frequently low IgM levels in secondary infections29,30. 
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A correct and early dengue diagnosis is required in order to reduce dengue fatalities due 
to misdiagnosis and untimely management of severe cases. Additionally, unnecessary 
hospitalization and overburden of health services can be avoided. An algorithm that 
allows timely identified dengue infections and prediction of progression to severe 
disease is highly desirable.
An observational prospective study in three primary health centers was established 
in a dengue hyperendemic city with the aim of:
a. Identifying clinical and laboratory parameters that differentiate dengue from 
other febrile illnesses (OFI)
b. Identifying clinical and laboratory parameters that indicate progression to 
severe dengue disease. 
2. Study Area
Maracay is the capital of Aragua state and is situated in the north-central region of 
Venezuela. The city is divided into municipalities of which Girardot and Mario Briceño 
Iragorry have a history of high dengue incidence31 (LARDIDEV, personal communication). 
Three public health centres (HCs), situated within the two municipalities mentioned 
before, were chosen for the study due their availability of 24h emergency units and the 
presence of laboratory facilities. The selected HCs were: 
a) Unidad de Emergencia la Candelaria and the Instituto Venezolano de los 
Seguros Sociales (IVSS) El Limón. These HCs are located in the Mario Briceño 
Iragorry municipality.
b) The Ambulatorio del Norte is located in the Girardot municipality. 
c) Hospital Central de Maracay is a tertiary level hospital where patients with 
severe manifestations of dengue are referred for hospitalization. This hospital 
covers the whole of Maracay city.
3. Study Design
An HC-based prospective observational cohort study, to be conducted between 
October 2010 and December 2013, was initiated in order to identify clinical and 
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laboratory parameters that could early differentiate dengue from OFI, and to identify 
parameters that indicate progression to severe dengue. 
3.1. Data Collection
Patients of all ages, presenting at the HC within a maximum of 4 days (96 h) of 
fever onset, with symptoms suggesting dengue infection5 (Fig. 1) or without any signs 
of a localised infection were identified by trained medical doctors and study nurses 
(see section 5). The aim, scope, risks and benefits of the study were explained to the 
selected participants. If the patient or the parent/guardian of minors agreed to participate 
in the study, he/she was asked to sign an informed-consent form and a copy was left 
with the participant (see section 4). If the patient was a minor between 8-17 years old, 
he/she was asked to sign an informed-assent form. In order to ensure anonymity, study 
participants were identified with a unique code. 
Figure 1. Dengue criteria and classification according to WHO (2009)5, adapted to the study. The 
original criteria ”aches and pains” in the 2009 WHO guidelines, were expanded into two criteria: “headache/
retro-orbital pain” and “myalgia and/or arthralgia” for our study.
The patient was physically evaluated by the treating physician together with the study 
nurse. Data on signs and symptoms were documented in the follow-up questionnaire 
(see below). A blood sample was taken on presentation to perform a full blood count and 
dengue diagnosis by RT-PCR32 and serology. Vital signs, tourniquet test (section 5.2f, 
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below), clinical history, treatment received, socio-demographic and epidemiological 
data and laboratory results were filled into the questionnaire by the study nurse (Fig. 
2a; see below). 
The patient was asked to return daily for monitoring and evaluation until 48 h afebrile 
and at 21-30 days after fever onset for a follow-up visit. New signs and symptoms were 
evaluated by the medical doctor and documented in the follow-up questionnaire by the 
study nurse (Fig. 2b) during the medical interview. The result of the dengue diagnosis by 
RT-PCR test was available within 24-48 h after presentation. Blood samples to perform 
total blood count and blood biochemistry were taken at 24h, 48h and 72h during the 
febrile phase, 48h post-febrile and at 21-30 days (convalescent sample; Fig. 3a). A 
serum aliquot from the convalescent sample was tested for IgM seroconversion at the 
Regional Laboratory for Dengue Diagnosis and Investigation and other Viral Diseases 
(LARDIDEV) using a modified MAC-ELISA test33. In case of warning signs or severe 
disease5 (Fig. 1), the patient was referred and hospitalized at the main tertiary Central 
Hospital of Maracay where study medical personnel continued the monitoring and data 
collection until discharge. Two extra blood samples were taken on alternate days during 
hospitalisation (Fig. 3b). 
3.2. Follow-up Questionnaire
In order to identify predictive factors for dengue infection and dengue severe 
disease, we collected demographic, epidemiological, background clinical history, 
clinical findings, laboratory tests, complementary tests and received-treatment data in 
a follow-up questionnaire. Demographic data included personal data, date of birth, sex, 
address of household and place of study or job. Epidemiological data included history 
of past dengue infection, hospitalisation due to dengue disease, recent travel history, 
and disability proxies such as absence from work or school during recent dengue 
infection. Background clinical data included the presence of diabetes, hypertension, 
asthma, hepatitis, lupus, sickle cell anaemia or neoplasia. It has been reported that 
these diseases and/or treatment could influence dengue evolution34-37. Clinical findings 
were collected according to the protocol and scheme in Fig. 3. Clinical evaluation data 
included: a) vital signs; b) general signs and symptoms; c) haemorrhagic manifestations; 
d) alarm signs; e) gastro-intestinal manifestations; f) respiratory manifestations; g) signs 
of plasma leakage; h) signs of shock; i) organ alterations and j) other observed signs 
and symptoms. Laboratory data included: a) total blood count; b) blood coagulation 
indicators (prothrombin and thrombin time) when indicated and c) blood biochemistry 
(urea, creatinine, triglyceride, cholesterol, transaminases, total proteins, albumin, 
globulins, bilirubin, alkaline phosphatase, lactate dehydrogenase, creatine kinase). 
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Modification of the levels of these biochemical parameters have been reported in patients 
with dengue38-42. Total blood count and blood coagulation indicators were performed at 
the HC. These tests were indicated by the treating physician according to each patient. 
Blood biochemistry was performed in a private laboratory as part of our protocol.
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Figure 2. Flow-chart for febrile patient follow-up during the two first days of clinical 
monitoring. a) First day or day of presentation at the HC. Febrile patients with dengue criteria were 
notified to the study nurse by HC doctors. If the patient satisfied all inclusion criteria, including the 
signing of the informed consent form, a blood sample was taken for dengue diagnosis (RT-PCR), 
biochemistry tests and a total blood count. b) Second day of follow-up. Vital signs, tourniquet 
test, general signs and symptoms data were collected in the follow-up questionnaire and shown 
to the medical doctor together with the RT-PCR result. The patient was physically evaluated by 
the medical doctor and data was collected in the questionnaire. A blood sample was taken for 
different purposes. The procedure for the subsequent days of clinical monitoring were similar to 
those at day 2, except for the IgM which serological test which was done on day 2 of presentation 
and day 7 after fever onset.
4. Written Informed Consent and Assent 
According to the ethical principles from the Helsinki declaration43, each individual has 
the freedom to voluntarily participate in a human investigation. For that, the individual 
must sign an informed written consent form, once the study information has been 
understood. 
The information of the HC-based observational study presented in the written 
informed consent form was:
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a) Title of the study: Dengue in Venezuela: Epidemiology, risk factors and 
determinants of severe disease.
Figure 3. Days of patient follow up. a) Patients with fever and dengue criteria. A maximum of 
6 blood samples were taken together with clinical monitoring. b) Patients with severe dengue. A 
maximum of 8 blood samples were taken together with clinical monitoring. The blue line represents 
the period of fever  and viraemia (acute period). The red line represents the post-febrile period 
when the patient was hospitalized due to haemorrhagic manifestations. The convalescent sample 
was taken between 21-30 days after fever onset. The first day of visit to the HC is denoted as 0h. 
To test for dengue seroconversion, an IgM test was performed in both acute and convalescent 
samples
b) Institutional affiliation of the investigators: LARDIDEV, Maracay, Venezuela; 
Centre of Biomedical Investigation of Carabobo University, Maracay, Venezuela 
(BIOMED-UC) and University Medical Center of Groningen, Groningen, the 
Netherlands, were the institutional affiliations of the investigators.
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c) Study purposes: The aim of the study explained to the patient was: identify 
clinical and haematological predictors that could early differentiate dengue from 
other febrile diseases and within dengue, dengue fever from severe dengue.
d) Expected duration of individual’s participation: 1 month
e) Study procedure: Physical examination for dengue criteria5 (Fig. 1) will 
be performed by the HC’s medical doctor. A blood sample for early dengue 
diagnosis by RT-PCR, total blood count, serology and biochemistry tests will be 
extracted if the participant fulfils the dengue criteria. The participant must visit 
the HCs daily for clinical and haematological monitoring according to medical 
doctor indication and during the days shown in Figure 3a. In case of severe 
dengue, the participant will be referred to the Central Hospital of Maracay, where 
medical personnel will monitor the health of the patient and indicate treatment. 
Two more study blood samples will be taken in alternate days (Fig. 3b).   
f) Risk of the study: Because the only invasive procedure to be performed, 
involving both the participant as well as the study personnel, was the blood 
sample taken, the risks of this procedure were explained. Pain or discomfort 
could be felt by the participants and bruising or swelling could occur.
g) Benefits of the study: Early and free dengue diagnosis by molecular test (RT-
PCR), preference monitoring by the study nurse during dengue disease, were 
the benefits for the study participants. 
h) Confidentiality of the information: The assignation of a unique code to the 
participants in order to maintain their anonymity was explained. Only the study 
nurse, medical doctor and personnel of dengue diagnosis will know his/her 
name. All information given will be stored in locked cabinets at the BIOMED-UC 
institute. 
i) Voluntary participation: the voluntary participation in the study and the freedom 
to withdraw from the research at any time without penalty or loss of actual 
benefits were explained to the participant.
j) Contact details of research coordinator: the names and telephone numbers 
of the research local coordinators were given to the participants in case of 
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questions or problems with the study.
k) Residual blood sample: Permission to use the blood sample in other related 
dengue studies was asked to the participant in case of any residual blood.
Two written informed consent forms and two assent forms were prepared according 
to local ethical guidelines. The informed consents forms were applicable to adults (≥ 
18 years old) and parents or legal guardians of minors, while the assents were applied 
to children aged between 8 and 11 years and adolescents aged between 12 and 17 
years. The information contained in both consents and assents were the same but with 
a simpler explanation given in the assent form. 
5. Personnel Training
5.1. Medical doctors
Recruitment of patients into the study was performed at the emergency units of the 
HCs. Medical doctors working in these units were trained on study procedures every 
6 months by study personnel. New medical personnel was informed about study aims 
and procedures and trained on the filling up of the questionnaire in conjunction with the 
study nurse.  
5.2. Nurses 
The study nurses were trained in the standard operational procedure of the health 
centre-based study (SOP-follow-up). The main points of this SOP-follow-up training 
were:  
a) Identification of febrile patients: The febrile patients could be identified by 
the study nurse in the waiting room or by the medical doctor during the 
interview.
b) Dengue criteria: Dengue criteria according to WHO and adapted to our 
study5 (Fig. 1) were explained to the nurses. Even though the preliminary 
dengue clinical diagnosis was performed by the medical doctor of the HC, 
the study nurses were trained in the correct identification of these signs and 
symptoms. A proper documentation of these signs and symptoms in the 
follow-up questionnaire was explained.
c) Inclusion criteria: Participants of the study must fulfil the inclusion criteria 
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mentioned in section 3.1.  
d) Explanation of the study to the patients: The nurses were trained to 
clearly explain the study to the patient as well as all the items present in 
the informed-consent form. The training also included the type of consent/
assent to be signed by the patient according to his/her age. 
e) The follow-up questionnaire and its documentation: The nurses were trained 
in the definition of each variable present in the follow-up questionnaire and 
in the proper documentation of the data.
f) Tourniquet test: The nurses were trained in the correct performance of the 
Tourniquet test. The test is positive if ≥ 10 petechiae are counted within a 
diameter of 2 cm after inflating a blood pressure cuff to the midway pressure 
between the systolic and diastolic blood pressure for 3 min44.
g) Blood sampling: The blood sampling strategy according to the scheme of 
Fig. 3 was explained and training on the different case possibilities given. 
Once the training period was finished, uniforms and personnel identification cards 
were given. 
6. Study Approval and Funding
6.1. Bioethics committee
This study was approved by national and institutional bioethical committees.  At the 
national level, by the Ethics, Bioethics and Biodiversity Committee (CEBioBio) of the 
National Foundation for Science, Technology and Innovation (FONACIT) of the Ministry 
of Science, Technology and Innovation. At the institutional level, by the Ethics Review 
Committee of the Biomedical Research Institute, Carabobo University (Aval Bioetico 
#CBIIB(UC)-014), Maracay, Venezuela. 
6.2. CORPOSALUD Aragua
The Regional Health authorities of Aragua state approved the establishment of 
the study in Maracay city. CORPOSALUD is a governmental entity responsible for 
the planning, administration and supervision of the health system in the Aragua state. 
This entity is in charge of collecting epidemiological records of diseases of public 
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health relevance that occur in the Aragua state, as well as coordinating vector control 
measures45.
6.3. Ministry of Science and Technology
Our 4-year studies were approved on January, 2010 by the Ministry of Science and 
Technology (certification N° DGCAFIDCTI/204-214-10). With this approval, we were 
able to obtain funding from private companies during the first year of the study after 
meetings with company directives where our project and its importance were presented. 
The companies that financially supported the study were: Shell de Venezuela, 
Venezolana de Iluminación IVISA, Ferretería Hermanos Fridegotto, PC actual Valencia 
and Fundación Vollmer. Since 2011, our project was entirely financially supported by the 
National Science, Technology and Innovation Funds FONACIT, Project No. 2011000303 
under contract No. 201100129. For financial details see Chapter 2 of this thesis.
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Dengue transmission in Venezuela has become perennial and a major public health 
problem. The increase in frequency and magnitude of recent epidemics prompted a 
comprehensive community-based cross-sectional study of 2014 individuals in high 
incidence neighborhoods of Maracay city, Venezuela. We found a high seroprevalence 
(77.4%) with 10% of people experiencing recent infections. Multivariate logistic 
regression analysis showed that poverty-related socio-economic factors (place 
and duration of residence, crowding, household size, living in a shack) and factors/
constraints related to intradomiciliary potential mosquito breeding sites (storing water 
and used tires) were linked with a greater risk of acquiring a dengue infection. Our 
results also suggest that transmission occurs mainly at home.  The combination of 
increasingly crowded living conditions, growing population density, precarious homes 
and water storage due to enduring problems in public services in Maracay, are the 
most likely factors that determine the permanent dengue transmission and the failure of 
vector control programs. 
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1. Introduction
Despite control measures, dengue has become a major public-health problem in 
Venezuela. Epidemics of increasing magnitude regularly occur against a background 
of an established endemic situation. The most recent and largest outbreak took place 
in 2010 with 124,931 reported cases, 8.2% of them representing severe cases (Figure 
1)1. Concomitantly, the number of severe dengue cases has risen with time. Venezuela 
reported the highest proportion of severe cases (35.1%) in the Americas during 1980-
20072  and, together with Colombia, Mexico and Brazil, is predicted to bear the highest 
burden of disease in the region3. Although previous studies have pointed out certain risk 
factors for dengue transmission4-6, a detailed evaluation is warranted in order to identify 
possible control targets that can inform health authorities and ameliorate future dengue 
epidemics7. 
Dengue virus (DENV) belongs to the Flavivirus genus of the family Flaviviridae8. 
DENV is transmitted in urban and peri-urban settings by female infected day-biting 
Aedes mosquitoes, predominantly A. aegypti and A. albopictus9. There are four closely 
related serotypes (DENV-1 to -4) each of them capable of causing the entire range 
of dengue-related disease symptoms. Infected individuals can be asymptomatic or 
present with clinical manifestations varying from mild febrile illness, dengue fever (DF) to 
severe illness such as dengue hemorrhagic fever (DHF) and dengue shock syndrome10. 
According to recent estimates, 390 million dengue infections occur annually worldwide 
with approximately 96 million apparent infections3. WHO estimates that 500,000 people 
develop severe disease and of these 2.5% die9. Between 2000-2006, the Americas 
experienced 68% of worldwide dengue infections11, and over the last three decades, 
the number of dengue cases increased 4.6 times with a concomitant 8.3 times increase 
of severe cases2. Several factors are related to the increase of dengue incidence in the 
Americas. Amongst the most important ones are uncontrolled urbanization, absence 
of public services such as water supply, sewers and waste disposal12-14. Deterioration 
of mosquito eradication programs, decay in public-health infrastructure and changes 
in public-health policy contribute to the increase of vector density15. Globalization, 
international travel and climate change have also influenced the recent rapid spread of 
dengue10. 
Epidemic outbreaks of  DF were first recorded in Venezuela in 196416  and were 
partly attributed to the (re-)introduction of previously non-circulating DENV serotypes 
and strains coinciding with increased spread and densities of Aedes aegypti16-20 . In 
South-America, infection with the Asian DENV-2 genotype has been related with higher 
risk for DHF17, 20, 21. The first documented DHF case in Venezuela occurred in 1989, 
specifically in Maracay city, Aragua State, and coincided with the introduction of this 
strain22-24. Since then, Maracay has become one of the most important endemic urban 
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areas of the country with the co-circulation of all four dengue serotypes5. Recently, 
the presence of A. albopictus has been reported for the first time in Venezuela25. The 
introduction of this new vector may affect transmission patterns26. 
The persistence and increase of dengue transmission and severe disease in 
Venezuela (Figure 1) merit an assessment of the epidemiological dynamics of dengue 
infection. The present study was designed to estimate dengue seroprevalence and 
identify current risk factors for dengue transmission in high incidence areas of Maracay 
city, Venezuela.  
Figure 1.- Number of reported dengue cases in Venezuela and Aragua state, 2001-2012. 
DHF: Dengue hemorrhagic fever cases, shown as a proportion (hash bar) of the total number of 
cases (whole bar), values are shown on top of bars.  Source: MPPS Boletines Epidemiológicos 
2002-20121.
2. Materials and Methods
2.1. Study Area
Maracay is the fourth largest city of Venezuela and has become highly endemic 
for dengue transmission and DHF epidemics6, 27. It is the capital of Aragua state in 
the north-central region of Venezuela (10°15´N, 67°36´W) with an estimated 1.300.000 
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inhabitants28. The climate is tropical with two defined seasons: a dry (November-April) 
and a rainy (May-October) season. The temperature ranges between 25-35°C with a 
mean total annual precipitation of 834 mm. 
This study was conducted in two municipalities of Maracay with high dengue 
incidence. Within them, 3 neighborhoods or “barrios”, Candelaria, Cooperativa and 
Caña de Azúcar, were chosen for their proximity and access to a local (governmental) 
health centre (HC) where dengue cases can be identified. Cooperativa neighborhood 
is located in the north-east area of Maracay, while Caña de Azúcar and Candelaria 
are close to each other and located north-westerly. To place the present study into 
epidemiological context, national and regional dengue incidence data between the 
years 2001 to 2012 were compiled from the Epidemiological Bulletins reported by the 
Venezuelan Ministry of Health  (Figure 1)1.
2.2. Study Design
A cross-sectional study was carried out during the recruitment process of a 
prospective community-based cohort study to estimate dengue seroprevalence and 
identify risk factors for dengue infection. The study was set up with the intention of 
recruiting 2000 individuals between 5-30 years old, living in the neighborhoods of Caña 
de Azúcar (sectors 1 & 2), Cooperativa and Candelaria in Maracay city. Participants 
were recruited from August 2010 to January 2011 through house-to-house visits. The 
aims and scope of the project were clearly explained to all members of the household. 
Individuals invited to participate in the study were asked to sign a written informed 
consent and a copy was left with the participant. The inclusion criteria were: a) age 
between 5-30 years old, b) living in the study area with no intention to move in the 
following 3 years, c) consenting to attend the designated HC in case of any symptoms, 
d) absence of immune-compromising conditions, such as current immunosuppressive 
therapy or human immunodeficiency virus infection.
A structured questionnaire was applied to consenting individuals were demographic 
(age, gender, place of residence), socio-economic (occupation) and epidemiological 
data plus clinical history were collected. Given that informal work is a frequent source of 
income in developing countries, apart from asking to define their occupation, we asked 
our interviewees to indicate if they performed any kind of job or were engaged in any 
kind of study, or if they did not do any of those at the time of interview. All participants 
were physically examined by medically qualified study personnel. A 10 ml blood sample 
was collected to perform baseline dengue serology and a full blood count. A unique 
identification number was assigned to each participant to maintain anonymity. Socio-
economic and environmental data were gathered through a household questionnaire 
including type of housing, household ownership, number of people and rooms in 
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a household (all rooms except bathrooms); the presence of indoor/outdoor water 
containers (see below), litter, used tires and other possible mosquito breeding sites; 
the quality of public services in particular piped-water supply; and the use of mosquito-
protective measures (windows/door screening, use of indoor insecticide sprays/coils, 
use of mosquito repellent, use of mosquito nets, frequent washing of water containers). 
In Venezuela, the supply of piped water is not always regular and some households 
may store water in tanks and/or in containers to have constant access to water. In 
this study, tanks were defined as large plastic or concrete water storage repositories 
of at least 1000 liters capacity that supply water to the entire dwelling mostly via the 
intradomiciliary piping system, while containers were any type of water storage devices 
of different sizes including 200 liter metal drums. Each house was identified with a 
unique code and its geoposition was recorded with a hand-held Global Positioning 
System (GPS, Garmin Ltd.). 
The study was approved by the Ethics Review Committee of the Biomedical Research 
Institute, Carabobo University (Aval Bioetico #CBIIB(UC)-014), Maracay, Venezuela, the 
Ethics, Bioethics and Biodiversity Committee (CEBioBio) of the National Foundation for 
Science, Technology and Innovation (FONACIT) of the Ministry of Science, Technology 
and Innovation, Caracas, Venezuela; and by the Regional Health authorities of Aragua 
State (CORPOSALUD Aragua). The study was conducted according to the principles 
expressed in the Declaration of Helsinki29. All adult subjects provided written informed 
consent, and a parent or guardian of any child participant provided written informed 
consent on their behalf. Children between 8 and 17 years old provided written informed 
assent.
2.3. Haemaglutination-Inhibition (HI) Assay
Previous DENV infection at baseline for cohort study participants was determined 
using the HI test30. Dengue antigens, obtained from mouse brain, were provided by the 
Laboratory of Viral Immunoserology of the Venezuelan National Institute of Hygiene. 
The treated samples were screened in serial two-fold dilutions from 1:40 to 1:2560 
using DENV-1 as a broadly reactive antigen31. Those samples with titers below 40 
were retested in serial two-fold dilutions from 1:10 to 1:40 with a pool of all four DENV 
antigens using 4-8 haemaglutinin units per antigen. In accordance with the distribution 
of our data, a titer > 20 was taken as the cut-off point for seropositivity. 
2.4. Statistical Analysis
Two outcome variables for dengue infection were defined based on serology testing: 
a) Past dengue infection: HI titers > 20, b) Recent dengue infection:  HI titers ≥ 128031-33. 
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Univariate and multivariate analyses of potential risk factors for dengue infection were 
performed using SPSS (SPSS Inc., version 20.0, Chicago, Illinois) and STATA (Stata 
Statistical Software: Release 10. College Station, TX,) softwares. Data were analyzed 
anonymously. Variables considered as confounders were age, gender and place of 
residence. Continuous variables were converted into ordered categorical variables 
when suitable. Proportions were compared using chi-square tests and means by Z- and 
Student’s t-test. Fisher’s exact test was used when applicable. The Mantel-Haenszel 
score test examined trends in ordered categorical variables. Logistic regression was 
used to compare crude and adjusted odds ratios (OR). Significance was determined 
at the 5% level (P-value ≤ 0.05). Variables with a P-value ≤ 0.2 after adjusting by age 
group were fitted into multivariate logistic regression models and adjusted for further 
confounders. Effect modification was analyzed and resulting models compared by 
likelihood ratio test. Two separate final models contained variables independently 
associated with dengue infection for each of the outcome variables defined above.
3. Results
3.1. General Description of the Study Population.
Between August 2010 and January 2011, 2014 individuals living in 840 households 
were enrolled. Table 1 shows the general characteristics of the study population. The 
mean age was 17.2 years and differed between males (15.9 years) and females (18.2 
years, P < 0.001) but not between neighborhoods. There was a higher proportion 
of females recruited (57.1%, P = 0.023) mainly in Cooperativa neighborhood (Table 
1). The (geometric) mean number of persons per household was similar between 
neighborhoods. However, a lower mean number of rooms per household was found 
in Caña de Azúcar compared to the other neighborhoods (5.45 vs. 5.74, P = 0.017) as 
well as a higher proportion of people living under more crowded conditions (P < 0.001, 
Table 1). 
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Table 1. General characteristics of the study population (n = 2014)
Place of residence
Candelaria Cooperativa Caña de Azúcar Total
n (%) n (%) n (%) n (%)
Age (years)
5-10 119 (24.8) 144 (24.0) 195 (20.9) 458 (22.8)
11-15 96 (20.0) 110 (18.3) 204 (21.9) 411 (20.4)
16-20 85 (17.7) 117 (19.5) 188 (20.2) 390 (19.4)
21-25 89 (18.5) 105 (17.5) 148 (15.9) 342 (17.0)
26-30 91 (19.0) 125 (20.8) 197 (21.1) 413 (20.5)
Gender
M 226 (47.1) 233 (38.8) 404 (43.4) 864 (42.9)
F 254 (52.9) 368 (61.2) 528 (56.7) 1150 (57.1)




5.68 (1-17) 6.01 (1-21) 6.07 (1-15) 5.96 (1-21)
Num. people 
living in houses 
≤ 4 rooms




117 (26.0) 152 (26.5) 311 (35.3) 580 (30.5)
a Geometric mean (range). b Crowding is defined as the number of people in a household 
divided by the number of rooms of the household. This variable reports the number of people 
(and the proportion) that live in houses with high crowding defined as ≥ 1.5 persons per room.
3.2. Seroprevalence and Previous Clinical Dengue Disease
The recruitment of participants for our cohort study, and therefore the cross-sectional 
survey, coincided with the largest dengue epidemic experienced by the country and 
Aragua State (Figure 1). Dengue seroprevalence was determined by HI assay in 2002 
participants whose samples were available for testing. The majority of individuals (1550, 
77.4%) had been previously infected by DENV. Recent dengue infections (HI titers ≥ 
1280) were detected in 10% (201) of the individuals31, 32.
Overall, 20.5% (410/2005) of the individuals reported ever having had dengue, 
but 55 (13%) of them had HI levels below the cut-off point. Of those individuals who 
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had antibodies showing past or recent dengue infection, 77% (1190/1544) and 71.3% 
(142/199) respectively reported not having had dengue previously. 
3.3. Demographic and Socio-Economic Risk Factors
Table 2 shows adjacent univariate analyses of risk factors for each of the two 
outcome variables. 
Demographic factors. Age, gender, and occupation were significantly associated 
with past dengue infection whereas, age and place of residence, were related with 
recent dengue infection (Table 2). As expected, past dengue infection was associated 
with increasing age (score test for trend P < 0.001) and peaking at age 21-25 years. This 
age group was 14.5 times more likely to have been infected than children aged 5--10 
years (P < 0.001). However, subjects aged 16-20 years were more likely to be recently 
infected by DENV (OR = 2.49; P < 0.001). Females were 1.53 times more infected by 
DENV in the past (P < 0.001), but there was no gender difference with regard to recent 
DENV infection. The three neighborhoods chosen in this study have a history of high 
dengue incidence. However, people living in Cooperativa were 1.28 times more likely 
to be infected in the past than those living in the other two neighborhoods. On the other 
hand, subjects living in Caña de Azúcar were almost 2 times more likely to be recently 
infected by DENV (P = 0.001). 
The majority of the individuals recruited into the study reported to be students 
(68.5%), and of these 61% were younger than 15 years old. Only 123 people (6%) 
reported unemployment status. The only significant association within the variable 
















































































































































































































































































































































































































































































































































































































































































































































































































































































































































to DENV in the past (P < 0.001). However, when controlled by age group, the 
association disappeared (OR = 0.76, P = 0.362). In relation with recent dengue 
infection, housewives /domestic workers were at a higher risk of acquiring a recent 
dengue infection. This association became more evident when controlling for age (OR = 
1.92, P = 0.086). Individuals who work outside homes were less likely of having a recent 
infection (Table 2).
Socio-economic risk factors. The type of housing (P = 0.061), residing more than 16 
years in a household, having a job or being unemployed without any other activity at 
the time of the interview increased the likelihood of a past dengue infection, while the 
number of people living in a household and studying were protective (Table 3). The risk 
of having acquired a recent dengue infection was negatively associated with a higher 
number of rooms in the house and having a job at the time of interview, whereas a 
higher number of years living in a household and ‘crowding’, defined as the number of 
people per room in a house, were positively associated (Table 3).
“Rancho” is the vernacular name used in Venezuela to define a “shack” or an informal 
substandard type of housing typical of slum areas34. In our area of study, ranchos were 
found clustered in the outskirts of the neighborhoods. Most of them lacked piped-water 
supply. Despite the small sample size (n = 24 individuals in 13 dwellings), people that 
lived in ranchos were nearly 7 times more likely to acquire a previous dengue infection 
than those living in a house with a better structure (P = 0.061, Table 3). This association 
was not confounded by age, gender, number of people living in the house or crowding. 
The number of rooms and of persons per household, and ‘crowding’, are surrogate 
markers of socio-economic status. Individuals that inhabited households with more than 
4 rooms were less likely to have had a recent DENV infection (P = 0.038), whilst those 
sharing a crowded household with more than 1.5 persons per room were at higher 
risk (OR = 1.4, P = 0.046; Table 3). The strength of both associations increased when 
controlled by age. A larger number of household dwellers decreased the risk of past 























































































































































































































































































































































































































































































































































































































































































































































































































































































































As expected, the longer a person lives in an endemic area the higher the likelihood 
of infection by DENV. Both recent and past dengue infection were positively associated 
with the number of years people have lived in the same residence (Table 3). The risk 
of past dengue infection increased by 6.3% for every year lived in the household and 
those with more than 16 years inhabiting the same place were at a 1.56 higher risk. This 
effect was not completely explained by age since the association remained significant 
although its strength diminished after adjusting (OR = 1.18, P = 0.004). The association 
of this variable with recent dengue infection is somewhat weaker and loses significance 
after adjusting (P = 0.088).
Performing any kind of job or following any kind of study, or not doing any of those 
at the time of interview were all associated with past dengue infection, while recent 
dengue infection was only significantly associated with having a job (Table 3, last three 
variables). After adjusting for age, only to follow any kind of study remained significantly 
associated and was protective against acquiring dengue in the past while having a 
job provided almost 40% protection against being recently infected by dengue and 
remained significant after adjusting (P = 0.005).
3.4. Household and Environmental Risk Factors
Univariate analysis showed that to store water at home in general and to store water 
in containers (whether people stored water in tanks or not) increased the risk of having 
been infected with DENV in the past by 1.4 times (Table 4). Likely, people who stored 
water in containers were 1.34 times more likely to have acquired a recent DENV infection 
(Table 4). The number of water storage devices (tanks, containers, other) ranged from 
1 to 20 per house, with a mean of 1.8, however, there was no relation between the 
number of storage devices and dengue seropositivity. Approximately 94% (1897/2014) 
of the individuals reported that their homes were provided with all public services such 
as water, electricity, sewers and urban garbage collection, while 72% reported the 
daily supply of piped water or “regular water supply” to their dwellings. There was no 
association between the availability of all public services and regular water supply with 
dengue infection. The different ways of final trash disposal were not associated with 
DENV infection (Table 4). However, the presence of used car tires in people’s gardens/








































































































































































































































































































































































































































































































































































































































































































































































































































































































recent dengue infection (P = 0.035). Other known potential mosquito breeding sites 
such as litter and bottles in people’s gardens (outdoors) or flower/plant pots indoors, did 
not show a statistically significant association with dengue infection (Table 4). Similar 
results were found after adjusting by age group.
3.5. Mosquito Preventive Measures
All mosquito preventive measures showed a degree of protection against past 
(non-significant associations, data not shown) and particularly against recent dengue 
infection (Figure 2). In Venezuela, the use of indoor insecticide spraying is one of the 
most frequently used personal control measures against mosquito bites. This measure 
reduced the risk of recent dengue infection by 30% (P = 0.046). The strongest protective 
effect against recent infection was experienced by those reporting the use of mosquito 
nets (OR = 0.34) although the association was not significant (P = 0.14) probably due 
to the small sample size (n = 53). 
Figure 2.- Mosquito preventive measures and recent dengue infection. Association of the use of measures 
against mosquitoes or mosquito breeding sites and the risk of recent dengue infection. Values within bars 
indicate the number and proportion (in brackets) of seropositive individuals using/performing each measure 
(“yes”, hash bars) compared to seropositive people not using/carrying out those measures (“no”, empty bars). 
The total sample size for each mosquito preventive measure variable was n = 1993, except for the variable 
“mosquito net” (n = 1985). “Screened windows” indicates household’s where windows/doors houses were/
were not screened; “Mosquito net”: people reporting/not reporting the use of nets; “Indoor insecticide spray”: 
proportion of people reporting/not reporting the use of insecticide spray to kill indoor adult mosquitoes ; 
“Insect repellent”: proportion of people reporting/not reporting the use of insect repellent body lotions/spray 
to repel mosquitoes; “Frequent containers wash”: proportion of people reporting/not reporting the washing of 
containers used for storing water at least once a week. *OR = 0.74 (0.55-0.99) P = 0.046.
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3.6. Multivariate Analyses
The final models of factors independently associated with past and recent dengue 
infection are shown in Table 5. Increasing age, to store water in containers at home, 
increasing length of time living in the same residence and living in a shack (‘rancho’) 
were all positively associated with past dengue infection (Table 5, Part A). Those that 
increased the risk of recent dengue infection were: age, to live in Caña de Azúcar (place 
of residence) and having used car tires outdoors of households. Whereas people who 
reported having a job, and those who lived in houses with more than 4 rooms were less 
likely to have acquired a recent dengue infection. Individuals aged 16--20 years showed 
a higher risk of having been infected recently with DENV. Participants living in Caña 
de Azúcar were 1.71 times more at risk of exposure to a recent dengue infection than 
participants living in Cooperativa and Candelaria, while those that kept used tires in 
their household’s gardens or patios were 1.56 times more likely of having been infected 
recently with DENV.  People that reported to perform a job of any kind had a 44% 
reduction in the risk of being infected by DENV while a 26% reduction was observed for 
those living in better housing conditions represented by households with more rooms. 
4. Discussion
During the recruitment phase of a dengue community-based cohort study in 
Maracay city, Aragua State, Venezuela, a baseline cross-sectional study involving 
all 2014 recruited individuals was carried out. The study aimed to estimate dengue 
seroprevalence and to assess risk factors for dengue transmission that could partially 
explain the increase in the frequency and magnitude of recent epidemics in Venezuela, 
despite control measures. We found that 77.4% of the individuals had been exposed 
to dengue infection however, only 23% recalled a disease episode. Ten percent of 
the sampled population showed serological markers of a recent dengue infection. 
Multivariate analysis demonstrated that socio-economic factors (place of residence, 
number of rooms in the household, number of years living in this household, and living in 
a shack) and environmental factors related to mosquito breeding sites (storing water at 
home and having used car tires in their gardens/patios) determine the risk of acquiring a 
dengue infection in this population. Our data also suggest that people become infected 
mostly at home.
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Table 5.- Multivariate logistic regression models of risk factors for 
dengue infection
Part A.- Final model of risk factors for past dengue infection (n = 1939)
OR CI95 P-value
Age (years) 
5-10 1 - -
11-15 2.65 1.98-3.54 < 0.001
16-20 5.72 3.95-8.29 < 0.001
 21-30 9.31 6.44-13.46 < 0.001
Water storage in Containers 
No 1 - -
Yes 1.35 1.07-1.71 0.013
Number of years living in household 
0 – 16 1 - -
≥ 17 1.18 1.06-1.32 0.004
Type of housing 
House/apartment/other 1 - -
Ranchoa 7.65 0.99-59.15 0.051
Part B.-  Final model of risk factors for recent dengue infection (n = 1965)
OR CI95 P-value
Age (years) 
5-10 1 - -
11-15 1.92 1.16- 3.17 0.011
16-20 2.77 1.70-4.52 < 0.001
21-30 2.07 1.26- 3.39 0.004
Place of residence 
Candelaria/Cooperativa 1 - -
Caña de Azúcar 1.71 1.26- 2.31 < 0.001
Used car tires outdoors 
No 1 - -
Yes 1.56 1.01- 2.40 0.046
Having a job 
No 1 - -
Yes 0.56 0.36- 0.86 0.008
Number of rooms in the household 
1-4 1 - -
≥ 5 0.73 0.53-1.00 0.053
a The word “Rancho” in Venezuela is used to define a “shack” or informal housing typical of slum 
areas.
Maracay is one of the highly dengue endemic cities in Venezuela. The gradual 
introduction or re-emergence of DENV serotypes has been associated with substantial 
epidemics which mostly began in the central region of the country6, 17, 18, 20, 35. In the last 
decade, Venezuela has witnessed three dengue epidemic years (Figure 1)1. Dengue 
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incidence in Aragua State has mirrored these national epidemics. However, the last 
epidemic was exceptional in magnitude and duration, lasting for two years (Figure 1). 
Our cross-sectional survey took place during the second half of 2010 when the epidemic 
was at its peak. We found a high overall seroprevalence of 77.4% amongst the individuals 
recruited into the study. A previous study in schoolchildren 5--13 years-old in Maracay 
carried out during the 2001 epidemic found a lower prevalence (51%)27 compared to our 
study where 59% of children from the same age group were seropositive. This denotes 
an increase in transmission intensity in time though less steep than in areas where 
DENV was recently introduced36. Similar high population-based seroprevalences have 
been reported from other Latin American countries such as Peru37, Mexico38, Brazil39, 
40  and Nicaragua which reported higher figures41. Transmission intensity in Maracay is 
lower compared to current figures in Asia42, 43  but similar to those reported 15--20 years 
ago44, 45. 
Poverty-related socio-economic factors found in our study increased the risk for both 
recent and past infection. We have also found indirect evidence suggesting that DENV 
transmission occurs mainly at home in agreement with other authors39, 46. People that 
spent more time within homes, such as domestic workers and housewives were at a 
higher risk of acquiring a recent dengue infection (Table 2), while individuals that worked 
away from home were 44% less likely to have been recently infected  (Table 5). The 
place of residence, living in households with fewer rooms, duration of residence in the 
same household, and living in a shack, all increased the likelihood of dengue infection. 
Individuals that lived in more spacious dwellings were 27% less likely to have had a 
recent dengue infection while those sharing a crowded household were at higher risk. 
Braga et al.39  reported a 3 times increase in seropositivity in those living in crowded 
conditions in Brazil while others reported that low income was the main risk factor for 
past and recent dengue infection47. In our study neighborhoods, population growth and 
the need for extra income resulted in the sub-division of one-family dwellings into smaller 
“apartments” to house two or more families. The consequences are more crammed 
living conditions and deprivation48. Further, people that live in ranchos or shacks are 
subjected to the poorest living standards34 and to higher dengue  risk33, 39, 40. Despite 
the small sample size, living in ranchos was strongly associated with the risk of past 
dengue exposure (OR = 7.65, P = 0.051). This suggests that the low socio-economic 
situation of these individuals had not substantially changed over time48 keeping them 
at a higher risk of dengue infection. Between 0.4--21% of the dwellings in Aragua State 
are classified as ranchos49. Unplanned urbanization and population growth are some of 
the major determinants that have shaped the spread and persistence of dengue in the 
last decades2, 50, 51. 
Though most people in Maracay are aware of dengue as a disease, preventive 
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measures to avoid mosquito breeding sites are not always taken52. People who kept 
discarded car tires in their household premises had a 50% higher risk of a recent 
dengue infection, consistent with another study53.  Vehicle tires have played a major 
role in the international spread of dengue54. They appear to be a preferred breeding site 
for A. aegypti55  and also A. albopictus56, a newly introduced species in Venezuela25. 
Other intradomiciliary potential mosquito breeding sites, such as indoor flower vases, 
discarded bottles, animal pans and other type of litter kept in the open were not 
associated with dengue seropositivity in our study, contrary to others6, 53. Individuals 
that lived in dwellings where water was stored had on average a 1.4 times higher 
seroprevalence indicative of recent or past DENV infection (Table 4) in agreement 
with some57  but not others47. In our multivariate analysis, storing water in containers 
remained independently associated with dengue infection in the past corroborating that 
this practice is not new and may account for sustained dengue transmission at our study 
sites6, 14. People in all neighborhoods reported long-lasting deficits in public services 
such as frequent and prolonged interruptions in water supply and electricity, and 
irregular and insufficient garbage collection. Such shortcomings in public services have 
been associated to higher DF and DHF incidence and persistence in a 6-year analysis 
(1993--1998) in Maracay that included our study areas6. Although present for many 
years, these inadequacies have become more pronounced in recent years as people 
report daily interruptions of water supply for up to 12 hours or for several days a week. 
Shortage of piped-water supply has obliged residents to store water intradomiciliary 
maintaining adequate breeding conditions for dengue vectors during the dry season 
and throughout the year6, 14, 50, 58. 
The three neighborhoods selected for our study are areas of high incidence and 
persistence of dengue6. Although there were no significant differences between areas 
for past dengue seroprevalence, people living in Caña de Azúcar were 71% more at risk 
of acquiring a recent infection (Tables 2 and 5-B). This neighborhood is one of the most 
densely populated areas of Maracay49. Caña de Azúcar was related to a higher proportion 
of water storage in general (98%, P < 0.001) and in containers (67%, P < 0.001) than the 
other neighborhoods, as well as living in smaller houses and more crowded conditions 
(Table 1) increasing the chance for dengue transmission7, 40. The characteristics of this 
neighborhood seem to encompass the major risk factors found in this study. However, 
‘place of residence’ remained independently associated with dengue infection in the 
multivariate model, implying that hidden confounders not measured in this study may 
determine the higher dengue transmission in this neighborhood5, 36, 59. Finally, we 
evaluated the effect of personal mosquito preventive measures on the risk of dengue 
infection and found that all measures afforded some degree of protection. Yet, only the 
indoor use of insecticide spray was significantly associated with a lower prevalence 
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of recent infection (Figure 2) in agreement with others60. Mosquito nets showed the 
biggest effect against recent infection, but random error could not be excluded due to 
the small sample size (n = 53). 
In Cooperativa neighborhood, 5--10% of households with a probable higher socio-
economic status refused to participate. Socio-economic variables were similar between 
Cooperativa and Candelaria, where refusal was minimal. Therefore, we believe that 
selection bias in Cooperativa was small. A degree of recall bias is present when 
interviewing people on past experiences, such as having had dengue. However, people’s 
awareness about dengue is high in Maracay thus we do not expect a significant bias.
5. Conclusions and Implications for Dengue Control 
To our knowledge, this is the first comprehensive, systematic, community-based 
study of the impact of dengue and risk factors for transmission in Venezuela. High 
dengue seroprevalences were found in the studied neighborhoods of Maracay city. An 
important proportion of the population with preexisting immunity is a risk factor for the 
development of DHF in Venezuela27, 61, 62. A high proportion of individuals with dengue 
antibodies denied having had dengue previously. Dengue surveillance in Aragua 
State is based on a proactive system whereby laboratory confirmation of suspected 
cases identified in health centers is made20. This system may recognize increases 
in symptomatic cases prior to epidemics, but might not detect increases in “silent” 
transmission of inapparent infections. We suggest to complement this method with 
serological surveillance at community level during interepidemic years in sentinel areas 
already known for their high and perennial dengue incidence5, 6, 63.
In an endemic situation where all 4 DENV serotypes circulate, factors other than the 
solely (re-)introduction of different DENV genotypes may influence the maintenance of 
dengue transmission and rise in epidemic peaks2. Our findings show that socio-economic 
status and environmental factors/constraints linked to intradomiciliary potential mosquito 
breeding sites, determined the risk of recent and past dengue infection. Moreover, 
transmission appears to occur mainly at home, thus control strategies should be aimed 
at reducing vector-host contact in residential areas. The combination of increasingly 
crowded living conditions, higher population density51, precarious homes (shacks) and 
a high proportion of households storing water due to lasting  problems in public services 
in Maracay4, 6, 14, are the most likely factors that determine the permanent dengue 
transmission and the failure of vector control programs. 
Dengue control in Venezuela is restricted to actions around the notification of 
suspected dengue cases such as fogging around blocks of houses of reported cases; 
and to campaigns of larval/pupae control plus information on dengue preventive 
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measures during high transmission/epidemic periods20, 64. Unfortunately, these focal 
activities have proven unsuccessful51, 52, 65. We suggest to improve the current focal 
control activities and establish i) community sentinel-site surveillance alongside the 
already existing health centre-based surveillance, ii) a permanent and updated vector 
control program52, 64, 66  and iii) continued public education on dengue prevention 
measures (e.g. elimination of discarded used tires). Alongside, political commitment 
is essential to direct enough resources to improve public services and socio-economic 
conditions of the less privileged if a change in epidemic patterns is to be expected.
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Dengue has become one of the most important public health problems of urban 
areas in Venezuela. Despite control measures, transmission of dengue in Venezuela has 
become perennial. Control of dengue and of its mosquito vector has proven challenging 
in settings of uncontrolled urban growth and unreliable water supply. Using mapping 
technology and spatial analysis of epidemiological and seroprevalence data we attempt 
to draw risk-maps at a fine scale to identify clusters (hot spots) of dengue transmission 
within neighbourhoods with high dengue incidence in Maracay, Venezuela. We found 
clusters of high dengue transmission at block and household levels for recent dengue 
prevalence, but not for past infection. Hot spots were mainly found in Caña de Azúcar 
neighbourhood as well as the only Kulldorff cluster. Our results suggest that dengue 
transmission is highly focal (50-80 mts). The identified hot spots can be used to target 




Dengue is a mosquito-borne viral disease of global impact, with a rapid increase in 
the number of cases. According to WHO estimations, 50-100 millions of new infections 
occur annually in the tropical and subtropical areas of the world4,12. However, a recent 
cartographic study estimated the number of annual infections to be 390 million1. DENV 
and its vector have spread into previously unaffected areas and currently dengue 
is endemic in 125 countries2-4. Factors related with dengue expansion and with the 
increase of dengue incidence are human population growth, uncontrolled urbanization, 
international travel, transport of the mosquito larvae/eggs by water, land or air, inefficient 
control vector strategies, increase of mosquito habitats and low socio-economic status5-8. 
Dengue virus (DENV) belongs to the Flavivirus genus of the family Flaviviridae 
together with yellow fever, West Nile and Japanese encephalitis viruses9. It is transmitted 
by the bite of the female Aedes mosquito, mainly A. aegypti10. Although  A. albopictus 
is a less efficient vector, it has been related to dengue outbreaks11. The dengue viruses 
consist of four serologically distinct serotypes (DENV-1 to -4)7. Dengue infection can be 
asymptomatic, or present with a symptomatic clinical spectrum ranging from dengue 
without warning signs to sever dengue. Fatal cases occur when patients are not properly 
and timely treated12.
Dengue has become one of the most important public health problems of urban 
areas in Venezuela. Dengue is endemic in this country with the co-circulation of the 4 
viral serotypes13. Control of dengue and of its mosquito vector has proven challenging 
in settings of uncontrolled urban growth and unreliable water supply. Despite control 
measures, transmission of dengue in Venezuela has become perennial with three 
large epidemics in the past decade14. The most recent and biggest dengue epidemic in 
Venezuela occurred in 2010, where approximately 125,000 dengue cases with 10,300 
(8.6%) of severe cases were reported14. In this year, Venezuela was the third country 
with the highest number of dengue cases in the Americas and the second reporting 
a high number of severe cases15. Dengue control in Venezuela involves strategies 
to reduce the mosquito vector such as the elimination of breeding sites, fogging and 
the use of larvicides16. Also, epidemiological surveillance and education programs are 
involved in dengue control17. 
Currently, spatial analysis has become an important tool for public health. This 
methodology has been used in the identification of areas of high transmission of vector-
borne diseases such as malaria and dengue in order to target control measures18-20. 
Previous studies in Venezuela using reported epidemiological data show that certain 
areas are more prone to maintain higher dengue transmission and for longer periods 
than other21 indicating that some conditions are stable through time. The ability to identify 
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high-risk areas of dengue transmission can be used to target surveillance and control 
measures to those locations in a cost-effective manner, particularly in countries where 
resources are scarce. Using mapping technology and spatial analysis of epidemiological 
and seroprevalence data we attempt to draw risk-maps at a fine scale to identify clusters 
(hot spots) of dengue transmission within neighbourhoods with high dengue incidence 
in Maracay city, Venezuela.
2. Materials and Methods
2.1. Area of Study
Maracay is the capital of Aragua state in the north-central region of Venezuela 
(10° 15′ 6″ N, 67° 36′ 5″ W) with an estimated population of 1.139.000 inhabitants22. 
There are two seasons, a dry (November-April) and a rainy season (May-October). The 
annual average temperature is  25.5°C (min 19 °C, max 31 °C) with 74% of humidity and 
an annual precipitation of 910 mm23. Three neighbourhoods within two municipalities of 
high dengue incidence21 were chosen for the study (Figure 1). Caña de Azúcar and 
Candelaria neighbourhoods, from Mario Briceño Iragorry municipality, are located close 
to each other in the north-western area of Maracay. These neighbourhoods have a 
population of 99.852 inhabitants22 in an area of 54 km², are divided by the “Limón” 
river, and surrounded by the mountainous National park “Henri Pittier” in the north 
(Figure 1). Cooperativa neighbourhood belongs to Girardot municipality and is situated 
in the north-east of Maracay. The river “Las Delicias” runs along Cooperativa’s Eastern 
border24 (Figure 1). Girardot municipality has a population of 407.577 inhabitants22 in 
an area of 31.157 km². Both municipalities are located within the metropolitan area of 
Maracay which is part of the watershed of Valencia Lake. 
The metropolitan area of Maracay comprises pre-planned urban areas. However, 
unplanned developments can be found in the same area. These unplanned areas 
are characterized by the lack of public services such as electricity, water supply and 
garbage collection. In addition, piped-water supply is deficient in the entire Aragua 
state. Therefore, the population store water in tanks and other containers in order to 
ensure constant access to water25.
2.2. Study Design
The baseline cross-sectional study that was carried out during the recruitment 
process of a four years prospective community-based cohort study is fully explained 
elsewhere25. Briefly, 2012 individuals aged 5-30 years located in 840 households of 
the before mentioned neighbourhoods were enrolled, from August 2010 to January 
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2011, through house-to-house visits. The aim and the scope of the study were 
clearly explained to all members of the household and the individuals were enrolled 
after informed consent. Data were collected in two structured questionnaires, an 
individual and a household questionnaire. In the individual questionnaire, data related 
to socio-demographic, epidemiologic and clinical history were recorded while, socio-
economic and environmental factors were recorded in the household questionnaire. 
Serological and hematological data were acquired through blood sample collection. The 
geographical location of each house was obtained using a hand-held Global Positioning 
System (GPS, Garmin Ltd.)25.
Figure 1.- Area of Study: 1) Map of America; 2) Venezuela; 3) Aragua State and study sites 4a) Candelaria 
neighbourhood; 4b) Caña de Azúcar neighbourhood and, 5) Cooperativa neighbourhood.
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2.3. Dengue Seroprevalence
 Dengue seropositivity was determined using the Haemaglutination Inhibition (HI) 
Assay and described elsewhere25.  Dengue antigens, obtained from mouse brain, 
were provided by the Department of Viral Immunoserology of the Venezuelan National 
Institute of Hygiene. Two outcome variables for dengue infection were defined based on 
serology testing:  a) Past dengue infection: HI titres >1:20, b) Recent dengue infection: 
HI titres ≥ 128025.
2.4. Spatial Analysis. Hot Spot Detection
To evaluate the presence of spatial dependency of dengue seroprevalence, we used 
two local measures of spatial association, the Kulldorff scan statistic26 and the local 
Getis statistic Gi*(d)27. We used two units of spatial analysis: 1) at household level, and 
2) at block level. Dengue seroprevalence at block and household level was calculated 
as the total number of individuals seropositive divided by the total number of individuals 
surveyed in a block or household respectively. 
The Kulldorf scan statistics identifies significant excesses of dengue cases (e.g., the 
most likely cluster of seropositive individuals) with respect to the adjacent geographic 
area18,28,29. This method generates a circular scanning window that moves systematically 
across space in order to find an unusual clustering of data18,28,30. In our case, an excess 
of recent or past dengue infections at block level. The probability for the most likely 
cluster (P value) is obtained through multinomial Monte Carlo simulations26.
The local Getis statistic, Gi* (d), was used to identify significant local clustering 
(hot spots) of high positive dengue values with respect to past and recent dengue 
prevalence at household and block level. This method, uses a circular analysis window 
of specific distance d (radius) that surrounds a particular block or household with nearby 
locations being expected to have similar values. The test measures if the clustering of 
dengue cases is greater than expected by chance and the probability is defined by a P 
value<0.05. Gi* (d) was calculated at varying distances from 20 km to 200 km.
ClusterSeer software 2.2.8.1 (TerraSeer, Ann Harbor, MI) was used to perform the 
Kulldorff scan statistic and the local Getis statistic (Gi*). The results were shown in maps 
using the softwares QGIS 1.8.0-Lisboa (GNU - General Public License) and ArcGIS 10 
(ESRI Corporation, Redlands, CA). The satellite images of each neighbourhood were 
obtained from Google EarthTM.
2.5. Ethics 
The study was approved by the Ethics Review Committee of the Biomedical Research 
Institute, Carabobo University (Aval Bioetico #CBIIB(UC)-014), Maracay, Venezuela, the 
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Ethics, Bioethics and Biodiversity Committee (CEBioBio) of the National Foundation for 
Science, Technology and Innovation (FONACIT) of the Ministry of Science, Technology 
and Innovation, Caracas, Venezuela; and by the Regional Health authorities of Aragua 
State (CORPOSALUD Aragua). The study was conducted according to the principles 
expressed in the Declaration of Helsinki.
3. Results
The risk maps shown in Figure 2 represent the spatial distribution and local 
clustering of dengue seroprevalence at a fine scale in the area of study.  Only those 
blocks where data was collected are included in the analysis. Dengue seroprevalence 
is stratified at block level whereby past infection is visualised by a colour grading of the 
blocks themselves indicating a prevalence from 0% to 100%. Similarly, recent dengue 
prevalence is represented by a block centroid (a point that defines the geometric centre 
of an object) that varies in size and colour according to the prevalence (from 0% to 50%). 
All neighbourhoods showed geographic variability of recent dengue seroprevalence at 
block level indicating heterogeneity in the geographic distribution of dengue. However, 
past infection had a more homogeneous distribution with most blocks displaying 
prevalences above 40%. 
The two local measures of spatial association applied in this study look for unusual 
clustering of data. However, there were not significant results with regards to past 
dengue infection probably due to the high prevalence in the population under study 
(77%)25.Cluster results refer therefore, to the prevalence of recent dengue infection. The 
area were most clusters were identified was Caña de Azúcar neighbourhood (Figure 
2-1b). This neighbourhood encompassed the only significant cluster of recent dengue 
infections detected by the Kulldorff scan statistic.
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Figure 2.- Stratification of recent and past dengue seroprevalence at block and household level in the 
studied neighbourhoods. 1a) Candelaria; 1b) Caña de Azúcar; 2) Cooperativa. Past dengue seroprevalence 
is presented as coloured blocks. The grading of colours in the blocks indicates percentage of dengue 
seroprevalence from 0% (lighter) to 100% (darker). Recent dengue seroprevalence at block level is represented 
as filled circles. The grading of colours and the size of the circles indicate recent dengue prevalence from 
low (small and lightly coloured circle) to high (bigger and darker circles). Black dots represent the households 
surveyed in each block. Yellow circles represent hot spots for recent dengue prevalence at block level (Gi* 
[d]> 2.58; P <0.05). The red dashed circle represents Kulldorff clusters for recent dengue prevalence. Green 
dots represent hot spots at household level for recent dengue prevalence.
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Significant hot spots of recent dengue infection (Gi* [d]> 2.58; P <0.05) were detected 
at block and household levels in Caña de Azúcar and Cooperativa neighbourhoods 
(Figure 2-1b and 2-2). In Caña de Azúcar, 4 significant clusters at block level and 32 
at household level were detected (Figure 2-1b) while Cooperativa showed 1 cluster 
at block level and 6 clusters at household level (Figure 2-2). No significant clusters 
at block nor household level for recent dengue prevalence were found in Candelaria 
neighbourhood (Figure 2-1a). Significant differences were detected in all clusters when 
the distance (d, radius of the window) oscillated between 50-80 meters. 
4. Discussion
From August 2010 to January 2011, a baseline cross-sectional study was carried out 
during the recruitment process of a prospective community-based cohort study. Dengue 
seroprevalence for past and recent dengue infection was determined in the study 
population and their households were georeferenced. We used map technology and 
spatial analysis of seroprevalence data to draw risk-maps at a fine scale and identify 
clusters (hot spots) of dengue transmission. We found that recent dengue prevalence is 
highly heterogeneous at the studied spatial scale. The results also suggest that dengue 
transmission is highly focal. The majority of hot spots of recent dengue infection were 
detected in Caña de Azúcar neighbourhood. 
Spatial hot spots of recent, but not past, dengue seroprevalence were found at 
block and household levels in the studied neighbourhoods. These results indicate a 
more homogeneous distribution of past dengue infection. The high proportion (77%) of 
individuals with total anti-dengue antibodies may partially explain this homogeneity25. 
On the other hand, the presence of hot spots at block and household levels for recent 
dengue prevalence indicates a heterogeneous distribution with areas of increased 
dengue transmission especially in one neighbourhood (Caña de Azúcar). Recent 
dengue transmission occurred in a range of 50-80 mts suggesting that dengue infection 
is highly focal. This may be related to the vector (Aedes aegypti) finding all the conditions 
needed to breed and reproduce at that spatial scale (indoor house transmission/
risk). Environmental variables such as rainfall, temperature, humidity and proximity of 
water bodies may be creating suitable ecological conditions for the development of A. 
aegypti31-33. In a previous study in the same communities, the presence of used car 
tires in people’s gardens/patios and the practice of water storage were independent risk 
factors for dengue transmission25. These potential intra- and peri-domiciliary breeding 
sites may increase the probability that female A. aegypti lay their eggs in different 
breeding sites in one gonotrophic cycle34. Female mosquitoes spend their lives in or near 
households if feeding sources and breeding sites are available35,36. Caña de Azúcar was 
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the neighbourhood with the highest number of hot spots of recent dengue transmission 
compared to the other two neighbourhoods. Indeed, the only cluster detected by the 
Kulldorf scan test was found in this area. This result is in concordance with that found by 
Velasco-Salas et al. where people that resided in this neighbourhood were 71% more 
at risk of being recently infected with dengue25. Caña de Azúcar was related to a higher 
proportion of water storage in general and in containers than the other neighbourhoods, 
as well as living in smaller houses and more crowded conditions increasing the chance 
for dengue transmission5,25,37.
This study has as a limitation the absence of entomological data that may complement 
our results. However, these results can be supported by the identified risk factors for 
dengue infection performed in the same population in a previous study.
5. Conclusion
In this study, we draw risk maps at fine scale with the identified clusters of high 
dengue transmission. We found clusters at block and household levels for recent dengue 
prevalence, but not for the past. Our results suggest that dengue transmission is highly 
focal. Hot spots were mainly found in Caña de Azúcar neighbourhoods as well as the 
only Kulldorff cluster. Awareness about the geographic location of dengue hot spots 
helps target control measures in the areas of greatest transmission risk. Targeting hot 
spot houses or blocks may lead to a general decrease in dengue cases in the studied 
localities. Geographic Information Systems (GIS) tools provide relevant information 
about geographical distribution patterns of dengue disease risk, providing insights into 
the possible causes that lead to the perennial dengue transmission in Venezuela.
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Patients infected with dengue virus may have a clinical presentation that varies 
from mild to the severe forms of the disease. However, at the beginning of the llness 
the patient presents with non-specific symptoms that can be easily confused with 
other febrile illnesses (OFI). The identification of dengue patients at the early stage of 
the disease may substantially decrease fatalities due to misdiagnosis and lower the 
overburdening of health centres. To date, there are not accepted guidelines for the early 
recognition of dengue infection. The purpose of this study was to identify parameters 
that could differentiate dengue from OFI at the early stage of the disease (≤72h from 
fever onset) and design a decision-tree algorithm using clinical features and routine 
laboratory tests. Data was derived from a three year health centre-based cohort study 
that was established in a dengue hyperendemic city of Venezuela. We constructed 
a diagnostic algorithm using white blood cells (WBC) count, rash, mean corpuscular 
haemoglobin (MCH) levels and haemorrhagic manifestations in sequential order that 
distinguished dengue from other febrile illness. Multivariate analysis determined that 
the presence of rash, haemorrhagic manifestations and the decrease of platelet counts, 
WBC count and MCH were independently associated with dengue during the first 3 days 
of the disease. On the other hand, during days 4-7 of the disease, body temperature 
<39°C, the presence of rash, haemorrhagic manifestations and the decrease of platelet 
counts and WBC count were independently associated with dengue cases. Finally, the 
decrease of cholesterol and an increase of albumin were the two biochemical parameters 
independently associated with dengue infection during the first 3 days of the disease. 
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1. Introduction
Dengue fever has become the most important viral vector-borne disease of the 
tropical and subtropical areas of the World1. The average number of dengue cases 
reported by the World Health Organization (WHO) has increased considerably in the 
past decades2. Recently, 390 million of dengue cases have been estimated to occur 
annually according to cartographic studies3. Dengue has also expanded to new areas. 
In 1950, only nine countries reported the presence of dengue4. Up to now, more than 
120 countries report dengue cases5. Recently, autochthonous dengue outbreaks were 
reported in European countries including France, Croatia and Portugal6. The expansion 
of dengue and the rising number of cases have been attributed to globalization, increase 
of population density and uncontrolled urbanization. The latter is the consequence of 
the increased exodus of people from rural to urban areas1,7,8. The lack of basic services 
linked to uncontrolled urbanization have led to an increase of breeding sites of the main 
dengue vector, Aedes aegypti 9-11.
There are four serologically different types of dengue virus (DENV1-4)12.  Infection 
with any of the DENV serotypes may result in the clinical spectrum characteristic of 
dengue disease13. The majority of DENV infections are considered to be asymptomatic14. 
However, when infections are symptomatic, they can present with a wide range of 
clinical manifestations. According with the recent WHO classification, these vary from 
dengue without or with warning signs to severe dengue (defined as severe plasma 
leakage or severe bleeding or severe organ involvement)15. Death can occur when 
severe cases are not opportunely and appropriately treated15. At the beginning of the 
disease, the patient presents with non-specific symptoms such as fever, headache, 
myalgia, arthralgia, retroocular pain, nausea, vomiting and rash. These symptoms can 
be easily confused with other febrile illnesses like influenza, leptospirosis, malaria, 
rickettsiosis, typhoid fever or chikungunya among others16-19. During the first 24-48h 
after the fever recedes (critical phase), the patient has to be carefully monitored to guard 
the appearance of warning signs. However, the patient in this phase can already be 
critically ill20. To date there are no antiviral treatment modalities for dengue and vaccines 
are still under study21. Nevertheless, an early treatment intervention can reduce the 
case fatality from 20% to 1% or less2,15,22.
To date, there are not accepted guidelines for the early recognition of dengue 
infection23. Therefore, an algorithm that differentiates dengue from other febrile illnesses 
(OFI) at the early stage of the disease is urgently needed in order to avoid fatalities due 
to misdiagnosis and overburdening of health centres. In many countries, a serological 
test is the most common laboratory investigation used to diagnose dengue. This test 
confirms dengue infection at the late stage of the disease24. Laboratory techniques for 
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early dengue virus detection, such as molecular (Reverse Transcriptase Polymerase 
Chain Reaction, RT-PCR) and virus isolation techniques, are expensive and not 
available at primary health care services25. On the other hand, suspected cases clinically 
detected at the early days of the disease present low concordance with laboratory-
confirmed cases in the American countries26,27 creating unnecessary hospitalizations. 
The purpose of this study was to identify parameters that could differentiate dengue 
from OFI at the early stage of the disease (≤72h from fever onset) and design a decision-
tree algorithm using clinical features and routine laboratory tests. Data was derived 
from a three year health centre-based cohort study that was established in a dengue 
hyperendemic city of Venezuela. We also present a multivariate analysis that identified 
parameters that discriminate dengue from OFI after day 3 of fever onset.
2. Materials and Methods 
2.1. Study Site
Maracay is the capital of Aragua state and is located in the north-central region 
of Venezuela. It is the fourth largest city of the country with approximately 1 million 
inhabitants and has become highly endemic for dengue transmission and dengue 
haemorrhagic fever epidemics28,29. Three public primary health centres (HCs) located in 
areas with a history of high dengue incidence30 (LARDIDEV personal communication), 
availability of 24h emergency service and the presence of laboratory facilities were 
selected for the study. The HCs “Unidad de Emergencia la Candelaria” and the “Instituto 
Venezolano de los Seguros Sociales (IVSS) El Limón” are located in the north-west 
area of Maracay (Mario Briceño Iragorry municipality), while the “Ambulatorio del Norte” 
is found north-easterly (Girardot municipality). The Hospital Central de Maracay is a 
tertiary level hospital where patients with severe manifestations of dengue were referred 
for hospitalization. This hospital covers the whole of Maracay city’s population.
2.2. Study Design
A health centre-based prospective observational cohort study was established in 
Maracay, Aragua state, Venezuela to identify clinical and laboratory parameters that 
could differentiate dengue from OFI at an early phase of the disease.
2.3. Data Collection
Our study was conducted between October 2010 and December 2013. Patients 
of all ages, presenting at the HC within a maximum of 72 hours of fever onset with 
clinical signs and symptoms suggesting dengue infection15 or without any signs of a 
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localised infection were identified by trained medical doctors and study nurses. The 
patient was physically evaluated by the treating physician together with the study nurse 
and enrolled in the study after signing an informed consent/assent form. A blood sample 
was taken on presentation to perform a full blood count and dengue diagnosis by RT-
PCR31. The patient was asked to return daily for medical monitoring and evaluation 
until he/she was afebrile for 48 hours and at 21-30 days after fever onset for a follow-
up visit. Blood samples to perform total blood count and blood biochemistry were 
taken at 24h, 48h and 72h during the febrile phase, 48h post-febrile and at 21-30 days 
(convalescent sample). If the patient was hospitalised by the treating physician, study 
medical personnel continued the monitoring until discharge. Two extra blood samples 
were taken on alternate days during hospitalisation. A modified IgM antibody-capture 
enzyme-linked immunosorbent assay (MAC-ELISA)32 was performed in blood samples 
taken on the second day of the visit to the HC and during the convalescence visit.
On presentation, demographic, epidemiological data and clinical history were 
documented in a structured follow-up questionnaire. Demographic data included: 
personal data, date of birth, sex, address of household and place of study or job. 
Epidemiological data included history of past dengue infection, hospitalisation due to 
dengue disease and recent travel history. The presence of diseases and/or treatment 
that could influence dengue evolution like diabetes, hypertension, asthma, hepatitis, 
lupus, sickle cell anaemia or neoplasia33-36 was recorded. Information on clinical findings, 
laboratory tests, complementary tests and treatment received were documented daily 
in the follow-up questionnaire. Laboratory data included daily full blood count and 
blood biochemistry: urea, creatinine, triglycerides, cholesterol, hepatic transaminases, 
pancreatic amylase, total proteins, albumin, globulins, total and fractionated bilirubin, 
alkaline phosphatase, lactate dehydrogenase (LDH) and creatine kinase (CK). Blood 
coagulation indicators (prothrombin and thrombin time) and other tests were performed 
when indicated by the treating physician.
2.4. Definitions
Patients with dengue were defined as those with a positive single anti-dengue IgM 
or anti-dengue IgM seroconversion and/or positive RT-PCR test. Patients that fulfilled 
the inclusion criteria but who did not have a laboratory positive test for dengue were 
defined as OFI. The days of the disease were defined as follows: day 0 (<12h); day 
1 (12-24h); day 2 (24-48h); and day 3 (48-72h) after fever onset. The early phase 
of the disease comprised days 0 to 3. Age was divided in two groups: children and 
adults. Those patients aged up to 14 years old were considered children, while adults 
were patients over 14 years of age. Haemorrhagic manifestations were defined as the 
presence of at least one of the following: positive tourniquet test, petechiae, epistaxis, 
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gingivorrhagia, melena, bloody stools, haematuria, menorrhagia and/or haematemesis. 
Positive tourniquet test was defined as the presence of ≥ 10 petechiae within a diameter 
of 2 cm after inflating a blood pressure cuff to the midway pressure between the systolic 
and diastolic blood pressure for 3 min37.
2.5. Statistical Analysis
The outcome variable was defined as laboratory confirmed dengue infection. Two 
separate analysis were performed, one for parameters differentiating dengue vs. OFI at the 
early stage of the illness (≤72h from fever onset) and a second analysis comprising days 
4-7, or late disease stage. Data was checked for consistency and analysed anonymously. 
The proportions of clinical signs and symptoms per day of illness were analysed using 
a chi-square test in case of expected frequencies higher than 5, whereas Fisher’s exact 
test was used when the expected counts were smaller than 5. For normally distributed 
quantitative data, means were compared using Student’s t-test. If the quantitative data 
was not normally distributed, a Mann-Whitney U test was used. Cut-off point values were 
calculated according to the means in normally distributed quantitative data and on data 
distribution for non-normally distributed data. Cut-off point values reported in the literature 
were also used. The slopes of continuous variables that were normally distributed were 
estimated for each participant by lineal regression analysis. These slopes were calculated 
at the early stage and 4-7 days of the disease separately. Slopes of variables that equalled 
zero meant that there was no change in time for that particular variable. Data from the first 
three days of the disease and from 4 to 7 days were collapsed and analysed separately. 
Multivariate logistic regression analysis was used to identify parameters that were 
independently associated with confirmed dengue infection. All variables were adjusted by 
age group and those with P-values ≤ 0.2 were chosen for the final multivariate analysis. 
A manual step-wise forward selection was used, considering a P-value equal or less than 
0.05 or a modification of more than 10% in other variables’ odds ratio (OR) as the criterion 
to maintain variables. Data was analysed using SPSS (SPSS Inc., version 20.0, Chicago, 
Illinois) and STATA (version 11, College Station, TX) software. 
Decision-tree algorithm: Parameters independently associated with dengue infection 
in the final multivariate analysis at the early stage of the disease were used for the 
decision-tree algorithm construction. Only cases without missing values were used in the 
analysis. Based on logistic regression models, variables with highest OR and smallest 
P-values were used for node decision. In case of high standard errors and confidence 
intervals due to small numbers in a branch of the tree, Fisher’s exact test was used for 
node decision. Nodes became end notes if there were no significant variables left or cells 




2.6. Ethic Statement 
The study was approved by the Ethics Review Committee of the Biomedical Research 
Institute, Carabobo University (Aval Bioetico #CBIIB(UC)-014), Maracay, Venezuela, the 
Ethics, Bioethics and Biodiversity Committee (CEBioBio) of the National Foundation for 
Science, Technology and Innovation (FONACIT) of the Ministry of Science, Technology 
and Innovation, Caracas, Venezuela; and by the Regional Health authorities of Aragua 
State (CORPOSALUD Aragua). The study was conducted according to the principles 
expressed in the Declaration of Helsinki38. All adult subjects provided written informed 
consent, and a parent or guardian of any child participant provided written informed 
consent on their behalf. Children between 8 and 17 years old provided written informed 
assent.
3. Results
3.1. General Description of the Study Population 
Between October 2010 and December 2013, 275 patients met the inclusion 
criteria and accepted to participate in the study. Data from 21 patients was excluded 
from the analysis as the patients were lost to follow up. The mean age of the 254 
participants included in the analysis was 19.2 years old (range 11 months-74 years 
old). Within the total population, 111 (43.7%) were children (≤14 years old) and 145 
(57.1%) were male. Based on the diagnosis criteria described above (see materials and 
methods, section definitions), 112 (44.1%) patients were defined as having an acute 
dengue infection while 142 were classified as presenting with an OFI at the moment 
of recruitment. According to the 1997 World Health Organization (WHO) criteria39, 101 
(90.2%) participants were classified as presenting with dengue fever (DF) and 8 (7.3%) 
with dengue haemorrhagic fever (DHF), while 68 (63%) patients were categorized as 
dengue without warning signs, 34 (31.5%) as dengue with warning signs and 6 (5.6%) 
as severe dengue according to the 2009 WHO criteria15. The four dengue serotypes 
circulated during the study period with a predominance of DENV-3 (33.0%) followed by 
DENV-1 (29.5%), DENV-2 (20.5%) and finally DENV-4 (17.0%). The serotype mostly 
associated with severe cases was DENV-2, 5 out of 6 (83.3%) severe cases carried this 
serotype. DENV-1 was present in 21 out of 55 (38.2%) patients diagnosed with dengue 
without warning signs while DENV-3 was detected in 12 out of 27 (44.4%) cases of 
dengue with warning signs.
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3.2. General Characteristics of Patients with Dengue and OFI 
Approximately, 71% of the patients were recruited between the second or third day after 
fever onset. Patients infected with dengue were younger than those with OFI (median 
age 14.5 years vs 18.6 years old respectively; P=0.032), however no gender differences 
were found. There was also no difference in the proportion of enrolled children and 
adults comparing dengue vs OFI. 
Figure 1.- Daily frequencies of relevant signs and symptoms in dengue and OFI patients The scale 
of the Y-axis varies per sign/symptom accordingly. The days of the disease were defined as follows: day 0 
(<12h); day 1 (12-24h); day 2 (24-48h); day 3 (48-72h) and day 4 (72-96h) after fever onset. The number of 
individuals presenting the relevant sign/symptom by OFI and dengue is indicated in the figure under each day. 
The daily total sample size for all was: day 0, n=50; day 1, n=138; day 2=218; day 3=195; day 4, n=130; day 
5, n=82; day 6, n=55; day 7, n=30. *Chi-square test. **Fisher’s exact test.
3.3. Daily Evolution of Relevant Clinical and Haematological Parameters 
in Patients with Dengue and OFI 
The frequencies of relevant general signs and symptoms, haemorrhagic manifestations 
and selected haematological parameters in dengue and OFI patients are presented from 
fever onset until day 7 of the illness in Figures 1, 2 and 3 respectively. In general, during the 
whole 7 day period, a higher proportion of patients with dengue compared to those with OFI 
presented bodily pain, rash, nausea and vomiting (Figure 1). The same pattern was found for 
the presence of petechiae, positive tourniquet test and haemorrhagic manifestations (Figure 
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2). The levels of platelet count, WBC count and MCH were lower in patients with dengue 
vs OFI (Figure 3). Conversely, a mild increase of haematocrit levels was found in dengue 
patients, mainly after day 5. General signs and symptoms like bodily pain, rash, nausea 
and vomiting appeared from the time of fever onset until day 7 of the disease, especially in 
dengue patients (Figure 1). Bodily pain was referred by a high proportion of patients (both 
dengue and OFI) until day 4 of the disease. Afterwards, less than 40% of patients presented 
this symptom. Although there were not significant differences in the daily presentation of 
this symptom, the proportion of dengue patients (89.3%) ever presenting this symptom 
during the whole 7 day period was higher than OFI (78.7%; P=0.025). The proportion of 
dengue patients presenting rash increased with time reaching a plateau of 50% on day 3 
of the disease. Patients with OFI presented rash at the beginning of the illness but with low 
frequency (<20%). Significant differences in the presence of rash between dengue and OFI 
Figure 2.- Daily frequencies of relevant haemorrhagic manifestations and sore throat in dengue and 
OFI patients The scale of the Y-axis varies per sign/symptom accordingly. The days of the disease were 
defined as follows: day 0 (<12h); day 1 (12-24h); day 2 (24-48h); day 3 (48-72h) and day 4 (72-96h) after fever 
onset. The number of individuals presenting haemorrhagic manifestation and sore throat by OFI and dengue 
is indicated in the figure under each day. The daily total sample size for petechiae and sore throat was: day 0, 
n=50; day 1, n=138; day 2=218; day 3=195; day 4, n=130; day 5, n=82; day 6, n=55; day 7, n=30. The daily 
total sample size for haemorrhagic manifestation and positive tourniquet was: day 0, n=4; day 1, n=61; day 
2=141; day 3=177; day 4, n=124; day 5, n=75; day 6, n=50; day 7, n=27. *chi-square test. **Fisher’s exact 
test.  
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patients were found from day 2 to day 6 of the illness. The frequency of dengue patients 
presenting nausea was higher than OFI starting on day 2 of the illness with a significant 
difference on day 3. The proportion of dengue and OFI patients that presented vomiting 
was low (˂25%). Although, the frequency of dengue patients with vomiting was higher 
than OFI, no significant differences in the presence of this sign was found in the daily 
evolution of the illness. 
The daily evolution of haemorrhagic manifestations and sore throat in patients with 
dengue and OFI is presented in Figure 2. In general, haemorrhagic manifestations and 
within them, petechiae and positive tourniquet test were mainly present in patients with 
dengue. These manifestations appear from the first or second day of the disease. On the 
other hand, sore throat was mainly present in patients with OFI. Petechiae and positive 
tourniquet test were the main haemorrhagic manifestations present in dengue patients. 
Petechiae and positive tourniquet test were presented by dengue and OFI patients on 
Figure 3.- Daily values of selected haematological parameters in dengue and OFI patients. The days of 
the disease were defined as follows: day 0 (<12h); day 1 (12-24h); day 2 (24-48h); day 3 (48-72h) and day 4 
(72-96h) after fever onset. The number of patients with dengue or OFI is placed daily under the days of the 
disease. Shaded boxes represent dengue, while empty boxes represent OFI. Middle line, median; Upper and 
lower boundary of the box, 25-75% interquartile range (IQR); whiskers, range of value that are outside of the 
IQR but are close enough not to be considered outliers (≤1.5*IQR); empty circles, outliers (˃1.5*IQR); black 
circles extreme outliers. WBC = with blood cells; MCH= mean corpuscular haemoglobin. *P-value ≤0.05.
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days 2-4 of the disease and only present in dengue patients on days 5-7. The proportion 
of dengue patients presenting petechiae and positive tourniquet test increased with 
time with a maximum (13%) on day 4 of the disease. Patients with OFI presented these 
two signs at the beginning of the illness but with low frequency (<5%). Haemorrhagic 
manifestations were present from fever onset until the day 7 of the disease mainly in 
dengue patients. The main differences were found on days 3-4 of the disease. Sore 
throat was present in dengue and OFI patients from fever onset until day 5 of the illness. 
This symptom was significantly more frequent in patients with OFI than dengue on days 
1-3 and day 5 of the disease. 
Figure 3 shows the daily evolution of platelet count, white blood cells (WBC), 
haematocrit and mean corpuscular haemoglobin (MCH) in patients with dengue 
and OFI. In general, a decrease in platelet count, WBC count and MCH levels were 
observed in patients with dengue while, an increase of haematocrit levels was seen in 
dengue patients. During the first 3 days of the disease, platelet counts were significantly 
lower and decreased steeply in dengue patients (slope -1.47) while there was little 
change over time in OFI patients (slope -0.35) (P=0.051). The mean platelet count 
of dengue patients (166 x 103 platelet/uL) was significantly lower than that of patients 
with OFI (192 x 103 platelet/uL) (P=0.002) during the first 3 days of the disease. WBC 
decreased in both dengue and OFI patients, however dengue patients had significantly 
lower median WBC counts on days 2-4 of the illness and as well as during the first 3 
days of the disease taking as a whole (dengue= 3.60 x 103 cells/uL vs OFI= 4.88 x 103 
cell/uL, P<0.001). Although no major changes in haematocrit level seemed to occur 
until day 4 of disease evolution, a significant difference was found on days 5 and 6 as 
well as differences in the slopes of this haematological parameter between patients 
with dengue (0.07) and OFI (-0.72) during the first 3 days of the disease (P=0.027). The 
levels of MCH were lower in dengue than in OFI patients since the start of the illness 
episode with a significant difference on days 2 and 3 of the illness. The mean MCH in 
patients with dengue (27.6 pg) were significantly lower than patients with OFI (28.5 pg) 
during the first 3 days of the disease (P=0.015). 
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Figure 4.- Biochemical parameters in patients with dengue and other febrile illnesses at the early 
stage of the disease (≤ 72h after fever onset). *iferencia o la razon, deben estar contenidos en el 
CI**Geometric means. * P≤0.05. AST= aspartate aminotransferase, ALT= alanine aminotransferase, LDH= 
Lactate dehydrogenase. Right axis is used for Creatinine, Total bilirubin, Direct bilirubin and Indirect bilirubin.
 
3.4. Biochemical Parameters 
The arithmetic and geometric means of the biochemical parameters observed during 
the first 3 days of the disease in patients with dengue or OFI are presented in Figure 
4. Dengue patients showed statistically significant lower cholesterol and globulin levels 
and increased levels of albumin and creatin kinase compared with patients with OFI. 
Dengue patients presented lower cholesterol (geometric mean 108.4 mg/dl) and globulin 
(mean 2.6 mg/dl) values than OFI patients (139.53 mg/dl and 2.97 mg/dl; P=0.002 and 
P=0.046, respectively). On the other hand, albumin (mean 4.01 mg/dl) and creatin 
kinase (mean 124.7 u/L) values in patients with dengue were higher than in patients 
with OFI (3.61 mg/dl and 81.5 u/L; P=0.003 and P=0.012, respectively). Cholesterol 
and albumin were the only two parameters independently associated with dengue in 
multivariate analysis. Patients with cholesterol levels <140 mg/dl were 8.1 times more 
likely to have dengue than OFI (P=0.007) while those with albumin levels >3.6 mg/dl 
were 12.0 times more prone to have dengue than OFI (P=0.001). The association of 
cholesterol and albumin with dengue was independent of age, sex, WBC count (˂4000 
cells/uL) or platelets (˂150 x 103 platelet/uL) (data not shown).
3.5. Clinical and Haematological Parameters that Differentiate Dengue 
from OFI at the Early Stage of the Disease (0-3 days)
The proportions and ORs (adjusted by age group) of clinical and haematological 
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parameters in patients with dengue and OFI at the early stage of the disease (≤72h) are 
presented in Table 1 and 2, respectively. A temperature ≥ 39°C, rash, chills, petechiae, 
positive tourniquet test and haemorrhagic manifestations were the clinical parameters 
significantly associated with dengue infection during the early stage of the illness. 
Conversely, the presence of a sore throat was significantly associated with OFI (Table 
1). Platelet count (˂150 x 103 platelet/uL), WBC count (˂4000 cells/uL), MCH (<29 
pg) and an increase of haematocrit and haemoglobin levels were the haematological 
parameters associated with dengue at the early stage of the disease (Table 2). Patients 
with a temperature ≥ 39°C were 2 times more likely to have dengue than OFI at the early 
stage of the illness (P=0.014). Rash and haemorrhagic manifestations were the two 
strongest parameters associated with dengue at the early stage of the disease (OR=5.4; 
OR= 3.5 respectively, P<0.001 in both cases).  Among the haemorrhagic manifestations, 
petechiae and a positive tourniquet test were the most frequent. Patients with petechiae 
or with a positive tourniquet test at the early stage of the disease were 3.7 and 3.9 
(respectively) times more prone to have dengue than OFI (P=0.016; P=0.024). Patients 
with chills during the first 3 days of the disease were 2.7 times more likely to have dengue 
than OFI (P=0.027). As expected, platelet count ˂150 x 103 platelet/uL and WBC count 
˂4000 cells/uL were associated with dengue at the early stage. Patients with platelet 
counts ˂150 x 103 platelet/uL were 2.8 times more likely to have dengue than OFI at the 
early stage of the illness (P=0.001). On the other hand, patients with WBC counts ˂ 4000 
cells/uL were 5.1 times more likely to have dengue than OFI during the first 3 days of the 
disease. The slopes of haematocrit and haemoglobin were calculated during the first 3 
days of the illness. A slope equal to zero means no change in the values during these 
days. An increase of haematocrit and haemoglobin levels is an indication of plasma 
leakage. A rise in haematocrit and haemoglobin levels increased the probability to have 
dengue by 2.6 and 2.9 times respectively. In our study population, patients with MCH 
levels ˂29 pg as well as a mean corpuscular volume <85 fL during the first 3 days of 
the disease were more likely to have dengue than OFI. Patients with a sore throat were 
40% less likely to have dengue than OFI (P=0.033).
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3.6. Clinical and Haematological Parameters that Differentiate Dengue 
from OFI During Days 4-7 of the Disease
The proportions and ORs (adjusted by age group) of clinical and haematological 
parameters in patients with dengue and OFI during days 4-7 of the illness are presented 
in Table 3 and 4, respectively. Rash, petechiae and haemorrhagic manifestations 
were the clinical manifestations positively associated with dengue during days 4-7 of 
the disease. Conversely, a temperature ≥ 39 °C and cough were associated with OFI 
(Table 3). A platelet count ˂150 x 103 platelet/uL and WBC count ˂4000 cells/uL were 
*Adjusted by age group. Early stage of the disease was defined as ≤ 72h after fever onset. The symptoms 
refer to “presence of the symptom”. OFI= Other febrile illnesses; Haemorrhagic manifestations= presence 
of at least one of the following: positive tourniquet test, petechiae, epistaxis, gingivorrhagia, melena, bloody 
stools, haematuria, menorrhagia and/or haematemesis. Hepatomegaly was determined through physical 
examination and/or ultrasound.




(n=112) OR* CI95 P-value
N n (%) n (%)
Temperature (≥39°C) 240 87 (66.9) 89 (80.9) 2.1 1.2-3.9 0.014
Paleness 248 51 (37.5) 46 (41.1) 1.2 0.7-2.0 0.501
Anorexia 248 91 (66.9) 83 (74.1) 1.4 0.8-2.5 0.219
Rash 248 26 (19.1) 63 (56.2) 5.4 3.1-9.6 <0.001
Nausea 248 75 (55.1) 74 (66.1) 1.6 0.9-2.7 0.075
Headache 248 123 (90.4) 102 (91.1) 1.1 0.5-2.7 0.793
Retroocular pain 248 105 (77.2) 83 (74.1) 0.9 0.5-1.6 0.697
Bodily pain 248 106 (77.9) 95 (84.8) 1.8 0.9-3.5 0.100
Myalgia/Arthralgia 248 96 (70.6) 84 (75.0) 1.4 0.8-2.5 0.261
Chills 248 115 (84.6) 105 (93.8) 2.7 1.1-6.7 0.027
Petechiae 248 5 (3.7) 14 (12.5) 3.7 1.3-10.6 0.016
Gingivorrhagia 248 6 (4.4) 7 (6.2) 1.5 0.5-4.6 0.476
Epistaxis 248 2 (1.5) 5 (4.5) 3.0 0.6-16.0 0.191
Positive  Tourniquet 
test 225 4 (3.3) 11 (10.8) 3.9 1.2-12.9 0.024
Haemorrhagic 
manifestations 229 15 (12.2) 34 (32.1) 3.5 1.8-7.0 <0.001
Abdominal Pain 248 29 (21.3) 23 (20.5) 0.9 0.5-1.7 0.804
Hepatomegaly 248 2 (1.5) 1 (0.9) 0.6 0.1-6.3 0.642
Vomiting 248 42 (30.9) 46 (41.1) 1.5 0.9-2.6 0.116
Diarrhoea 248 29 (21.3) 18 (16.1) 0.7 0.4-1.4 0.299
Sore throat 248 56 (41.2) 31 (27.7) 0.6 0.3-0.9 0.033
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the two haematological parameters positively associated with dengue during days 
4-7 of the illness (Table 4). Patients with temperatures ≥ 39°C during  days 4-7 of the 
disease were 60% less likely to have dengue than OFI (P=0.048). The presence of 
rash in patients during days 4-7 of the illness was a strong indication of having dengue 
(OR=3.8; P<0.001). Patients presenting with haemorrhagic manifestations on days 4-7 
of the illness were 7 times more prone to have dengue than OFI (P=0.002). Among the 
haemorrhagic manifestations, having petechiae during days 4-7 of the disease increased 
the probability to have dengue by almost 9 times (P=0.037). Patients presenting with 
a positive tourniquet test on days 4-7 of the disease were 7 times more likely to have 
dengue than OFI, with a P-value approaching significance (P=0.069). Instead presenting 
with cough decreased the likelihood of having dengue by 50% (P=0.043). The only two 
haematological parameters associated with dengue at the late stage of the disease 
were platelet and WBC counts. Patients with platelet counts ˂150 x 103 platelet/uL and 
WBC counts ˂4000 cells/uL were 6.7 and almost 6 times more likely to have dengue, 
respectively, than OFI during days 4-7 of the disease (P<0.001 in both cases).
Table 2. Haematological parameters that differentiate dengue versus OFI at the 
early stage of the disease (n=254)
Total OFI (n=142)
Dengue 
(n=112) OR* CI95 P-value
N n (%) n (%)
Platelet count 212 24 (22.2) 45 (43.3) 2.8 1.5-5.2 0.001
(<150 x 103 platelets /uL)
Leukocyte 212 30 (27.8) 69 (66.3) 5.1 2.8-9.2 <0.001
(<4000 cells/uL)
Lymphocyte (>43%) 210 34 32.1 43 41.3 1.5 0.8-2.6 0.187
Haematocrit slope (>0) 145 21 (31.8) 44 (55.7) 2.6 1.3-5.2 0.007
Haemoglobin slope 
(>0) 141 19 (29.7) 44 (57.1) 2.9 1.4-5.9 0.003
Erythrocyte slope (>0) 90 14 (36.8) 28 (53.8) 1.8 0.8-4.4 0.169
MCH (<29 pg) 182 53 (55.2) 65 (75.6) 2.7 1.3-5.3 0.005
MCV (<85 fL) 178 18 (19.4) 27 (31.8) 2.0 0.9-4.2 0.060
MCHC (˂31 gr/dL) 200 84 (83.2) 88 (88.9) 1.7 0.7-3.8 0.220
*Adjusted by age group. Early stage of the disease was defined as ≤ 72h after fever onset. The symptoms 
refer to “presence of the symptom”. OFI= other febrile illnesses; MCH= mean corpuscular haemoglobin; MCV= 
mean corpuscular volume, MCHC= mean corpuscular haemoglobin concentration. Lymphocyte refers to 
proportion. The slopes of haematocrit, haemoglobin and erythrocyte were calculated during the first 3 days of 
the illness. Slopes equal to 0 mean no changes of values during these days.
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3.7. Final Multivariate Analysis 
The final models of clinical-haematological parameters independently associated with 
dengue during the early stage of the disease and during days 4-7 are presented in Table 5. 
The presence of rash, haemorrhagic manifestations, platelet count <150 x 103 platelets/
uL, WBC count <4000 cells/uL and MCH levels <29 pg were predictive variables for 
dengue infection (Table 5; part A). Those patients with rash, haemorrhagic manifestations, 
platelet count ˂150 x 103 platelet/uL, WBC count <4000 cells/uL and a temperature < 
39°C between 4-7 days of the disease were more likely to have dengue (Table 5; part B)




(n=103) OR* CI95 P-value
n n (%) n (%)
Temperature (≥39°C) 154 10 (18.2) 7 (7.1) 0.4 0.1-0.9 0.048
Paleness 154 16 (29.1) 26 (26.3) 1.0 0.4-2.0 0.893
Anorexia 154 23 (41.8) 46 (46.5) 1.3 0.6-2.5 0.508
Rash 154 13 (23.6) 54 (54.5) 3.8 1.8-7.9 <0.001
Nausea 154 14 (25.5) 38 (38.4) 2.0 0.9-4.1 0.074
Headache 154 21 (38.2) 38 (38.4) 1.1 0.5-2.2 0.785
Retroocular pain 154 16 (29.1) 29 (29.3) 1.1 0.5-2.4 0.749
Bodily pain 154 25 (45.5) 47 (47.5) 1.2 0.6-2.4 0.609
Myalgia/Arthralgia 154 19 (34.5) 34 (34.3) 1.1 0.5-2.2 0.862
Chills 154 21 (38.2) 40 (40.4) 1.2 0.6-2.3 0.673
Petechiae 154 1 (1.8) 14 (14.1) 8.9 1.1-69.8 0.037
Gingivorrhagia 154 0 (0.0) 12 (12.1) - - -
Epistaxis 154 1 (1.8) 4 (4.0) 2.3 0.3-21.5 0.457
Positive Tourniquet Test 146 1 (2.0) 11 (11.6) 6.9 0.9-55.6 0.069
Haemorrhagic 
Manifestations 149 3 (5.8) 28 (28.9) 7.0 2.0-24.3 0.002
Abdominal Pain 154 8 (14.5) 14 (14.1) 1.0 0.4-2.5 0.936
Hepatomegaly 154 1 (1.8) 11 (11.1) 6.7 0.8-53.2 0.074
Vomiting 154 6 (10.9) 15 (15.2) 1.4 0.5-3.9 0.505
Diarrhoea 154 5 (9.1) 14 (14.1) 1.6 0.6-4.8 0.376
Sore throat 154 12 (21.8) 19 (19.2) 0.9 0.4-2.0 0.769
Cough 154 23 (41.8) 26 (26.3) 0.5 0.2-0.9 0.043
*Adjusted by age group. The symptoms refer to “presence of the symptom”. OFI= other febrile illnesses; 
Haemorrhagic manifestations= presence of at least one of the following: positive tourniquet test, petechiae, 
epistaxis, gingivorrhagia, melena, bloody stools, haematuria, menorrhagia and/or haematemesis. 








(n=103) OR* CI95 P-value
n n (%) n (%)
Platelet count 133 10 (22.2) 56 (63.6) 6.8 2.9-15.9 <0.001
(<150 x 103 platelets /uL)
Leukocyte 133 13 (28.9) 62 (70.5) 5.9 2.7-13.0 <0.001
(<4000 cells/uL)
Lymphocyte (>43%) 132 24 (54.5) 53 (60.2) 1.3 0.6-2.7 0.528
Haematocrit slope (>0) 73 6 (46.2) 22 (36.7) 0.7 0.2-2.3 0.547
Haemoglobin slope (>0) 63 5 (45.5) 23 (44.2) 0.9 0.2-3.4 0.879
Erythrocyte slope (>0) 54 3 (60.0) 19 (38.8) 0.4 0.1-2.7 0.357
MCH (<29 pg) 108 25 (75.8) 57 (76.0) 1.0 0.4-2.8 0.930
MCV (<85 fL) 109 11 (32.4) 24 (32.0) 1.0 0.4-2.4 0.992
MCHC (˂31 gr/dL) 131 31 (70.5) 66 (75.9) 1.3 0.6-3.0 0.504
*Adjusted by age group. The symptoms refer to “presence of the symptom”. OFI= other febrile illnesses; MCH= 
mean corpuscular haemoglobin; MCV= mean corpuscular volume, MCHC= mean corpuscular haemoglobin 
concentration. Lymphocyte refers to proportion. The slopes of haematocrit, haemoglobin and erythrocyte 
were calculated during the first 3 days of the illness. Slopes equal to 0 mean no changes of values during 
these days.
Table 5.- Multivariate logistic regression models of clinical-haematological parameters that 
differentiate dengue from OFI
Part A.- Final model at the early stage of the disease (n=169)
OR CI95 P-value
Rash 3.40 1.55-7.42 0.002
Haemorrhagic manifestations 3.47 1.33-9.06 0.011
Platelet count (<150 platelets x 103/uL) 2.48 1.12-5.49 0.026
Leukocyte count (<4000 cells/uL) 4.71 2.23-9.94 <0.001
MCH (<29 pg) 2.61 1.16-5.89 0.021
Part B.- Final model during 4-7 days of the disease (n=122)
Temperature (≥39°C) 0.15 0.04-0.61 0.008
Rash 3.71 1.27-10.81 0.017
Haemorrhagic manifestations 6.64 1.27-34.58 0.025
Platelet count (<150 platelets x 103/uL) 5.15 1.58-16.80 0.007
Leukocyte count (<4000 cells/uL) 3.91 1.33-11.44 0.013
Early stage of the disease was defined as ≤ 72h after fever onset. Haemorrhagic manifestations= presence 
of at least one of the following: positive tourniquet test, petechiae, epistaxis, gingivorrhagia, melena, bloody 
stools, haematuria, menorrhagia and/or haematemesis.
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3.8. Decision-Tree Algorithm
Rash, haemorrhagic manifestations, WBC count and MCH levels were the predictive 
variables used for the decision tree algorithm construction (Figure 5) based on the 
multivariate model described above (Table 5A). Even though a platelet count ˂150 
x 103 platelet/uL was positively associated with dengue in the multivariate analysis, 
this parameter was not used in the decision tree algorithm because its contribution 
to the classification was too low in our study population. The decision tree algorithms 
had a sensitivity of 88% and a specificity of 63%. Out of 169 patients included in 
the analysis, 83 (49.1%) were dengue positive. The two parameters that best predict 
dengue diagnosis were WBC and MCH (node 2b, right). Out of 65 patients with a 
WBC count ˂4000 cells/uL and MCH ˂29 pg, 50 (77%) were correctly diagnosed with 
dengue. Conversely, 44 (84.6%) out of 52 patients with a WBC count ≥ 4000 cells/uL, 
without rash and no haemorrhagic manifestations were properly diagnosed with OFI 
(node 3a left). Other predicting algorithms involved lower number of patients: 44% 
(11/25) of patients with a WBC count ≥ 4000 cells/uL and with rash were correctly 
diagnosed with dengue (node 2a, right) while 83.4% (10/12) of patients with a WBC 
count ˂4000 cells/uL, MCH ≥29 pg, without rash and no haemorrhagic manifestations 
were diagnosed with OFI (node 4a).  
Figure 5.- Decision-tree algorithm for prediction of dengue during the first 3 days of the disease. The 
decision tree algorithm was performed on the 169 patients that remained in the multivariate logistic model 
(Table 4). The number and percentage of patients with other febrile illnesses (OFI) and dengue is presented 
in each box. Each node is represented by numbers and letters within circles. MCH= mean corpuscular 




Between October 2010 and December 2013, a health centre-based prospective 
observational cohort study was performed in Maracay, Venezuela. The aim of this 
study was to design a decision-tree algorithm that, at an early stage, could differentiate 
dengue from OFI using clinical and accessible haematological tests. We constructed 
a diagnostic algorithm using WBC count, rash, MCH levels and haemorrhagic 
manifestations in sequential order that distinguished dengue from OFI with a sensitivity 
of 88% and specificity of 63%.  Multivariate analysis determined that the presence 
of rash, haemorrhagic manifestations and the decrease of platelet count, WBC 
count and MCH were positively and independently associated with dengue during 
the first 3 days of the disease. On the other hand, during days 4-7 of the disease, 
body temperature <39°C, the presence of rash, haemorrhagic manifestations and 
the decrease of platelet count and WBC count were positively and independently 
associated with dengue cases. Finally, the increase of cholesterol and a decrease of 
albumin were the two biochemical parameters independently associated with dengue 
infection during the first 3 days of the disease.
To our knowledge, this is the first decision-tree algorithm designed with data from 
the Americas that differentiates dengue from OFI during the first 3 days of the disease 
using clinical and accessible laboratory tests. The majority of the published decision 
tree algorithms have been designed to discriminate dengue from severe dengue40,41. 
One study using a decision tree that differentiates dengue from OFI has, so far, been 
performed in Asia42. Platelet count (cut off point 193 platelet/uL), WBC count (cut 
off point 6000 cells/uL), lymphocytes, temperature, haematocrit and neutrophils were 
used by Tanner et al in the decision tree to identify probable dengue, likely dengue, 
likely no dengue and probable no dengue42. The clinical-haematological parameters 
presented in our decision-tree algorithm were rash, haemorrhagic manifestations, 
WBC count (cut-off point 4000 cells/uL) and MCH (cut-off point 29 pg). In this study, 
WBC count was the strongest parameter that discriminated dengue from OFI and 
was presented in the first node of the decision-tree. Indeed, the majority of dengue 
patients presented WBC count ˂4000 cells/uL from the second day of the disease. 
The other two strong parameters that enabled the discrimination of dengue from OFI 
were rash and MCH. Although multivariate analysis showed that platelet counts were 
independently associated with dengue during the early stage of the disease, platelets 
did not rank amongst the most discriminatory parameters when used in the decision 
tree algorithm. The reason may be that platelet counts ˂150 x 103 platelet/uL were 
mainly observed after the third or fourth day of the disease in dengue patients. Our 
results were in accordance with other studies where the drop in WBC counts occurred 
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before thrombocytopenia in dengue patients43,44. Thrombocytopenia is useful in the 
differential diagnosis at the later stage of dengue illness45. Rash and WBC count 
(ranging from 5000 to 3600 cells/uL) have been consistently reported as predictors in 
the diagnosis of dengue20,46,47. Mild haemorrhagic manifestations, as demonstrated by 
a positive tourniquet test and petechiae, have also been associated with dengue at 
the early stage of the illness20,47,48.
Our study shows that MCH (<29 pg) together with WBC counts (<4000 cells/uL) 
were the most important parameters that discriminated dengue patients from OFI at the 
early stage of the disease. In our study, a decrease of mean corpuscular haemoglobin 
(MCH) was strongly associated with dengue infection during the first 3 days of the 
illness. A possible explanation to this finding is that increased levels of IL-6 in dengue 
patients stimulate the production of the hormone hepcidin49-51. This hormone inhibits 
the release of iron into the plasma from macrophages and duodenum enterocytes52. 
Iron deficiency may decrease MCH levels as well as the mean corpuscular volume 
(MCV) (NIH). MCV was also decreased in our dengue patients. High levels of IL-6 have 
been mainly associated with dengue haemorrhagic fever53,54. However, significantly 
high IL-6 levels were found in patients with dengue fever compared to OFI since the 
second day of the illness by Pinto et al. in Brazil55. 
Although our first goal was to differentiate patients with dengue from OFI at the 
early stage of the illness, we also present clinical and haematological determinants 
associated to dengue on days 4-7 of the disease. The variation in time of clinical-
haematological parameters has previously been reported20,44. This variation makes 
the diagnosis of dengue difficult. Body temperature <39°C, the presence of rash, 
haemorrhagic manifestations and the decrease of platelet count  (˂150 x 103 platelet/
uL ) and WBC count (˂4000 cells/uL) were positively and independently associated 
with dengue cases during days 4-7 of the illness. Although the presence of these 
parameters has been frequently associated with dengue in other studies20,44,47,56 they 
have not been reported as a result of a multivariate analysis that differentiates dengue 
from OFI after day 4 of the disease. 
The alterations of biochemical parameters in dengue patients have previously been 
described. Increased levels of transaminases (AST/ALT), amylase, creatine kinase, 
bilirubin and globulins have been associated with severe dengue41,48,57-61. On the other 
hand, decreases of cholesterol, triglycerides and albumin levels have been reported 
in dengue severe cases57,61,62. Few studies have compared biochemical parameters 
between dengue and OFI patients48,59,63. In our study, a significant decrease of 
cholesterol and globulins levels and an increase in albumin and creatine kinase levels 
were found in patients with dengue compared to those with OFI. Cholesterol and 
albumin were the biochemical parameters significantly and independently associated 
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with dengue during the first 3 days of the illness. Inconsistent associations and/or 
patterns have been reported for albumin levels. In concordance with our results, an 
increase of albumin levels in dengue patients compared to OFI has previously been 
reported in another study63. However, other authors have reported a decrease of 
albumin levels in dengue patients48,59. A non-significant decrease of cholesterol levels 
in dengue patients compared with OFI has previously been reported59. Contrary to our 
results, a decrease of creatine kinase levels was found in dengue patients but, with 
no significant difference59. Differences in globulin levels between dengue and OFI 
patients have not been previously reported.   
A strength of the study was the patients’ compliance with the clinical and laboratory 
study protocol since most patients completed monitoring up to the convalescent visit 
(21-30 days post fever onset). This allowed the comparison of the daily evolution of 
clinical-haematological parameters between dengue and OFI patients. It was possible 
to design a decision-tree algorithm to diagnose dengue patients during the first 3 days 
of the disease and to identify determinants associated with dengue from day 4 of the 
illness. The majority of the patients were recruited on day 2 or 3 after fever onset. 
Therefore, many patients had either one observation if they arrived on day 3 or only 
two if they arrived on day 2. The analysis of biochemical parameters together with the 
clinical-haematological parameters was limited by the small sample size of patients 
with biochemical tests.
5. Conclusion 
In this study, we propose a decision-tree algorithm that differentiates dengue from OFI 
at the early stage of the disease using clinical and reliable haematological parameters. 
In this decision-tree, WBC count, rash, MCH levels and haemorrhagic manifestations in 
sequential order distinguished dengue from OFI with a sensitivity of 88% and specificity 
of 63%. With the identification of patients at the early stage of the disease fatalities due 
to misdiagnosis and overburdening of health centres can be avoided. We recommend 
the validation of the decision tree algorithm in a bigger and independent population.
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Dengue in Venezuela is a major public health problem with an increasing incidence of 
severe cases. Early diagnosis and treatment influences the outcome of dengue illness. 
We aimed to understand patterns of health seeking behaviour (HSB) in individuals 
exposed to high dengue incidence in order to improve early attendance to health 
centres. Between September 2013 and February 2014 a cross-sectional household 
survey was performed in Maracay, Venezuela. Intended HSB of adults and parents/
guardians was assessed. Data was collected by structured questionnaires from 105 
individuals. Intended pathways to care differed for suspected dengue compared to 
fever, and between children and adults. In case of fever, most individuals would firstly 
treat at home before seeking medical care, while the contrary was reported in case of 
suspected dengue. Parents/guardians would take children earlier to the health facility 
than adults. Suspected dengue would prompt people to search medical help earlier than 
for fever (P<0.001).  For dengue, the appearance of new symptoms (77.1%) and high 
fever (74.3%) were the main reasons for seeking medical help. Primary health centres 
were the first intended choice to find medical care for nearly (93%) all participants. 
Dengue risk perception was high with a relative good general dengue knowledge. Delay 
in care-seeking is found to be significantly associated with severe dengue. Our study 
shows that intentions to seek medical help differed between fever or suspected dengue. 
Improving the knowledge and awareness of dengue symptoms may enhance early 




Dengue fever, a viral vector-borne disease spread by the day-biting mosquito Aedes 
aegypti, is a global health problem of increasing importance (1). Currently, dengue 
affects over 2.5 billion people living in dengue endemic areas, which comprises 40% of 
the world’s population (2). According to estimations of the WHO, 50-100 million dengue 
infections occur every year, leading to 500 000 cases of severe disease that need 
hospitalisation (2). However, recent estimations speak of approximately 400 million 
dengue infections annually (3). Where in the 1950s dengue cases were reported in only 
nine countries, today more than 125 countries in the tropics and subtropics are endemic 
for dengue (4). In the Americas, almost all countries struggle with recurrent epidemics 
(5). The poverty, poor sanitation and overcrowding that accompanies the uncontrolled 
urbanisation in this region creates environments in favour of vector-breeding and rapid 
spread of the virus, which leads to serious obstacles in disease control (6). 
Dengue has become a major public health problem in Venezuela, with epidemics 
of increasing magnitude regularly occurring against a background of an established 
endemic situation. Initial descriptions of dengue-like illness in Venezuela based on 
clinical manifestations date from 1828 and 1946 (7). Since the first dengue hemorrhagic 
fever epidemic reported in the country in 1989-1990 and the second in the Americas 
(8), the frequency of severe cases has increased. Between 1989 and 2007, the 
highest proportion (35%) of severe dengue cases within the Americas were reported 
in Venezuela (4). In effect, dengue transmission in Venezuela has become perennial 
with poverty-related socio-economic factors and behavioural determinants fuelling the 
increasing incidence of dengue in the urban areas of the country (9)(Velasco et al., in 
press).The most recent and largest dengue outbreak took place in 2010 with more than 
120.000 reported cases, of which 8% represented severe cases (10). 
Early diagnosis and adequate supportive care are of great importance in the management 
of dengue so as to avoid the development of severe disease. Thereby, early treatment 
intervention can reduce the case fatality rate from 20% to 1% or less (1,11). While knowledge 
and possibilities to diagnose and treat dengue fever increase, efforts have to be made to make 
these new developments accessible for those who have a dengue infection. An important 
factor to be taken into consideration is the patient’s health seeking behaviour (HSB), because 
for early diagnosis and supportive care, people must have the intention and the means to seek 
medical care early in the disease (12). Therefore, local studies on health believe and practice, 
HSB and access to care with respect to dengue fever are needed to identify opportunities 
for applying these new developments in diagnostics and treatment (13). Insights in HSB of 
dengue could help to attain a reduction of late diagnosis, an increase of treatment adherence 
and improvement of health promotion strategies applied to a specific culture (14).
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In Venezuela, patients with a suspected dengue infection tend to seek medical help 
beyond the third day after the onset of fever (15). At this time, the patient may be already 
critically ill (16). Delay in care-seeking is found to be significantly associated with severe 
dengue (17), which stresses the importance of understanding HSB and access to 
care for dengue patients. However, research on HSB applied to dengue appears to be 
scarce, especially in the Americas, for the majority of studies on this topic have been 
performed in Asia (12, 18-23). 
This study aims to understand the patterns of HSB in the Venezuelan population 
exposed to high dengue incidence in order to find ways to improve early attendance to 
health centres and medical care. We compared HSB intentions of adults and of parent/
guardians with respect to their children in the case of fever or suspected dengue. By 
using both quantitative and qualitative data we aim to present a better insight in social, 
psychological and cultural motives of the intended behaviour and attitudes.
2. Materials and Methods
2.1. Study Site
In August 2010 a prospective, community-based cohort study was set up in Maracay, 
Aragua state, Venezuela to understand dengue temporo-spatial spread and estimate 
dengue incidence (Velasco et al., in press). Aragua state witnessed the highest 
incidence of dengue in Venezuela in 2012, reaching nearly 7000 reported cases of 
which 2% were severe (10).. Maracay is one of the largest cities of Venezuela with 
dengue hyper-endemicity (9, 24). It is the capital of Aragua state with an estimated of 
1.300.000 inhabitants (25). There are two seasons, a dry (November-April) and a rainy 
season (May-October). The temperature ranges from 25°C to 35°C with a mean annual 
precipitation of 834 mm (26). Within Maracay, three neighbourhoods called Candelaria, 
Caña de Azúcar and Cooperativa were selected for their high dengue incidence (9) 
(LARDIDEV, personal communication). Candelaria and Caña de Azúcar are located 
close to each other in the north-westerly area of Maracay, while Cooperativa is situated 
in the north-east. All are served by public (governmental) primary and secondary health 
centres. Patients that require further specialised treatment are referred to the main 
public tertiary level hospital, the Hospital Central de Maracay. 
2.2. Study Design
Between August 2010 and January 2011, 2014 individuals in the age range of 5-30 
years old living in 840 households were enrolled in a community-based prospective 
cohort study through house-to-house visits (Velasco et al., in press). Participants 
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are followed through active and passive surveillance. Annual surveys are performed 
to estimate the incidence of dengue and to assess the temporo-spatial dynamics of 
dengue transmission. 
The present study was carried out during the annual survey that took place between 
September 2013 and February 2014. A cross-sectional survey of a randomly chosen 
sub-sample of the cohort participants was carried out to gather quantitative and 
qualitative data on HSB intentions at community level of the general population exposed 
to dengue. 
2.3. Study population
A randomized sub-sample of approximately 100 households included in the cohort 
study was selected. One individual was interviewed in each household. The intention 
was to interview an equal number of adults and parents or guardians of children (<18 
years old) who were already participating in the cohort study. Adults (18 years and older) 
were randomly chosen from all present adults at the moment of visiting the selected 
households.
2.4. Data Collection
A structured questionnaire, the HSB-questionnaire, was developed containing 
pre-coded and open questions on socio-demographic and socio-economic details, 
knowledge of dengue symptoms and dengue transmission, risk perception, pathways 
of HSB in relation to presenting fever and suspicion of dengue infection, and finally 
individuals were asked to rank the quality of available health centres in their area. With 
respect to the parents/guardians interviewed, questions on HSB and risk perception 
referred to the child, while adults were interviewed with respect to their own knowledge, 
attitudes and practices. The questionnaires were prepared in English, translated to 
Spanish, pre-tested and adapted in a pilot study. Data on mosquito preventive practices 
and other socio-economic variables were collected from a household questionnaire 
which was applied as part of the annual survey of the cohort study. 
a) Socio-Demographic and Socio-Economic Characteristics
From the HSB-questionnaire we gathered demographic characteristics of the 
interviewed person: age, place of residence (neighbourhood), level of education, 
occupation, religion, and (in case of a child-questionnaire) the identification code of 
the child(ren) from the cohort study. Additional socio-economic data was gathered in 
the household questionnaire, and included characteristics of the residence (type of 
residence, number of persons living in the household, number of rooms (bathrooms 
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not included), roof type, floor material, what materials were used to separate sleeping 
rooms from the rest of the household (wooden doors, curtains, nothing, etc), availability 
of all public services (tap water, electricity, gas and garbage collection), total income 
per household, ownership of 19 different items (TV, DVD, computer, cable-TV, internet, 
washing machine, dryer, gas stove, electric stove, water heater, fridge, microwave, 
landline telephone, portable plug-in telephone, mobile phone, air-conditioning, car, 
motorcycle, bicycle). Socio-economic data was used as proxy markers to estimate 
socio-economic status of the individuals.
b) Knowledge of Dengue Infection 
Dengue knowledge was assessed during the interview by asking the following: 
having heard about dengue and from which sources, a 9-item question about dengue 
transmission and a 16-item question about dengue symptoms. Firstly, respondents 
were asked the open question: “how do you think people get infected by dengue?”. 
Their ‘self-mentioned’ answers were recorded according to the 9 pre-coded modes 
of transmission and those not matching these, were written down. Subsequently 
individuals were prompted to state if the pre-coded modes of transmission were 
true-or-false statements. The same methodology was used to assess knowledge on 
dengue symptoms. The pre-coded transmission routes included: bite of a mosquito, 
touching other people, being near to a dengue patient, coughing/sneezing, kissing, bad 
hygiene, sexual intercourse, being at health centres, and via spiritual beings. Pre-coded 
symptoms were: fever, headache, eye pain, body pain, face redness/rash, muscle 
pain, abdominal pain, runny nose, sore throat, vomiting, coughing/sneezing, diarrhoea, 
malaise, nausea, constipation, bleeding. If an answer was ‘self mentioned’ 2 points were 
granted, if a prompted question item was answered correctly with ‘yes’ or ‘no’ 1 point. If 
the question item was answered with ‘don’t know’, 0 points were given. Wrong answers 
scored minus 2 points when ‘self mentioned’ and minus 1 point when prompted. A 
‘transmission knowledge score’ (maximum score: 10 points) and a ‘symptom knowledge 
score’ (maximum score: 30 points) was derived by adding the points obtained from each 
question respectively. Finally, an ‘Overall knowledge score’ (maximum score: 40 points) 
totalised the sum of both scores. Based on their score the respondents were divided in 
three categories (poor, medium or good knowledge). We defined seven symptoms as 
typical dengue symptoms: fever, eye pain (retroocular pain), headache, face redness/
rash, vomiting, muscle/joint pain and bodily pain. Abdominal pain, bleeding and vomiting 
were defined as warning symptoms for severe disease but we did not ask specifically for 
warning symptoms. The typical and warning symptoms were ‘recognised’ if they were 
self-mentioned or if they were answered with ‘yes’ after a true-or-false statement. 
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c) Behavioural Characteristics 
The behavioural characteristics were asked through open questions: ‘what would 
you do if you/your child had fever’; and ‘what would you do if you think that you/your 
child have/has dengue’. Pre-coded options were the possible most frequent options 
people would choose as their first and subsequent actions: a) staying and treat at home 
(‘home treatment’), b) ‘visit a medical doctor’, c) ‘alternative treatment’ (alternative 
medicine practitioner, traditional healer, community leaders, friends), d) ‘call a medical 
doctor’, e) ‘another action’, or f) ‘no action’. After each action mentioned, the person was 
asked: ‘would you do anything else?’ If ‘home treatment’ was mentioned, respondents 
were asked to specify the type of home treatment. If ‘go to the doctor’ was mentioned, 
they were asked when and to which health centre they would choose to go and if they 
would visit other health centres if needed. 
After asking if the interviewed individual chose to seek a medical doctor in the 
case of a possible dengue infection, we enquired what would make him/her decide 
to seek medical help. Possible pre-coded options were: the number of days of fever, 
temperature of the fever, the appearance of new symptoms or another reason (which 
was written down). If any of the first three options was mentioned, respondents were 
asked to specify the number of days, degree of temperature and type of symptoms. 
d) Risk Perception 
Perception of the risk of acquiring a dengue infection (either referred to children or 
adults) was assessed during the interview, as well as the reasons for feeling or not at 
risk. These reasons were summarised and categorised.
e) Logistics, Quality of Health Centres and Preventive Practices 
The health care system in Venezuela is comprised of a public and a private sector 
both under the umbrella of the Ministry of Health. The public sector was designed to 
offer care and most medicaments for free. It has a network of urban and rural out-
patient health centres at primary and secondary level named “Ambulatorios tipo I or 
tipo II”. Patients that cannot be managed as out-patients, are referred to tertiary level 
health centres or hospitals. The main public referral hospital in Maracay city is the 
Hospital Central de Maracay. The private sector comprises private practices and private 
hospitals were patients need to pay either via their health insurance or directly. In 2003, 
the government created a parallel public health care program under the name “Misión 
Barrio Adentro” (27). Within this program, a network of out-patient health facilities at 
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primary level were created (Ambulatorio ‘Barrio Adentro’) to reach communities with 
limited access to health care. In a second step, diagnostic centres or “Centros de 
Diagnóstico Integral” (CDI) and rehabilitation centres were set up. 
During the interview we asked which specific health centre individuals would attend 
in case of dengue (referring to child or adult), referring to six different Venezuelan types 
of health centres. These were: a) Ambulatorio, a public primary level out-patient health 
care facility; b) Hospital, referring to a public tertiary level hospital; c) Ambulatorio ‘Barrio 
Adentro’, referred in our study as “Ambulatorio BA”; d) CDI; e) Private practice; and f) 
Private hospital. People were also asked to assess the quality of care they perceived 
they would receive in each type of health centre (1= very poor; 2= poor; 3= average; 4= 
good; 5= very good). From the household questionnaire, data on means of transport to 
the health centre, and the time and costs of transport, were derived. Data on preventive 
practices against mosquitoes was also derived from the household questionnaire.
f) Qualitative Data 
During the interview, some individuals gave explanations to the answers they gave. 
In other occasions we asked the individual to explain the reasons for their answer(s). 
Questions asked and answers given were written down and used in the analysis.
2.5. Data Analysis
Information collected in the questionnaires was entered into a database using Epi Info 
(Epi InfoTM, version 3.5.4). Data was checked for consistency and analysed anonymously.
Differences in proportions were analysed using a chi-square test or Fisher’s exact test 
when applicable. Continuous variables were converted into ordered categorical variables 
when suitable. For normally distributed quantitative data, means were compared using 
Student’s t-test. If the quantitative data was not normally distributed, a Mann-Whitney U 
test was used. A Wilcoxon signed rank test was used for comparing related means within 
individuals when comparing HSB of fever and dengue while pair-wise proportions were 
compared with a McNemar’s test. Significance was determined at 5% level. By using 
principal components analysis (28, 29), the socio-economic variables were weighted to 
obtain a relative measure. Based on this relative score individuals were divided into low, 
average and high socio-economic status. The socio-economic variables used for this 
analysis were those related to their possessions (except of TV since this variable showed 
no variance), type of house, total household income, crowding (number of persons per 
room), material of the roof, material of the floor, door materials. Data was analyzed using 
SPSS (SPSS Inc., version 20.0, Chicago, Illinois) and STATA (Stata Statistical Software: 




The study was approved by the Ethics Review Committee of the Biomedical Research 
Institute, Carabobo University (Aval Bioetico #CBIIB(UC)-014), Maracay, Venezuela, the 
Ethics, Bioethics and Biodiversity Committee (CEBioBio) of the National Foundation for 
Science, Technology and Innovation (FONACIT) of the Ministry of Science, Technology 
and Innovation, Caracas, Venezuela; and by the Regional Health authorities of Aragua 
State (CORPOSALUD Aragua). All adult participants signed written informed consent, 
and a parent or guardian of any child participant provided written informed consent on 
their behalf. Children between 8 and 17 years old provided written informed assent.
3. Results
Between September 2013 and February 2014, we conducted a cross-sectional 
study within the third annual survey of a dengue community-based cohort study in 
three neighbourhoods of Maracay city, Venezuela. We aimed to understand the health 
seeking behaviour (HSB) and access to care of a population exposed to endemic 
dengue transmission. Individual and household-related interviews were conducted 
targeting adults and parents/guardians of children living in the area of study. Overall, 105 
individuals were interviewed on HSB of which 54 referred to adults and 51 to children. In 
addition, 92 household socio-economic questionnaires were applied. 
3.1. General Description of the Study Population
Table 1 shows a summary of the general characteristics of the study population and 
compares individuals interviewed with the adult versus the child questionnaire. The 105 
interviewed individuals had a mean age of 40 years (range: 18 – 87) and were mostly 
females (Table 1). Parents/guardians of children were older than those interviewed with 
the adult questionnaire (mean age 44 vs. 35 years respectively; P<0.001). This was 
expected, as those who care for the children were mainly mothers or grandmothers 
while the majority of those interviewed with the adult questionnaire were younger than 30 
years (Table 1). Most of the interviewed individuals lived in Candelaria. We were unable 
to complete the planned interviews in the other two neighbourhoods (Cooperativa and 
Caña de Azúcar) because of violence during anti-governmental protests in February 
and March 2014 in the country. The majority of the interviewed individuals completed 
secondary school and were housewives or domestic workers. Those interviewed 
with the adult questionnaire had a higher education level and consisted of a bigger 
proportion of students than parents/guardians of children. As in the rest of the country, 
the majority of the individuals professed a catholic religion. Atheists were less common 
within respondents of the child questionnaire (P=0.043). The majority of interviewed 
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individuals lived in households with 5-6 rooms and most households were occupied 
by more than 5 inhabitants. Households of parents/guardians of children were more 
crowded than those of the ones interviewed with the adult questionnaire (P=0.041). 
The households of respondents of the adult questionnaire had a higher monthly income 
(P=0.020) and a higher socio-economic status (Table 1).
3.2. Knowledge, Risk Perception and Influence of a Past Dengue 
Infection
The majority of interviewed individuals (103/105) indicated that they had heard about 
dengue. The main sources of information were the television (56.2%), and the health 
centres (43.8%). Other frequently mentioned sources were friends/family/neighbours, 
newspapers, school/university and information campaigns from the Ministry of Health 
(28%-34%). Radio, internet, brochures and our cohort study (where written and oral 
information on dengue was provided) were less frequently mentioned. 
a) Knowledge of Dengue Transmission 
The interviewed individuals showed a relative good knowledge of dengue 
transmission. There was no statistically significant difference in transmission knowledge 
between the interviewed parents/guardians and adults (Table 2). In response of the open 
question, most individuals (100/105, 95.2%) self-mentioned ‘the bite of a mosquito’ as 
the transmission source. There was one person who self-mentioned that kissing could 
transmit dengue, another one mentioned accumulation
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n (%) n (%) n (%) P-valuea
Age (n=103)
18-30 39 (37.9) 8 (16.3) 31 (57.4)
31-50 34 (33.0) 25 (51.0) 9 (16.7)
>50 30 (29.1) 16 (32.7) 14 (25.9) <0.001
Sex (n=105)
Females 91 (86.7) 47 (92.1) 44 (81.5)
Males 14 (13.3) 4 (7.8) 10 (18.5) 0.108
Place of residence (n=105)
Candelaria 72 (68.6) 36 (70.6) 36 (66.7)
Cooperativa 11 (10.5) 4 (7.8) 7 (13.0)
Caña de Azúcar 22 (21.0) 11 (21.6) 11 (20.4) 0.693
Education (n=104)
Illiterate/ pre or primary schoolb 17 (16.3) 11 (21.6) 6 (11.3)
Secondary school 54 (51.9) 31 (60.8) 23 (43.4)
University/ university polytechnic 33 (31.7) 9 (17.6) 24 (45.3) 0.009
Occupation (n=104)
Student 16 (15.4) 4 (7.8) 12 (22.6)
Housewife/Domestic worker 52 (50.0) 32 (62.7) 20 (37.7)
Manual worker 4 (3.8) 2 (3.9) 2 (3.8)
Merchant/ Employee/ Office worker 27 (26.0) 12 (23.5) 15 (26.0)
Professional/ University staff 5 (4.8) 1 (2.0) 4 (4.8) 0.065
Religion (n=101)
No religion 6 (5.9) 0 (0.0) 6 (11.3)
Catholic 79 (75.2) 37 (77.1) 76 (73.6)
Christian/Protestant/Evangelist 17 (18.8) 11 (22.9) 19 (15.1) 0.043
Availability of complete public services 
(n=91)
No 4 (4.4) 3 (6.8) 1 (2.1)
Yes 87 (95.6) 41 (93.2) 46 (97.9) 0.350
Persons per household (n=87)
2-4 25 (28.7) 11 (27.5) 14 (29.8)
5-6 28 (32.2) 12 (30.0) 16 (34.0)
≥7 34 (39.1) 17 (42.5) 17 (36.2) 0.831
Household roomsc (n=90)
2-4 35 (38.9) 21 (47.7) 14 (30.4)
5-6 42 (46.7) 18 (40.9) 24 (52.2)
≥7 13 (14.4) 5 (11.4) 8 (17.4) 0.234
Crowding (persons/room) (n=86)
<1.50 57 (66.3) 20 (50.0) 37 (80.4)
≥1.50 29 (33.7) 20 (50.0) 9 (19.6) 0.003
Monthly income (VEB) (n=76)
≤3000 VEB (minimum wages) 11 (14.5) 8 (20.5) 3 (8.1)
3001-6000 VEB 23 (30.3) 18 (46.2) 5 (13.5)
>6000 VEB 42 (55.3) 13 (33.3) 29 (78.4) <0.001
Socio-economic status (n=90)
Low 38 (42.2) 23 (52.3) 15 (32.6)
Average 30 (33.3) 17 (38.6) 13 (28.3)
High 22 (24.4) 4 (9.1) 18 (39.1) 0.004
aP-value corresponds to the comparison between the child and adult questionnaire responses. bFrom the total 
sample, there was one person illiterate. cNumber of rooms, bathrooms not included. 
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of garbage. With respect to the true or false questions dengue was believed to be 
transmitted through ‘health centres’ (21%) and ‘bad hygiene’ (21%), as well as via 
‘sneezing/coughing’ (16%) and ‘kissing’ (13%). The majority of the people (57%) did not 
give wrong answers with respect to the transmission knowledge questions for both the 
open and true or false questions. 
b) Knowledge of Dengue Symptoms 
Fever was the most frequent self-mentioned symptom, 97% of the individuals 
mentioned this symptom without prompting. Headache (57%), muscle/joint pain (34%), 
malaise (34%), body pain (31%), redness in face/rash (31%) and vomiting (30%) were 
other frequent self-mentioned symptoms. Those that were not recognized as dengue 
symptoms by the interviewed individuals were sore throat (48% of the individuals), 
diarrhoea (44%), nausea (41%) and vomiting (36%). The seven typical dengue 
symptoms were fully ‘recognized’ (either self-mentioned or prompted) by 28% of the 
people, and the three dengue warning symptoms by 27% of the respondents. Contrary 
to the transmission knowledge score, there was a poorer knowledge in the study 
population with regard to dengue symptomatology as 73% of the individuals scored 
a poor or medium symptom knowledge score. Although there was not a statistically 
significant difference between the adult and child interview, those who answered 
the adult questionnaire seemed to have a poorer knowledge compared to parents/
guardians (Table 2). We compared the means of mentioned information sources for 
dengue within the categories of the knowledge score with a Kruskal-Wallis test to see 
whether knowledge was associated with the amount of information sources reported. 
People with better transmission knowledge scores reported more information sources 
for dengue (P=0.068) and those with better symptom knowledge mentioned also 
more information sources (P=0.220). There was a significant association observed 
(P=0.038) when comparing the number of the reported information sources with the 
total knowledge score, showing a mean of reported information sources of respectively 
2.3 (poor knowledge), 2.5 (medium knowledge), 2.9 (good knowledge). While people 
who reported more typical dengue symptoms heard from dengue from more information 











n (%) n (%) n (%) P-valuea
Transmission score (max=10)
Poor (<7) 25 (23.8) 11 (21.6) 14 (25.9)
Medium (7-9) 20 (19.0) 6 (11.8) 14 (25.9)
Good (10) 60 (57.1) 34 (66.7) 26 (48.1) 0.103
Symptom  score (max=30)
Poor (≤9) 32 (30.5) 13 (25.5) 19 (35.2)
Medium (10-13) 45 (42.9) 21 (41.2) 24 (44.4)
Good (≥14) 28 (26.7) 17 (33.3) 11 (20.4) 0.283
Overall knowledge score (max=40) 
(n=105)
Poor (≤17) 32 (30.5) 10 (19.6) 22 (40.7)
Medium (18-22) 37 (35.2) 21 (41.2) 16 (29.6)
Good (≥23) 36 (34.3) 20 (39.2) 16 (29.6) 0.063
Typical dengue symptomsb
Reported ≤5 37 (36.3) 17 (34.7) 20 (37.7)
Reported 6 36 (35.3) 17 (34.7) 19 (35.8)
Reported 7 (all) 29 (28.4) 15 (30.6) 14 (26.4) 0.890
 Dengue warning symptoms
Reported ≤2 77 (73.3) 35 (68.6) 42 (77.8)
Reported 3 (all) 28 (26.7) 16 (31.4) 12 (22.2) 0.201
aP-value corresponds to the comparison between the child and adult questionnaire responses. bTotal sample: 
n=102, child sample n=49, adult sample: n=53.
c) Risk Perception 
The majority of the individuals (73/105; 69.5%) reported to feel at risk of dengue and 
2 (1.9%) individuals did not know. Almost all individuals (103/105, 98.1%) also believed 
that people could die from dengue disease. Feeling at risk was equally reported when 
referred to children and adults (14/51; 72.5% vs. 16/52; 69.2%; P=0.711). Reasons 
for feeling or not at risk were categorized in Table 3. The most frequently mentioned 
reason to feel at risk was the presence of mosquitoes in the household (n=46; 63.0%), 
while the presence of stagnant water (37.0%) and dengue cases nearby (28.8%) were 
other common reasons to feel at risk. Living near to mountains/hills were also reported 
as reasons to feel at risk of acquiring dengue. Other mentioned reasons for feeling at 
risk were ‘there are mosquitoes at school’, ‘presence of dark places’, ‘the necessary 
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measures to fight dengue are not being taken’, ‘children don’t care about mosquitoes’, 
‘dengue is in the environment’. The most frequently mentioned reason for not feeling 
at risk was the absence of stagnant water or uncovered water storage (n=10; 33.3%). 
People also reported that the usage of protection against the mosquitoes (30.0%) and 
the absence of rubbish (30.0%) made them feel they were not at risk of getting dengue. 
Other mentioned reasons for not feeling at risk were ‘I am immune to dengue’, ‘I scare 
mosquitoes’, ‘There are no mountains near’ and ‘I don’t have a garden’. The most 
important reasons which both influenced feeling at risk and feeling not at risk for was the 
presence/absence of mosquitoes in the household, followed by the presence/absence 
of stagnant/stored water and presence/absence of nearby dengue cases.
Table 3.- Reasons for feeling or not feeling at risk of dengue infection.
Reasons for feeling at risk Reasons for not feeling at risk
Mentioned reasons n (%)a Mentioned reasons n (%)a
Mosquitoes in the 
household





27 (37.0) Usage of protection against 
mosquitoes
9 (30.0)
Dengue cases in the 
vicinity 
21 (28.8) No rubbish nearby 9 (30.0)
Mountains/hills nearby 14 (19.2) No dengue cases nearby 7 (23.3)
Rubbish nearby 14 (19.2) No mosquitoes in the household 6 (20.0)
Rain 5 (6.8) No breeding sites around 6 (20.0)
Canal/River nearby 5 (6.8) Other 4 (13.3)
Other 15 (20.5)
aProportions within the population who felt (n=73)/ did not feel (n=30) at risk of dengue.
d) Preventive Measures Against Mosquitoes 
Data on practices to prevent mosquito bites were collected from 91 individuals, of 
which 17 (18.7%) reported that protection against mosquitoes was not being used in the 
household. Most household inhabitants used repellents (n=44; 48.4%) and insecticides 
(n=39; 42.9%). Less frequent reported preventive measures were the usage of mosquito 
nets (12%), ventilator or air-conditioning (15%), mosquito repellent vaporizer (11%), 
burning paper/cardboard (9%), repellent plants (5%), windows/doors screening (5%) 
and other (10%). Repellent oils, infusions, incense, closing the house and electric 
rackets were placed within the category ‘other’. The amount of preventive practices 
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varied from 0-5 per household, with a mean of 1.6. Feeling at risk of contracting dengue 
did not influence the amount of preventive measures (P=0.715).
e) Reporting a Past Dengue Infection 
Out of 103 respondents, 33 (32.0%) mentioned that they/their child(ren) had 
dengue in the past while one person did not know. Although dengue was reported more 
frequently when referred to children than adults (36.0% vs. 28.8% respectively) the 
difference was not significant (P=0.440). People who reported a past dengue infection 
(referring either to themselves or their children) were higher educated (P=0.033) and 
had a lower age (mean age: 34 years vs. 42 years; P=0.032). We explored if reporting 
a past dengue infection influenced dengue knowledge, risk perception and mosquito 
preventive practices overall. Although there was a higher proportion of individuals with 
a ‘good’ transmission knowledge score among those who reported a past dengue 
infection compared to those who did not (23/33; 69.7% vs. 35/69; 50.7%; P=0.070), the 
difference was not statistically significant. Reporting a past dengue infection seemed 
not to influence any of the knowledge scores nor the recognition of typical/warning 
symptoms overall. However, individuals who had reported a past dengue infection felt 
that they or their children were more at risk of dengue (n=28; 85% vs. n=44; 65%; 
P=0.036) and used more preventive practices in their household (mean: 2.11 vs. 1.37; 
P=0.038).
3.3. Intended Health Seeking Behaviour Pathways in the Case of 
Fever or Dengue
In order to understand the steps people would take in their search for health care, 
interviewees were confronted with the open questions: ‘what would you do if you/your 
child had fever’; and ‘what would you do if you think that you/your child have/has dengue’. 
Measuring the temperature with a thermometer was one of the first actions taken by 15 
(23.8%) respondents in case of fever and 9 (14.3%) respondents in suspected dengue 
out of the 105 individuals interviewed. 
In the case of fever, most people chose to first treat fever at home (88/105; 83.8%) 
versus only 12 (11.4%) who mentioned that they would first seek medical help. In the 
case of dengue, the opposite was observed: most people would first visit a doctor 
(63/105; 60%), while nearly a third decided they would first treat dengue at home (31/105; 
29.5%). Less frequently proposed initial actions in the case of fever were ‘performing 
blood tests’ (usually referring to a full blood count or platelet count), ‘inform my/the 
mother’, ‘rest’, while 2 adults decided they would take no action with as reasons ‘I will 
recover myself’, ‘There is no need for visiting a doctor in case of fever’ and ‘I don’t like 
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doctors’. Other first intended actions mentioned with respect to dengue were ‘to perform 
blood tests’, ‘call a medical doctor’, ‘visit an alternative doctor (not further specified)’ 
and ‘other’ (inform mother, change the clothes of the child and use a mosquito net, call 
the dengue project staff, evaluate the disease). There were people who mentioned to 
do a blood test before going to the doctor. A 25 years old business woman and mother 
of a 9 years-old explained this, referring to her daughter: ‘‘When I go to the doctor, he 
will tell me to go to a laboratory to do blood tests. If I do a blood test before going to the 
doctor, this will save me the cost of one consultation.’’ This woman told us she would 
test for platelets when asked what she would do if she thought her daughter would have 
dengue.
The first three steps individuals anticipated to take in the circumstance of fever or 
dengue, stratified by behaviour in case of adults or children are presented as a flowchart 
in Figure 1. Only the pathways that begin with either ‘home treatment’ or ‘visit medical 
doctor’ are shown, as these included 92.4% of all pathways.  
For fever, the most frequently mentioned pathway was to first treat at home. Another, 
less frequently mentioned first action was visiting a doctor (n=12; 11.4%). People 
differed in their choices when asked about HSB intentions in the case of dengue (Figure 
1). Unlike fever, the majority (n=63; 60.0%) of individuals would directly visit a doctor, 
while a minority (n=27; 25.7%) would chose to first treat dengue at home. For dengue, 
differences were observed when comparing the intended first actions and pathways of 
children and adults. In case of dengue more adults than parents/guardians referring to 
children reported to first visit a doctor (66.7% vs. 52.9%; P=0.151), however children 
were taken earlier to the doctor than adults (mean number of days: 1.15 in children 
versus 1.43 in adults; P=0.074) (Figure 1). When analyzing the pathways to care, 
parents/guardians referring to children were found to report more frequently to first treat 
dengue at home and then visit a doctor compared to adults (35.3% vs. 16.7%; P=0.029). 
No differences were found when comparing the intended first actions and pathways 
between children and adults in case of fever. 
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Figure 1.- Pathways of health seeking behaviour of dengue and fever. X= mean day when visiting medical 
doctor; R= range of days when visiting doctor (min – max).
The most common second action in case of fever was visiting a doctor. Less common 
second actions were treating at home, do a blood test and other (call a doctor, ‘call my 
mother’). For most of the people (n=10) who intended to visit a doctor as their first action 
(n=12; 11.4%), this was also the last intended action. One of them would subsequently 
treat the fever, another one reported to intend to go to a laboratory for a blood test as a 
second action. 
When referring to dengue, ‘visiting a doctor’ was mostly chosen as second action. 
Treating at home, do a blood test and other (do what the doctor says, ‘call my mother’ or 
call the dengue project staff) were mentioned less frequently. If a doctor would be visited 
as a first action, most people did not intend perform another action afterwards, with 
the exemption of four people who mentioned to subsequently treat dengue at home, 
three to perform a blood test and two to do anther action. For both fever and dengue, 
no differences in choice of second actions were observed when comparing adults and 
children.
In order to determine whether the intention to first treat at home would make people 
choose to go later to a doctor, we compared the day of seeking medical care from those 
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who would first treat at home with those who would take a different action. Those who 
intended to first treat at home reported a significant delay in their intentions to seek 
medical help versus those who did not, in the case of fever (mean day=1.92 vs. mean 
day=1.50; P=0.027) but not in case of dengue (mean day=1.52 vs. mean day=1.33; 
P=0.150).
We explored the influence of socio-demographic and socio-economic characteristics 
on HSB pathways by comparing those who would first treat at home with those who 
would first visit a doctor both in case of dengue and fever. There were no statistically 
significant associations of the different behaviours with the age of the interviewed person, 
religion, education, occupation, crowding of the household, income of the household or 
socio-economic status. However, those who would first treat fever at home had a higher 
degree of education (P=0.053) and the households of those who would first go to a 
doctor in case of dengue had a higher income (P=0.073).
3.4.  Home Treatment 
Overall, 90 (85.7%) individuals stated they would treat fever at home while only 
38 (36.2%) would take this decision in the case of suspected dengue infection 
(P<0.001). Paracetamol was the most common chosen home treatment overall 
while taking a cold bath/shower and oral rehydration were the second most common 
types of home treatments in the case of fever and dengue respectively (Figure 2). 
Within the people who reported to treat fever at home at any time during their health 
seeking decision process, most would use paracetamol (n=86, 95.6%) to lower the 
temperature, followed by a cold bath/shower (n=31, 34.4%), oral rehydration (n=8; 
8.9%), body sponging with a wet compress or sponge (n=7; 7.8%) and other ways 
of home treatment (n=7; 7.8%) such as rubbing the body with alcohol/cream, aspirin, 
other medication or rest. Paracetamol was also the most common choice among those 
who would treat dengue at home (n=30; 78.9%), however, the use of oral rehydration 
(n=9; 23.7%) was cited more frequently than in the case of fever, opposite to the use 
of a cold bath/shower (n=7; 18.4%). Other (n=2; 5.3%) home treatments for dengue 
included body sponging or rest. Combinations of home treatment for fever and dengue 
are shown in Figure 2.
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Figure 2.- Home treatment choices for fever and dengue. The categories of treatment combinations in 
fever and dengue are equal. However, reporting to treat at home with a ‘paracetamol’ (P) and ‘other treatment’ 
(OT) varies within categories home treatment of fever and dengue. If home treatment ‘P’ and/or ‘OT’ can 
either be present or not, they are placed within brackets behind the corresponding category.
Treating fever at home with a cold bath/shower was reported more frequently when 
referred to children compared to adults both in the case of fever (n=12; 26.7% vs. n=19; 
42.2%; P=0.120) and dengue (n=6; 23.1% vs. n=1; 8.3%; P=0.276). The other choices 
for home treatment showed no difference between children and adults.
3.5.  Day When Seeking Medical Help
If people reported to seek medical help when they/their child would have fever or 
suspected dengue, they were then asked on which day after onset of first symptoms 
they would visit the doctor. Most parents/guardians of children and adults would look for 
medical help on day 2 after fever onset, but when dengue was suspected most people 
would go on day 1 to the doctor (Figure 3). Parents/guardians would take their children 
earlier to the doctor in case of dengue than in case of fever (mean: 1.30 days vs. 1.78 
days; P<0.001). Referred to adults the mean reported day was 1.47 in case of dengue 
and 1.96 in case of fever (P<0.001). Although children would visit the doctor earlier than 
adults, this difference was not significant in the case of fever (P=0.206) nor for dengue 
(P=0.162). 
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Figure 3.- Intended day when interviewees would seek medical help in case of fever and suspected 
dengue. Day when parents/carers of children (left figure) and adults (right figure) would visit the doctor in case 
of fever or suspected dengue.
3.6. Reason for Visiting a Doctor in Suspected Dengue
The most frequent reported reasons that prompted individuals to visit a doctor in 
suspected dengue were the appearance of new symptoms (n=81; 77.1%), the degree 
of the temperature (n=78; 74.3%) and the persistence of fever (n=35; 33.3%). Almost 
10% of the people stated ‘Dengue is a severe disease’ as a reason to seek medical 
help. The most frequent symptoms mentioned were headache (n=36; 34.3%), corporal 
pain (n=32; 30.5%) and weakness (n=27; 25.7%). Other typical dengue symptoms were 
mentioned less frequently: rash (n=18; 17.1%), vomiting (n=11; 10.5%), eye pain (n=9; 
8.6%) and muscle pain (n=1; 1.0%). Moreover, warning symptoms were not frequently 
indicated as reasons to seek medical help in suspected dengue: vomiting (n=11; 10.5%), 
bleeding (n=9; 8.6%), abdominal pain (n=6; 5.7%). The mean temperature referred by 
interviewees was 39.4°C (range: 38.0°C - 42.0°C) while persistence of fever ranged 
between 1-4 days with a mean of 2 days. There were no significant differences when 
comparing the reasons to seek medical care in suspected dengue between children 
and adults. However, those who reported a previous dengue infection compared to 
those who did not were more likely to mention the appearance of new symptoms as a 
reason to look for medical help (n=29; 87.9% vs. n=49; 71.0%; P=0.060), and reported 




3.7. Pathways of Health Centres’ Choices in the Case of Fever or 
Suspected Dengue
As described above and in Figure 1, nearly all individuals (n=104; 99%) would decide 
to obtain medical help at some point in time if they or their child(ren) presented fever or 
had a suspicion of dengue infection. Once this decision was mentioned, interviewees 
were asked where would they first seek medical attention and if they were not satisfied, 
to cite the next options in order of preference. The answers were summarized in a 
flowchart (Figure 4) showing only the health centres chosen of those who would first visit 
an ambulatorio or CDI as this reflect the choices for health centres for 88% of the total 
sample. The flowchart shows from left to right the first, and if applicable the second, third 
and fourth choice for health centres in case of fever and dengue. On the whole, 5 (4.8%) 
individuals would decide not to obtain medical care in case of fever, and one (1.0%) in 
case of dengue. They would instead treat the fever at home (n=3) or take no action (n=2). 
One individual with a ‘doctor phobia’ stated not to go to a doctor in case of dengue, but 
call his mother. As shown in Figure 4, both in case of fever (n=82; 78.8%) and dengue 
(n=84; 80.8%) the most frequent first choice of health centre was an ambulatorio. Other 
first choices of health centres in case of fever were a CDI (n=10; 9.6%) a private practice 
(n=4; 3.8%), an ambulatorio BA (n=2; 1.9%), and a private hospital (n=1; 1.0%). With 
respect to dengue other first choices were a CDI (n=9; 8.7%) hospital (n=4; 3.8%), a 
private hospital (n=3; 2.9%), an ambulatorio BAs (n=2; 1.9%) and a private consult (n=1; 
1.0%). Tertiary health centres (private hospital and hospital) were mainly mentioned later 
in the pathways.  
Individuals would go to tertiary level health centres (hospital or private hospital) more 
often in case of dengue (n=61; 58.7%) than fever (n=46; 44.2%; P=0.001). Also, a higher 
proportion of people (dengue: 40; 41.3% vs. fever: 29; 27.9%; P=0.001) reported to go at 
some point in time to a hospital in case of dengue.
There were no statistical significant differences observed comparing children 
with adults for their preferred health centres. However a hospital was mentioned less 
frequently when referred to children than to adults with respect to fever (18; 36,0% vs. 
11; 20.4%; P=0.076) and dengue (n=24; 48.0% vs. n=19; 35.2%; P=0.185). The opposite 
was observed with respect to private hospitals, showing more adults than children who 
would visit a private hospital in case of fever (n=12; 22.2% vs. n=6; 12.0%; P=0.169) 
and dengue (n=14; 25.9% vs. n=7; 14.0%; P=0.130), although the differences were not 
statistically significant. 
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Figure 4.- Flowchart of chosen Health Centres in case of have fever and suspected dengue. The 
flowchart shows from left to right the first, and if applicable the second, third and fourth choice for health 
centres in case of fever (left side of the figure) and dengue (right side of the figure). CDI= “Centros de 
Diagnóstico Integral”; Ambulatorio BA= Ambulatorio “Barrio Adentro”.
3.8.  Reasons for Choosing Between Health Centres 
To obtain a general overview of intention to attend health centres, we asked individuals 
at the end of the interview if they would visit any of the six health centres listed if they/
their children would have dengue. The great majority (98%) would visit an ambulatorio 
and a hospital (82%), while less people would visit a CDI (71%), a private consult (71%) 
an ambulatorio BA (67%) or a private hospitals (65%). All individuals were then asked 
to score the quality of the total dengue treatment of the selected health centres, with a 
range of one (very poor quality) to five (very good quality) in which a three was ‘average’ 
and an option to answer ‘don’t know’. The highest scores were given to private practices 
(mean = 4.5) and private hospitals (mean = 4.2). Hospitals were valued with a mean of 
3.8, ambulatorios and CDIs with a mean of 3.7, ambulatorio BAs with a mean of 3.5. 
Data on means of transport and travel time to the chosen health centres were 
obtained from the household questionnaire. Out of 88 individuals, most people reported 
to go walking to the health centres (n=70; 79.5%) as these are located in the vicinity of 
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their homes. Other means of transport were using a car (n=14; 15.9%), by bus (n=6; 
6.8%), by taxi (n=3; 3.4%) or by motorcycle (n=3; 3.4%). The mean reported transport 
time to the health centre was 8 minutes, ranging from a mean of 3.0 minutes when 
motorcycles where used to a mean of 8.5 minutes for those who would go walking to 
the nearest health centre. The mean expected costs for a return trip to the health centre 
were 0 VEB for walking and 3 VEB when a car or motor were used, while the costs of a 
bus (mean=26 VEB) or taxi (mean= 43 VEB) were expected to be higher.
While ambulatorios were the most frequently chosen health centres, many people 
did not think the quality of care in these health centres was better than other health care 
institutions (see section ‘Quality of care’). The main reason to give the quality of care of 
ambulatorios a lower mark was the absence of medicines/ infusions/ needles and other 
medical materials for treatment, which forced people to buy them in pharmacies. A 59 
years-old woman with a university degree stated the following: ‘‘The care given at the 
ambulatorio was good, but they (the medical/nursing staff) have no air conditioned, the 
door was left open, there was no alcohol, no syringes, no cotton. I had to buy everything 
myself.’’ Other disadvantages that were pointed out were the presence of many patients 
and long waiting times. Reasons for still going to an ambulatorio were logistic (‘it’s the 
nearest health centre’), behavioural reasons (‘I am used to go to an ambulatorio’) and 
reasons referring to quality (‘they treat well’, ‘the doctors are good’, ‘there are good 
connections with the hospital for fast referring in cases of emergencies’). 
In general, the CDIs and ambulatorio BAs were appreciated for a good treatment, 
being situated near, having present medical supplies needed for treatment, nice buildings 
and a nice atmosphere. Therefore they were frequently mentioned to be visited for 
‘small health problems’. A housewife of 27 years old told the following: ‘‘Barrio adentros 
(ambulatorio Bas) and CDIs provide a good care, in a nice atmosphere. You are treated 
fast. But I only go there for non-severe health problems. In case of dengue I would 
go to an ambulatorio. These doctors are the best.’’ CDI’s and ambulatorio BAs were 
not frequently the first chosen health centres to visit in case of dengue. The principal 
reason mentioned for this was referred to the doctors working at CDI’s and ambulatorio 
BAs: ‘there are bad doctors’, ‘I don’t trust the doctors/diagnosis’, ‘the doctors are not 
Venezuelan’. Others just told ‘I don’t like CDI’s and ambulatorio BAs’, without explaining 
this. Referring specifically to an ambulatorio BAs, people mentioned they would not 
search care for dengue in an ambulatorio BAs because there was no possibility for 
hospitalization. Some people would first visit an ambulatorio and subsequently a CDI 
or ambulatorio BAs, to receive a diagnosis from a doctor from the ambulatorio and after 
obtain the medical supplies needed from a CDI or ambulatorio BAs which were not 
present in the ambulatorio.
While many people reported they would visit a hospital in case of dengue, the quality 
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given to care in the hospital in case of dengue was not higher than the other health 
centres. Many interviewed persons mentioned similar advantages and disadvantages 
for dengue treatment when referring to hospitals as those mentioned for ambulatorios. 
While good treatment, the quality of doctors, the presence of specialists and the fast 
treatment of emergencies were appreciated, many people mentioned that the hospitals 
were too crowded, which prolonged the waiting times. Moreover, referring to hospitals 
many individuals pointed out the absence of supplies for medical treatment which 
obliged people to buy medical supplies themselves. 
Appreciated about private hospitals was the ‘excellent care’ and the presence of 
specialists and medical materials for treatment. The mean quality of care given to private 
hospitals and private practices was the highest. A frequent mentioned reason to expect 
a good dengue treatment in private hospitals and practices was the assumption that ‘if 
one has to pay for a treatment, then the care given is probably better’. However, less 
people reported to visit these health centres in case of dengue because many people 
could not afford the prices of this care. The ones who would go to private hospitals and 
clinics frequently mentioned to have an insurance. A father, living with his own child and 
a child which is not officially his told the following: ‘‘When my own child falls ill, I call a 
private doctor who will come to my house and see my child. My insurance will pay the 
costs. But when the other child falls ill, I go to the ambulatorio, because in this case my 
insurance will not pay the costs.’’ However, there were also individuals who mentioned 
they did not want to spend their insurance on dengue treatment in private hospitals and 
private consults, because ‘dengue treatment does not need a specialized centre’. Other 
reasons for visiting private practices were the ‘good doctors’. Those who would go to a 
private practice frequently mentioned to know one of these doctors personally.
4. Discussion 
In this study, we aimed to understand the health seeking behaviour and access to care 
of a population exposed to endemic dengue transmission. To this end, we conducted a 
cross-sectional household study within the third annual survey of a dengue community-
based cohort study in three neighbourhoods of Maracay city, Venezuela. We showed that 
intended pathways to care differed for suspected dengue infection compared to fever, as 
well as for children and adults in case of suspected dengue. The majority of the participants 
sought medical care at primary health centres as a first choice. Furthermore, participants 
appeared to have a medium to good knowledge on dengue and most felt at risk of dengue. 
In case of fever, the majority of the people would treat at home before paying a visit to a 
doctor. This intended pathway for fever agrees with the findings of studies in Colombia 
(30) and Cambodia (12), where the majority of dengue infections were first treated at 
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home, since a dengue infection is probable to present with fever as a main symptom. In 
case of suspected dengue, on the contrary, most individuals reported they intended to 
seek medical care as their first action. Moreover, a suspected dengue infection would 
make people seek medical care earlier than in the case of fever. The earlier seeking 
of medical help in case of dengue suggests that dengue is in general perceived as 
more severe than fever. This is in agreement with a study in Brazil where patients with 
dengue were found to seek medical care significantly sooner than patients with other 
febrile illnesses (31). Our findings also support that a dengue infection results in more 
medical care seeking behaviour compared to fever from other causes, as suggested 
in a previous study (19). Interestingly, when individuals were faced with a fictitious 
possibility of a dengue infection parents or guardians were more likely to report that they 
would treat their children at home before visiting a doctor compared to adults. Although 
adults reported more frequently to first visit a doctor, they chose to seek medical help 
later than parents/guardians of children. In contrast, a study in Brazil found that young 
people experienced a longer delay in care-seeking than adults, which was attributed to 
the difficulty in diagnosing dengue in young people (17). Overall, a high temperature of 
fever and the appearance of new symptoms were the main reasons that would make 
the participants visit a doctor in case of dengue. This is in line with previous studies, 
where perceived severity of the condition of a child sick with dengue was found to 
influence the selection of a therapeutic option (12, 30).
In the current study, it appeared that participants with a higher education treated fever 
more frequently at home, though the association was not significant. Practicing home 
treatments in case of dengue is described to be associated with a higher education 
in Thailand as well (32). Despite the fact that no significant associations were found 
between socio-economic markers and choices made in HSB in case of dengue or fever, 
caution must be taken when interpreting the results, since socio-economic status was 
significantly lower in the child sample. This difference in socio-demographic and socio-
economic characteristics between the adults and parents/guardians of children can be 
attributed to the fact that almost half of the children in Aragua State, Venezuela, are 
part of a household run by a single mother, who have generally a lower degree of 
education and a lower income (33). This could have influenced the intended HSB, since 
in previous studies socio-economic status was found to influence HSB (12, 18, 32). 
In the present study it was found that in the case of dengue, individuals intended 
to seek medical care earlier than in the case of fever. It is conceivable that a timely 
care-seeking may be achieved when people are able to self-diagnose dengue. In self-
diagnosis, recognition of symptoms plays an important role. Different degrees of dengue 
knowledge are described in previous studies (12, 21, 30, 34). In our study, participants 
showed medium to good knowledge about dengue, where for most people knowledge 
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on dengue transmission tended to be broader than knowledge related to the symptoms 
of the disease. Among the participants, fever and headache were the symptoms most 
frequently associated with dengue. Similar results with regard to symptom recognition 
were found in previous studies in Mexico and Laos (34, 35). The difference in knowledge 
on dengue transmission compared to dengue symptoms can be explained by the fact 
that dengue fever is a complicated disease with a great variation in expression of 
symptoms, while the transmission routes are relatively uncomplicated and thus easier to 
understand. Moreover, dengue campaigns in the Venezuelan media are mainly focusing 
on eradicating the vector of dengue. This emphasis on vector eradication in anti-dengue 
campaigns is also observed in a study in Malaysia (21). Nonetheless, in a survey in 
Caracas, Venezuela in 1993, knowledge on dengue transmission was found to be rather 
poor, with less than half of the people being aware of the origin of a dengue infection. 
In the light of our results, this suggests an improvement of the general knowledge of 
dengue in Venezuela (36). In our study, people mentioned multiple different sources 
of information about dengue, implying that dengue is a major problem for society in 
Venezuela. Moreover, we found that exposure to a higher number of information sources 
raised the individuals general knowledge on dengue.
Several studies describe home treatments used in dengue which vary according 
to country or region. These include herbs and over-the-counter medicines such as 
paracetamol (12, 34), and liquids such as water (34) carbonated isotonic sports drinks, 
fruit and vegetable juices and frog or crab soup (21). We found that fever was treated at 
home most frequently with paracetamol or a cold bath, while dengue was treated at home 
principally with paracetamol or oral rehydration. This is in line with our expectations, 
because in Venezuela, a cold bath is widely used to lower the temperature when having 
fever. The finding that rehydration is frequently mentioned as home treatment indicates 
that the participants were aware of how dengue is treated, since rehydration is an 
important part in dengue treatment. When seeking medical care, primary health centres 
were the first and second choice for the vast majority of the participants, regardless if it 
concerned suspected dengue or fever, and choices were the same for both children and 
adults. However, when comparing suspected dengue and fever, a higher proportion of 
people would attend a hospital or a private hospital in case of dengue. This might indicate 
that the participants perceive dengue as a disease that needs specialized treatment and 
therefore choose tertiary health centres above other health centres. Indeed, dengue 
was found to lead to more hospitalizations compared to fever from other causes in a 
previous study (18, 19). We found that almost all participants would attend a public 
health centre in case of dengue at some point in the course of the disease. In Asia it 
was found that many people would not attend official health centres in case of dengue 
(3). It is possible that cultural differences influence these choices. Another possibility is 
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that the difference is due to the hesitation the participants might experience in reporting 
intended visits to unofficial health centres. In our study, individuals reported a number 
of different health centre types they intend to attend in the case of a dengue infection, 
where the Ambulatorio was the most frequently mentioned. This is consistent with 
results from Malaysia, where primary health centres were the first choice of treatment-
pathways (22). Various reasons were identified for choosing a particular health centre, 
the main factors that influenced the choice were good experiences at health centres, 
proximity of health centres to the home, absence or presence of medical materials, 
absence or presence of confidence in the doctors, and whether or not people had to 
pay for the given care. In another study, confidence in the provided care and costs are 
also reported to influence the type of care that is chosen (12). Despite complaints about 
the quality of care, the vast majority of the respondents would first attend primary health 
care centres. This stresses the importance of adequate care at this level. The majority 
of the participants felt that they or their children were at risk of dengue. The presence 
of mosquitoes in the living environment was the main reason for individuals to feel they 
or their children were at risk. Similar results were found in Asia, where the absence of 
mosquitoes was associated with a decreased risk perception in individuals (21). People 
with a reported previous dengue infection felt more susceptible to dengue and were 
more likely to take preventive practices against mosquitoes. Measures of protection 
against mosquito bites were widely used among the participants, where repellents and 
insecticides were by far the most frequently mentioned as was also found in a study 
in Asia (34). Evidence of differences in health beliefs and practices in people with a 
previous dengue infection was also found in a focus group study in Puerto Rico, where 
participants with previous dengue infection were more concerned about susceptibility 
to dengue and supported the use of repellents to avoid mosquito bites more than their 
counterparts (23). 
For some comparisons, such as choice of health centre and influence of a previous 
dengue infection on HSB, the sample size of the current study was too small. However, 
a strength of the study was that data was collected from a well characterised cohort 
study population of which socio-economic and epidemiological data was available. 
Moreover, contrary to hospital-based studies, our study design made us able to include 
people who would avoid attending health centres, thus obtaining insight in their intended 
HSB too. Besides, people were interviewed in their own houses, providing a safe and 
confident environment. Quantitative and qualitative data were combined in the current 
study, which provides an in-depth insight in HSB, but is not done often. Lastly, the 
influence of a past dengue infection on HSB was assessed as well, which is not often 
done earlier. 
In this study, HSB and knowledge on dengue seems to be influenced by a reported 
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past dengue infection. It is important to investigate this potential influence, since doctors 
can intervene in this easily by providing dengue patients with adequate advice on 
how to act in a next dengue infection.  In the current study, we were able to describe 
intended HSB in case of dengue and fever. Comparing these results with the results 
of health centre based HSB studies, would make it possible to also reveal the barriers 
for achieving the intended HSB. Therefore, more community and health centre based 
studies should be performed to achieve a wider view and stronger conclusions on HSB 
in people exposed to dengue in the Americas. The difference in HSB between fever and 
dengue found in the current study implies that unless people know that they may have 
dengue, their HSB would follow the one described for fever.
5. Conclusion
The present study showed that intended pathways to care differ for suspected 
dengue infection compared to fever, as well as when comparing intended actions for 
adults and children in case of dengue. A suspected dengue infection would make people 
seek medical care earlier than in case of fever which implies that dengue is perceived 
as more severe than fever. High fever and the appearance of new symptoms were 
the main reasons that would make the participants visit a doctor in case of dengue. 
The differences in HSB between fever and dengue imply that unless people know 
that they might have dengue, their HSB would follow the one described for fever. The 
early intended medical care-seeking in case of suspected dengue suggests a possible 
improvement of HSB if a tool can be designed to diagnose dengue at home. Despite of 
complaints, the vast majority of the respondents would first attend primary health care 
centres. This stresses the importance of adequate care at this level. When comparing 
suspected dengue and fever, a higher proportion of people would attend a tertiary health 
centre in case of dengue. More community- and health centre based research on HSB 
in dengue is needed to provide a better understanding of HSB and identify barriers in 
HSB of those who have a dengue infection.
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Dengue has become the most important mosquito-borne viral disease and a major 
international public health concern1. Despite control measures, epidemics of increasing 
magnitude regularly occur in Venezuela against a background of an established 
endemic situation2,3. Concomitantly, the number of severe dengue cases has risen over 
time2. An early diagnosis and proper treatment of dengue cases can reduce the risk 
of development of severe disease4-6. Furthermore, in Venezuela, patients with dengue 
infection tend to seek medical help at a relatively late stage after fever onset7.
In this thesis, three neighbourhoods of high dengue incidence in Maracay, Venezuela 
were studied through a prospective community-based cohort study (Chapters 2, 4, 5 
and 7). Dengue seroprevalence was estimated in the study population and risk factors 
for dengue infection were identified (Chapter 4). Areas of high dengue transmission 
were recognized at block and household level through spatial analysis (Chapter 5). 
This information can be used by the health authorities in order to direct personnel effort 
and control measures in an effective way and, thus reduce dengue transmission. In 
addition, a health center-based observational cohort study was established in three 
primary health centers in the same study area (Chapter 3). The aim of this study was to 
identify clinical, haematological and biochemical parameters that discriminate dengue 
from other febrile illnesses (OFI) at the early stage of the disease (Chapter 6). We 
proposed a decision-tree algorithm that distinguishes dengue from OFI during the first 
3 days of the illness. This decision-tree algorithm may aid the physician in the early 
identification of dengue patients and thus reduce case mortality due to misdiagnosis and 
overburdening of health centres. Early diagnosis is also influenced by health-seeking 
behaviour (HSB) and access to care (Chapter 7). We studied the intended patterns of 
HSB at community level. We showed that intended pathways to seek care for suspected 
dengue differed from fever. 
Summary of the Design of the Two Different Cohort Studies
In order to achieve the aims of this thesis, two cohort studies were established in 
three neighbourhoods of high dengue incidence in Maracay, Venezuela. The studies 
were: a) a prospective community-based cohort study and b) an observational health 
center-based cohort study. The set-up of the prospective community-based cohort study 
is described and explained in detail in Chapter 2. We enrolled 2014 individuals aged 
5-30 years belonging to Caña de Azúcar, Candelaria and Cooperativa neighbourhoods 
through house-to house visits. Similar to other cohort studies8, individuals recruited 
into the study signed a written informed consent and agreed to attend the designated 
health center in case of any symptoms. However, we decided to recruit individuals aged 
5-30 years since this age group reported the highest dengue incidence in this area. 
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Summarizing Discussion
During the recruitment process, a baseline cross-sectional study was performed. Data 
were collected in two structured questionnaires. Socio-demographic, epidemiologic 
and clinical history data were collected in an individual questionnaire. On the other 
hand, socio-economic and environmental risk factors were collected in a household 
questionnaire. At the same time, the geolocation of the households was recorded with 
a hand-held Global Positioning System (GPS, Garmin, Ltd). Blood samples were drawn 
to perform a total blood count and to determine dengue seroprevalence. The data 
collected were analyzed and presented in Chapters 4 and 5. To accomplish this study, 
health-related personnel were trained in the standardised operation procedures of the 
baseline study, bioethics and good clinical practices of research. A detailed description 
of the training process is presented in Chapter 2. The strategies used to inform the 
communities about this study and seek cooperation are also described in this chapter. 
The prospective community-based cohort study was followed for four years. Annual 
surveys were performed. Structured questionnaires were applied for different purposes 
and blood samples were collected in order to estimate dengue incidence in each annual 
survey. To better estimate the annual dengue incidence a weekly active surveillance 
of febrile individuals was carried out. The steps to follow in case of finding a febrile 
participant have also been explained in detail in Chapter 2.
The set-up of the observational health center-based cohort study is described and 
explained in detail in Chapter 3. The primary HCs chosen for this study covered the 
population of the neighbourhoods mentioned above. In case of severe dengue, patients 
were transferred and hospitalized at the main tertiary Central Hospital of Maracay. 
Patients of all ages, presenting at the HC within a maximum of 4 days (96 h) of fever, 
with symptoms suggesting dengue infection according to WHO 2009 criteria5 or without 
any signs of a localised infection were invited to participate in the study. Patients that 
agreed to participate were asked to sign an informed consent form, in case of adults 
(≥ 18 years old) and children guardians and, an assent form in case of children from 
8 to 17 years old. Demographic, epidemiological, background clinical history, clinical 
findings, laboratory tests, complementary tests and treatment received data were 
collected in a follow-up questionnaire and were the basis for the analysis presented in 
Chapter 6. The patient was asked to return daily for monitoring and evaluation until 48 h 
afebrile and at 21-30 days after fever onset for a follow-up visit. The procedures that the 
study nurse and medical doctor needed to follow in case of a suspected dengue patient 
are presented in a flow-chart and described in Chapter 3. This chapter also includes 
a detail explanation of the different topics contained in the informed consent form. 
Study nurses were trained in the identification of febrile patients, dengue criteria, study 
criteria, explanation of the study to the participants, the follow-up questionnaire and its 
documentation, the correct performance of the tourniquet test and blood sampling. 
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The set-up of both studies described in Chapters 2 and 3 was approved by the 
regional health authorities and two bioethics committees. Results obtained in the context 
of the cohort studies during the course of the study are discussed in the sections below.
   
Risk Factors for Past and Recent Dengue Infection in 
Venezuela
Although previous studies have described certain risk factors for dengue 
transmission3,9,10, a detailed evaluation was necessary in order to identify possible control 
targets that can inform health authorities and ameliorate future dengue epidemics. A 
prospective community-based cohort study was set up in three neighbourhoods of high 
dengue incidence in Maracay, Venezuela (Chapter 2) to estimate dengue prevalence 
and identify risk factors for dengue transmission. The set-up of this study was performed 
in 2010 when the biggest dengue epidemic occurred. Amongst 2014 individuals recruited 
into the study, we found that 77.4% had anti-DENV antibodies (Chapter 4) while 10% were 
recently infected. A previous study performed in the same city during the 2001 epidemic 
found a lower prevalence (51%) in schoolchildren 5-13 years old11 compared to our study 
where 59% of children from the same age group were seropositive. This finding indicates 
an increase in transmission intensity over time. We found that poverty-related socio-
economic factors and factors/constraints related to intradomiciliary potential mosquito 
breeding sites were associated with a greater risk of acquiring a dengue infection.  We 
therefore propose that the combination of increasingly crowded living conditions, growing 
population density, precarious homes and water storage due to enduring problems in 
public services in Maracay, are the most likely factors that determine the permanent 
dengue transmission and the failure of vector control programs. Unplanned urbanization 
and population growth are some of the major determinants that have been associated 
with the spread and persistence of dengue in the last decades1,2,12. In Aragua state, the 
population density grew from 209.5 individuals/km2 in the year 2001 to 235.6 individuals/
km2 in 2011. Concomitantly, the proportion of “ranchos” or shacks had enlarged from 
8% to 9.6%13. Deficits in public services such as frequent and prolonged interruptions 
in water supply and electricity, and irregular and insufficient garbage collection are the 
consequence of the unplanned urbanization and population growth. These shortcomings 
have been associated to higher dengue incidence and severe cases in Maracay, including 
our study areas3. Although present for many years, these inadequacies have become 
more pronounced in recent years. Our results also suggest that the study population 
have been mainly infected by DENV at home. Therefore, dengue control measures and 
surveillance by health authorities should be directed to residential areas.
CHAPTER 8
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Spatial Analysis of Dengue Transmission
Control of dengue and of its mosquito vector has proven challenging in settings 
of uncontrolled urban growth and unreliable water supply. Despite control measures, 
transmission of dengue in Venezuela has become perennial with three large epidemics 
in the past decade14. Previous studies in Venezuela using reported epidemiological data 
show that the neighbourhoods chosen for the prospective community-based cohort 
study (Chapter 2) are more prone to maintain higher dengue transmission and for longer 
periods than other areas10. The ability to identify high-risk areas of dengue transmission 
can be used to target surveillance and control measures to those locations in a cost-
effective manner. Using mapping technology and spatial analysis of epidemiological and 
seroprevalence data we attempted to draw risk-maps at a fine scale to identify clusters 
(“hot spots”) of dengue transmission within the studied neighbourhoods (chapter 5). 
We found significant clusters of recent dengue infection, but not for past infection, at 
block and household levels. The homogeneous distribution of past dengue infection 
in the studied areas could be explained by the high proportion (77%) of participants 
infected by dengue virus in the past (Chapter 4). On the other hand, the presence 
of hot spots at block and household levels for recent dengue prevalence indicates a 
heterogeneous distribution in recent dengue transmission. This transmission occurred 
in a range of 50-80 m suggesting that dengue infection is highly focal. We speculate 
that the majority of mosquitoe breeding sites are localized inside and outside of the 
households belonging to these small spatial areas. Thereby, the female mosquito flies 
short distances for oviposition15,16. The majority of hot spots were found in the Caña de 
Azúcar neighbourhood. Furthermore, the only cluster that indicates the most probable 
grouping of cases (Kulldorff cluster) was found in this neighbourhood. This result is in 
concordance with the study presented in Chapter 4 where living in Caña de Azúcar was 
found to be a risk factor for dengue infection17.
A Decision-Tree Algorithm Differentiating Dengue from Other 
Febrile Illness 
At the beginning of the disease, the patient presents with non-specific symptoms 
that can be easily confused with other diseases18-21. To date, there are not accepted 
guidelines for the early recognition of dengue infection22. In Chapter 6, we aimed to 
identify clinical parameters and accessible haematological and biochemical tests that, 
at an early stage, could differentiate dengue from OFI. For this purpose, as indicated 
above, an observational health center-based cohort study was established in three 
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primary health centers (Chapter 3). We constructed a diagnostic algorithm using 
WBC counts, rash, mean corpuscular haemoglobin (MCH) levels and haemorrhagic 
manifestations in sequential order that distinguished dengue from OFI with a sensitivity 
of 88% and specificity of 63%. The majority of the published decision-tree algorithms 
have been designed to discriminate dengue from severe dengue7,23. Only one study that 
differentiates dengue from OFI at the early stage of the disease has been published. 
This study, conducted in Asia, uses mainly haematological parameters with different cut-
offs compared to our study24. Among our decision tree, a novel parameter is included, 
MCH (≤ 29 pg). A decrease of MCH values has been associated to iron deficiency in 
the body25. We speculate that the decrease of MCH values during the first 3 days of the 
illness is due to the increased levels of Interleukine-6 (IL-6) in dengue patients26. IL-6 
stimulates the production of the hormone hepcidin27, which in turn inhibits the release 
of iron into the plasma from macrophages and duodenum enterocytes28. We also 
present clinical and haematological parameters associated to dengue after day 3 of the 
disease. We found that body temperature <39°C, the presence of rash, haemorrhagic 
manifestations, platelet count (˂150 x 103 platelet/uL) and WBC count (˂4000 cells/uL) 
were positively and independently associated with dengue cases. Those parameters 
have been previously associated to dengue and severe dengue29-32. Finally, a lower 
cholesterol and a higher albumin were the two biochemical parameters independently 
associated with dengue infection during the first 3 days of the disease. Few studies have 
compared biochemical parameters between dengue and OFI patients. Inconsistent 
associations and/or patterns have been reported for albumin levels33-35. Although, none 
of these studies have compared cholesterol levels between patients with dengue and 
OFI, a decrease of cholesterol levels has been associated with severe dengue36.
Health-Seeking Behaviour in Case of Suspected Dengue 
Early diagnosis and adequate supportive care are of great importance in the 
management of dengue so as to avoid the development of severe disease. Thus, 
an early treatment intervention can reduce the case-fatality rate from 20% to 1% or 
less5,6. In Venezuela, patients with a suspected dengue infection tend to seek medical 
help beyond the third day after the onset of fever7. Delay in care-seeking is found to 
be significantly associated with severe dengue37. We aimed to understand intended 
patterns of health-seeking behaviour (HSB) in individuals living in areas with a high 
dengue incidence in order to improve early attendance to health centres. A subsample 
of 105 individuals belonging to the prospective community-based cohort study (Chapter 
2) was interviewed during the annual survey from September 2013 to February 2014. 
CHAPTER 8
181
Structured questionnaires were applied to these individuals in order to compare HSB 
intentions of adults and of parent/guardians with respect to their children in the case of 
fever and/or suspected dengue. In Chapter 7 we found that intended pathways to care 
differed for suspected dengue infection compared to fever, as well as for children and 
adults in case of suspected dengue. In case of fever, the majority of the people would 
treat at home before paying a visit to a doctor while, in case of suspected dengue, most 
individuals reported that they would seek medical care as their first action. We also found 
that parents/guardians would take children earlier to the health facility than adults would 
seek medical care. These findings suggests that dengue is in general perceived as more 
severe than fever in agreement with other studies38,39. We also suspect that dengue 
infections will mostly be first treated at home, since a dengue infection is likely to present 
with fever as a main symptom40,41. We found that the appearance of a new symptom 
or a perceived increase in severity of the condition were the main reasons that would 
make the participants visit a doctor. Primary health centres were the first choice to visit 
for nearly all participants. Although we found an improvement of the general knowledge 
of dengue in Venezuela42, this improvement was related to dengue transmission and not 
related to the symptoms of the disease. This can be partially explained by the fact that 
dengue fever is a complicated disease with a great variation in expression of symptoms 
as shown in Chapter 6. Moreover, dengue campaigns in the Venezuelan media mainly 
focus on eradicating the dengue vector. Recognition of dengue symptoms plays an 
important role in self-diagnosis and thereby health-seeking. A timely care-seeking may 
be achieved when people will be able to properly self-diagnose dengue or when a tool 
that diagnoses dengue at home will be designed.
Perspectives
In this thesis, we identified risk factors for dengue infection in three neighbourhoods 
in Maracay city, the capital of Aragua state, Venezuela, which is an area of high dengue 
incidence. We also identified geographic clusters of high dengue transmission at block 
and household level. Is the presence of hot spots of dengue transmission related to 
certain risk factors for dengue infection? In this regard, it will be interesting to explore 
the persistence of hot spots over time. If the clusters of high dengue transmission at 
block and/or household level persist over time, the resources for dengue surveillance 
and mosquito control can be efficiently used in the target areas and reduce dengue 
incidence in a more permanent way.
Despite a quite good knowledge on dengue in our study population in general, we 
observed the presence of mosquito breeding sites inside and outside of the participants’ 
households. This paradoxical behaviour might be better understood if a study concerning 
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the relationship between knowledge on dengue, risk perception and practices were 
performed. Understanding human behaviour in relation with mosquito breeding sites in 
an endemic area is essential to detect and eliminate weaknesses in mosquitoe control 
campaigns.
We propose a decision-tree algorithm that differentiates dengue from OFI at the 
early stage of the disease. This decision-tree has to be validated in a large and different 
population. In addition, the decision-tree could be improved by the integration with 
biochemical parameters. We found a novel parameter that discriminates dengue from 
OFI during the first 3 days of the illness in our study population. Are MCH levels ˂ 29 
pg also present in dengue patients from other countries of the Americas and Asia? 
Are these levels of MCH also an early indicator of severe dengue? These questions 
remain unclear. Currently, chikungunya virus has been spreading in the Caribbean and 
the Americas. Indeed, recently, autochthonous chikungunya cases have been reported 
in Venezuela by the health authorities. Signs and symptoms of chikungunya are very 
similar to those of dengue. A study that differentiates both diseases at the early stage of 
the illness will be very helpful for physicians and the general population.
In this thesis, we demonstrate that people intend to seek medical help early in 
case of dengue. The early attendance to primary HC depends on dengue signs and 
recognition of symptoms. Knowledge on dengue clinical presentation can be improved 
in the Venezuelan population. Alternatively, a tool or device that early diagnoses dengue 
at home could be designed. 
Dengue control is a challenge that requires major efforts on the part of both the 
public health system and the community. Although knowledge on dengue has improved 
over time, several important issues remain. 
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Resumen de la tesis
El dengue se ha convertido en la enfermedad más importante transmitida por 
mosquitos a nivel internacional. A pesar de varios años de una situación endémica y de 
las medidas de control tomadas, epidemias con mayor magnitud ocurren regularmente 
en Venezuela. Concomitantemente, el número de casos severos ha aumentado con el 
tiempo. Un diagnostico temprano y un tratamiento apropiado puede reducir el riesgo 
de desarrollar dengue severo. Sin embargo en Venezuela, los pacientes con sospecha 
de dengue tienden a buscar ayuda médica en una etapa relativamente tardía de la 
enfermedad una vez la fiebre haya aparecido. De aquí la importancia de determinar 
parámetros que puedan identificar en etapa temprana a un paciente con dengue a la 
par de entender el comportamiento de la búsqueda de salud de dichos pacientes.
En esta tesis, tres barrios con una alta incidencia de dengue en Maracay, 
Venezuela, fueron estudiados a través de un estudio de cohorte prospectivo basado 
en la comunidad (Capítulos 2, 3, 5, 7). Se estimó la seroprevalencia del dengue en 
la población bajo estudio y los factores de riesgo para la infección a dengue a nivel 
comunitario fueron identificados (Capítulo 4). Áreas de alta transmisión del dengue, o 
focos calientes, fueron reconocidas a nivel de manzanas y de casas a través de análisis 
espaciales (Capítulo 5). Esta información puede ser usada por las autoridades de la 
salud con el fin de enfocar las medidas de control de una forma más eficiente y así, 
reducir la transmisión del dengue de forma global. Por otro lado, un estudio de cohorte 
observacional basado en centros de salud fue establecido en tres centros de atención 
primaria en las mismas áreas de estudio (Capítulo 3). El objetivo de este estudio fue 
identificar parámetros clínicos, hematológicos y bioquímicos que diferencien el dengue 
de otras enfermedades febriles (OFI) en la fase temprana de la enfermedad (Capítulo 
6). Se propuso un algoritmo que distingue dengue de OFI durante los tres primeros días 
de la enfermedad. Este algoritmo puede ayudar al médico en la identificación temprana 
de pacientes con dengue y así reducir el índice de mortalidad debido a un diagnóstico 
errado o tardío y el sobrecargo de los centros de salud con pacientes febriles que no 
tienen dengue. El diagnóstico temprano también es influenciado por el comportamiento 
en la búsqueda de ayuda médica y el acceso a los centros de salud (Capítulo 7). Se 
estudiaron los posibles patrones de comportamiento en la intención de la búsqueda de 
ayuda médica a nivel de comunidad, demostrando que los patrones en la intención de 
la búsqueda de la salud en caso de sospecha a dengue difieren de aquellos en caso 
de fiebre.
En el Capítulo 2 se describió en forma detallada el establecimiento del estudio de 
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cohorte prospectivo basado en la comunidad. A través de visitas casa por casa, se 
reclutaron 2014 individuos pertenecientes a los barrios de Caña de Azúcar, Candelaria 
y Cooperativa. Dentro del proceso de reclutamiento, se realizó un estudio transversal 
de base donde se colectaron datos socio-demográficos, epidemiológicos y de historia 
clínica mediante un cuestionario individual, mientras que en un cuestionario de 
vivienda se registraron datos socio-económicos y de factores de riesgo ambientales. 
Concomitantemente, las viviendas fueron geolocalizadas con un sistema de 
posicionamiento global manual (GPS, Garmin, Ltd). A cada participante se le tomó 
una muestra de sangre para determinar la seroprevalencia del dengue y realizar una 
hematología completa. Los datos colectados fueron analizados y presentados en los 
Capítulos 4 y 5. Para llevar a cabo este estudio, el personal de la salud fue entrenado 
en los procedimientos estandarizados de operación del estudio de base, en bioética 
y buenas prácticas de estudios clínicos. Una descripción detallada del proceso de 
entrenamiento fue presentado en el Capítulo 2 de esta tesis. Las estrategias usadas 
para informar a la comunidad acerca del estudio y la búsqueda de cooperación también 
fue descrita en este capítulo. El estudio de cohorte prospectivo basado en la comunidad 
tuvo una duración de 4 años dentro de los cuales se realizaron estudios transversales 
anuales. Se aplicaron cuestionarios estructurados con propósitos diferentes y muestras 
de sangre fueron tomadas para estimar la incidencia anual del dengue en nuestra 
población bajo estudio. Para optimizar la estimación de la incidencia anual del dengue, 
se realizó semanalmente una vigilancia activa. 
En el Capítulo 3 de esta tesis, se describió de forma detallada el establecimiento 
del estudio observacional basado en centros de salud. Los centros de atención 
primaria escogidos para este estudio cubren a la población de los barrios mencionados 
anteriormente. En caso de dengue severo, los pacientes fueron transferidos al principal 
centro de salud terciario, el Hospital Central de Maracay. Pacientes de todas las edades 
que se presentaron a los centros de salud con un máximo de 4 días de fiebre (96 h), 
con síntomas sugestivos de dengue según los criterios de la organización mundial de 
la salud del 2009 y sin signos de infección localizada fueron invitados a participar en 
el estudio luego de firmar un consentimiento informado escrito. Datos demográficos, 
epidemiológicos, historia clínica, nuevos hallazgos clínicos, resultados de laboratorio, 
análisis complementarios y tratamiento recibido fueron colectados en un cuestionario 
de seguimiento del paciente y presentados en el Capítulo 6. Se le pidió al paciente 
asistir al centro de salud para su monitoreo y evaluación diaria hasta después de las 48 
h de estar afebril y entre los días 21-30 después del comienzo de la primera fiebre para 
una evaluación final. El procedimiento a seguir por parte de la enfermera del estudio 
y del médico del centro de salud en caso de un paciente con sospecha de dengue fue 
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explicado y presentado en un diagrama en el Capítulo 3. Este capitulo también incluye 
una explicación detallada de los diferentes tópicos contenidos en el consentimiento 
informado. Las enfermeras del estudio fueron entrenadas en la identificación de 
pacientes febriles, criterios de dengue, criterios del estudio, explicación del estudio a 
los pacientes, llenado del cuestionario de seguimiento, la correcta realización del test 
de torniquete y la toma y distribución de la muestra de sangre.
En el Capítulo 4, la seroprevalencia de dengue en la población bajo estudio fue 
determinada y los factores de riesgo para la transmisión del dengue fueron identificados. 
Se estableció que el 77.4% de los 2014 individuos reclutados habían sido previamente 
infectados por el virus del dengue, mientras que el 10% tuvo una infección reciente. 
Nuestro análisis indica que la combinación de factores socioeconómicos y aquellos 
relacionados con criaderos de mosquitos intradomiciliarios, como el hacinamiento, una 
mayor densidad poblacional, viviendas en condiciones precarias y el almacenamiento 
de agua debido a la persistencia de problemas en los servicios públicos en Maracay, son 
elementos que probablemente determinan la permanente trasmisión del dengue y los 
fracasos de los programas de control del vector. Aunque estas condiciones han estado 
vigentes por muchos años, su presencia se ha venido pronunciando en años recientes. 
Nuestros resultados también sugieren que las personas se  infectan principalmente en 
sus hogares. Por lo tanto, las medidas de control del dengue y la vigilancia por parte de 
las autoridades de salud pública deberían ser direccionadas a las áreas residenciales.
En el Capítulo 5, se usó una combinación de tecnología de mapeo y análisis espacial 
de datos epidemiológicos y de seroprevalencia para producir mapas de riesgo a fina 
escala e identificar zonas de alta transmisión del dengue (zonas calientes, clusters) 
dentro de los barrios estudiados. Se identificaron zonas calientes significativas a nivel 
de manzanas y de casas para infección reciente de dengue pero no para infecciones 
pasadas, probablemente por la alta proporción (77%) de participantes infectados en el 
pasado por el virus dengue. La presencia de zonas calientes a nivel de manzana y de 
casas indica una distribución heterogénea en la transmisión reciente del dengue. Esta 
transmisión ocurrió en un rango de 50-80 m sugiriendo que la infección por dengue es 
altamente focal. La mayoría de las zonas calientes fueron encontradas en Caña de 
Azúcar al igual que el único cluster que indica la agrupación más probable de casos 
(Kulldorff cluster). Estos resultados coincidieron con lo reportado en el Capítulo 4 en 
donde vivir en Caña de Azúcar era un factor de riesgo para la transmisión del dengue.
En el Capítulo 6 se identificaron parámetros clínicos, hematológicos y bioquímicos 
que pudieran diferenciar el dengue de OFI en una fase temprana de la enfermedad. Se 
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construyó un algoritmo (árbol diagnóstico) de decisión en donde los niveles de glóbulos 
blancos, la presencia de exantema, los niveles de la hemoglobina corpuscular media y la 
presencia de manifestaciones hemorrágicas (en este orden) distinguieron el dengue de 
OFI con una sensibilidad del 88% y una especificidad del 63%. En este capítulo también 
se presentaron parámetros clínicos y hematológicos asociados a dengue después 
del tercer día de la enfermedad. Encontramos que temperaturas corporales altas, la 
presencia de exantema y manifestaciones hemorrágicas, contaje plaquetario y niveles 
de glóbulos blancos bajos fueron positiva e independientemente asociados con los 
casos de dengue. Finalmente una disminución en los niveles de colesterol y un aumento 
en los niveles de albúmina fueron los parámetros bioquímicos independientemente 
asociados a dengue durante los tres primeros días de la enfermedad.
En el Capítulo 7 dilucidamos los patrones de intención de búsqueda de la salud en 
caso de fiebre y sospecha de dengue en individuos que viven en áreas con una alta 
incidencia de dengue. Con este conocimiento se podría mejorar la asistencia temprana 
a los centros de salud. El patrón de intención de búsqueda de la salud en caso de 
fiebre es diferente a aquél cuando se sospecha de dengue. Estos patrones también son 
diferentes entre niños y adultos. La mayoría de las personas se tratarían la fiebre en sus 
hogares antes de visitar al médico mientras que en el caso de sospecha de dengue la 
mayoría de los individuos reportaron que buscarían ayuda médica desde un principio. 
Los padres/representantes llevarían más tempranamente a los niños a consulta con el 
médico que los adultos. Los individuos acudirían a los centros de salud primarios como 
primera opción. Estos resultados sugieren que en general, el dengue es percibido 
como una enfermedad severa comparado con la fiebre. En general, la población tiene 
un buen conocimiento acerca del dengue. Sin embargo, este conocimiento está más 
relacionado hacia la trasmisión del dengue y su control y no hacia los síntomas de la 
enfermedad. 
Finalmente en el Capítulo 8 se presenta un resumen y discusión de los principales 
hallazgos reportados en esta tesis y las perspectivas para un control eficiente del 
dengue en Venezuela y reconocimiento temprano de la enfermedad. Todos los estudios 
de esta tesis están enmarcados en el proyecto que fue aprobado por las autoridades de 
la salud a nivel regional y por dos comités de bioética.




 Dengue (knokkelkoorts) is in de afgelopen decennia wereldwijd uitgegroeid tot de 
belangrijkste door muggen overgebrachte ziekte. In Venezuela, waar de ziekte endemisch 
is, treden ondanks intensieve  controlemaatregelen regelmatig en met toenemende 
frequentie epidemieën op. Tegelijkertijd neemt het aantal gevallen van ernstige ziekte 
ten gevolge van dengue toe. Een vroege diagnose en adequate behandeling kunnen 
het risico op de ontwikkeling van ernstige ziekte verminderen. Echter, in het algemeen 
zoekt de Venezolaanse bevolking pas medische hulp in een laat stadium van de ziekte. 
Om deze reden is het belangrijk om op basis van specifieke criteria  patiënten met een 
verhoogd risico op ernstige vormen van ziekte te identificeren en het gedrag van de 
Venezolaanse met betrekking tot zoeken van medische zorg in kaart te brengen.
In het onderzoek beschreven in dit proefschrift werden drie buurten in de Venezolaanse 
stad Maracay, met een hoge knokkelkoorts-incidentie, bestudeerd door middel van een 
longitudinale prospectieve “community-based” cohortstudie (Hoofdstukken 2, 3, 5, 7). 
De dengue-seroprevalentie werd vastgesteld en risicofactoren voor dengue-infectie 
werden geïdentificeerd (Hoofdstuk 4). Met behulp van ruimtelijke analysemethoden 
werden gebieden met een hoge dengue-transmissie (“hot spots”) geïdentificeerd 
op het niveau van huizenblokken en huishoudens (Hoofdstuk 5). Deze informatie 
kan door de gezondheidsautoriteiten worden gebruikt om op een efficiënte manier 
controlemaatregelen te nemen en, aldus, transmissie van dengue te verminderen.
 
Daarnaast werd een observationele “health-based” cohortstudie uitgevoerd in drie 
primaire gezondheidscentra gelegen in dezelfde studiegebieden (Hoofdstuk 3). Het 
doel van deze studie was om klinische en hematologische parameters te identificeren 
op basis waarvan een onderscheid gemaakt kan worden tussen knokkelkoorts en 
andere met koorts gepaard gaande aandoeningen (OFI›s – “other febrile illnesses”) in 
het beginstadium van de ziekte (Hoofdstuk 6). Wij hebben een beslisboom-algoritme 
opgesteld dat dengue onderscheidt van OFI tijdens de eerste drie dagen van de ziekte. 
Deze beslisboom helpt de dokter bij een vroege identificatie van denguepatiënten en 
kan zo een bijdrage leveren aan de vermindering van ziekte en sterfte ten gevolge van 
een foutieve  diagnose en draagt daarmee ook bij aan vermindering van overbelasting 
van gezondheidscentra. 
Een vroege diagnose wordt ook beïnvloed door het “health-seeking” gedrag van de 
bevolking en het gemak waarmee patiënten toegang hebben tot gezondheidscentra 
(Hoofdstuk 7). De patronen van “health-seeking” gedrag werden bestudeerd op 
buurtniveau. We vonden dat het patroon van “health-seeking” gedrag in het  geval van 




De opzet van de prospectieve «community-based» cohortstudie is gedetailleerd 
beschreven in Hoofdstuk 2. In totaal werden 2014 personen uit de wijken Caña de 
Azúcar, Cooperativa en Candelaria geïncludeerd middels huisbezoeken. Gedurende 
het recruteringsproces werd een «baseline» cross-sectionele studie uitgevoerd. In 
deze «baseline» studie werden gegevens verzameld met gebruikmaking van twee 
vragenlijsten. Socio-demografische, epidemiologische gegevens en data met betrekking 
tot de ziektegeschiedenis van betrokkenen werden  vastgelegd in een persoonlijke 
vragenlijst. Data met betrekking tot socio-economische en omgevingsfactoren tav het 
risico op een dengue-infectie werden vastgelegd in een vragenlijst per huishouden. 
Tegelijkertijd werd de localisatie van de huizen vastgelegd  met behulp van een draagbaar 
«Global Positioning System» (GPS, Garmin, Ltd). Van iedere deelnemer werd een 
bloedmonster afgenomen om de aanwezigheid van dengue-specifieke antilichamen 
en het bloedbeeld te bepalen. De verzamelde gegevens werden geanalyseerd en zijn 
gepresenteerd in Hoofdstukken 4 en 5. 
Om bovengenoemde studies te kunnen verrichten werd medisch personeel getraind 
in «Standard Operation Procedures» (SOP), bioethica en «good clinical procedures». 
Een gedetailleerde beschrijving van de training van medisch personeel wordt gegeven 
in Hoofdstuk 2  van het proefschrift. De strategieën gebruikt om de gemeenschap te 
informeren over de studie en om medewerking voor de studie te verkrijgen worden 
ook in dit hoofdstuk beschreven. De prospectieve «community-based» cohortstudie 
is gedurende vier jaar uitgevoerd. Cross-sectionele studies werden jaarlijks verricht. 
Om de incidentie van dengue te bepalen werden bij alle deelnemers aan de studie 
bloedmonsters afgenomen. Tevens werden gestructureerde vragenlijsten aan de 
deelnemers voorgelegd. Er werd een actieve wekelijkse surveillance verricht om 
een zo goed mogelijk beeld te verkrijgen van het beloop van dengue-incidentie in de 
studiepopulatie. Ook de procedure die werd gevolgd in het geval er een deelnemer met 
koorts werd aangetroffen wordt in Hoofdstuk 2 in detail  beschreven.
In Hoofdstuk 3 van het proefschrift wordt de opzet van de observationele 
cohortstudie gedetailleerd beschreven. De primaire gezondheidscentra geselecteerd 
voor deze studie dekten de populatie van de eerder beschreven wijken. In het geval van 
ernstige dengue werden de patiënten verwezen naar het centrale tertiaire ziekenhuis 
van Maracay. Patiënten uit alle leeftijdscategorieën, met niet meer dan 96 u koorts, 
met symptomen van dengue volgens de Wereldgezondheidsorganisatie (WHO, 
2009), en geen gelokaliseerde infectie, werden uitgenodigd om aan de studie deel te 
nemen. Patiënten die de uitnodiging accepteerden tekenden een «informed consent» 
formulier (in het geval van volwassenen en kindervoogden) en een instemming (in 
het geval van kinderen van 8-17 jaar oud). Demografische en epidemiologische data, 
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gegevens aangaande klinische geschiedenis en symptomen gedurende de ziekte, 
en laboratorium-  en behandelingsgegevens werden verzameld door middel van een 
vragenlijst en zijn weergegeven in Hoofdstuk 6. De patiënt werd gevraagd dagelijks het 
gezondheidscentrum te bezoeken voor monitoring en evaluatie tot 48u na afloop van 
de periode van koorts, en één dag gedurende de convalescentieperiode (21-30 dagen 
na het begin van de koorts) voor een laatste onderzoek. De procedures die werden 
gevolgd door de verpleegster en arts in het geval van een patiënt verdacht van dengue 
worden uitgelegd en in een diagram weergegeven in Hoofdstuk 3. Een gedetailleerde 
beschrijving van de verschillende zaken beschreven in het «informed consent» 
formulier is ook aan dit hoofdstuk bijgevoegd. De verpleegsters werden getraind in de 
identificatie van een mogelijke deelnemer, dengue- en studiecriteria, uitleg van de studie 
aan de patiënt, verzameling van gegevens, goede uitvoering van een tourniquettest, 
bloedafname en -verzending.
De seroprevalentie van dengue in de studiepopulatie en risicofactoren voor dengue-
infectie worden beschreven in Hoofdstuk 4. We hebben gevonden dat 77.4% van de 
2014 gerecruteerde deelnemers eerder, en 10% recent, met dengue geïnfecteerd 
was. We hebben geïdentificeerd dat een combinatie van «overcrowding», hoge 
bevolkingsdichtheid, precaire staat van huishoudens en wateropslag als gevolg van 
aanhoudende problemen in Maracay op het gebied van publieke  voorzieningen, 
risicofactoren waren die het meest prominent geassocieerd waren met transmissie 
van dengue. Hoewel deze condities al jarenlang bestaan, is hun aanwezigheid op 
dit moment meer uitgesproken. Onze resultaten suggereren ook dat de bestudeerde 
populatie meestal geïnfecteerd wordt binnen de huiselijke omgeving. Daarom 
zouden denguecontrolemaatregelen en -surveillance vooral gericht moeten zijn op 
woongebieden.
In Hoofdstuk 5 werd een combinatie van kaarttechnologie en ruimtelijke analyse 
van epidemiologische en seroprevalentie data gebruikt. Doel van de studie was 
om in de bestudeerde wijken nauwkeurig gebieden van hoge dengue-incidentie te 
identificeren  (“hot spots” of “clusters”). Voor recente, maar niet voor eerdere, dengue-
infecties werden inderdaad “hot spots” op het niveau van huizenblokken en individuele 
huizen geïdentificeerd. De aanwezigheid van dergelijke gebieden met een hoge dengue-
transmissie vormt een indicatie dat de verspreiding van recente dengue-infecties zeer 
heterogeen is. De transmissie lijkt plaats te vinden in kleine gebieden (50-80 m), wat een 
hoge mate van lokale transmissie van dengue suggereert.  De meeste “hot spots” en 
ook het “Kulldorf cluster” werden gevonden in de wijk Caña de Azúcar. Deze resultaten 
zijn in overeenstemming met de resultaten gerapporteerd in Hoofdstuk 4, waar bleek 
dat wonen in Caña de Azúcar een risicofactor voor dengue-infectie vormt.
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In Hoofdstuk 6 zijn betrouwbare klinische, hematologische en biochemische 
parameters geïdentificeerd op basis waarvan in een vroeg stadium dengue van andere 
met koorts gepaard gaande ziekten (OFI) kan worden onderscheiden. We hebben een 
diagnostische beslisboom opgesteld, waarmee op basis van (i) witte-bloedcelniveaus, 
(ii) gemiddelde corpusculair-hemoglobineniveaus, (iii) de aanwezigheid van uitslag 
en hemorragische manifestaties (in die volgorde) met een gevoeligheid van 88% en 
een specificiteit van 63% onderscheid gemaakt kon worden tussen dengue en OFI. 
Klinische en hematologische parameters geassocieerd met dengue na de derde dag 
van de ziekte worden ook gepresenteerd in Hoofdstuk 6. We hebben gevonden dat 
een lichaamstemperatuur lager dan 39°C, uitslag en hemorragische manifestaties, lage 
niveaus van bloedplaatjes en witte bloedcellen positief en onafhankelijk geassocieerd 
waren met dengue. Tenslotte bleken, als biochemische parameters, een afname in 
cholesterol- en een toename in albumineniveaus onafhankelijk met dengue geassocieerd 
te zijn gedurende de eerste drie dagen van de ziekte.
In Hoofdstuk 7 hebben we de patronen van «health seeking» gedrag in het geval van 
koorts en verdenking op dengue bij mensen woonachtig in gebieden met hoge dengue-
incidentie onderzocht. Met deze kennis is het mogelijk om het tijdig consulteren van een 
gezondheidscentrum te verbeteren. Het patroon van «health seeking» gedrag bij het 
optreden van koorts is verschillend van dat in het geval van een concrete verdenking 
van dengue. Deze patronen verschilden ook tussen kinderen en volwassenen. De 
meeste mensen zullen koorts eerst binnen de huiselijke omgeving behandelen terwijl, 
in het geval van een verdenking van dengue, men in het algemeen direct medische 
hulp zal zoeken. Ouders van geïnfecteerde kinderen en kindervoogden zoeken eerder 
medische hulp dan geïnfecteerde volwassenen. En, als men medische hulp zoekt, 
zijn het de primaire gezondheidscentra waar in eerste instantie wordt aangeklopt. In 
het algemeen suggereren deze resultaten dat dengue als een ernstiger ziekte wordt 
beschouwd dan koorts. De bevolking heeft een goede kennis van dengue. Deze kennis 
is beweegt zich echter meer op het gebied van transmissie van dengue en controle dan 
op het gebied van ziektesymptomen.
Tenslotte is in Hoofdstuk 8 een samenvattende discussie van de belangrijkste 
bevindingen van dit proefschrift en de vooruitzichten op een effectieve controle van 
dengue in Venezuela en vroege herkenning van de ziekte gepresenteerd. 
Alle studies gepresenteerd in dit proefschrift zijn goedgekeurd door de regionale 
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